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 Abstract 
                                                                                     
 
It is of crucial importance to identify and disseminate effective treatments for 
paediatric obsessive-compulsive disorder (OCD). OCD is time-consuming and 
distressing, and can substantially disable functioning at school, at home, and with 
peers (Piacentini, 2003). Children who do not receive treatment are at risk of 
psychological difficulties in adulthood, including continued OCD, clinical anxiety 
and depression, personality disorders, and social maladjustment (Wewetzer et al., 
2001). Two-thirds of adult cases of OCD develop in childhood, and adults with OCD 
have lower employment, poorer academic achievement, and lower marital rates 
compared to non-OCD adults (Hollander et al., 1996; Koran, 2000; Lensi et al., 
1996; Steketee, 1993). The distressing nature of OCD in childhood, accompanying 
psychosocial impairment and risk of future psychopathology, underscore the need to 
identify effective treatments. The primary aim of this thesis was to expand 
knowledge of evidence-based treatments for paediatric OCD. A mixed-methodology 
approach was employed to examine key issues in this area.   
The first study used meta-analytic methodology to determine the evidence 
supporting available treatments for paediatric OCD. An extensive literature search 
revealed over 100 published reports of treatments, encompassing a broad array of 
theoretical approaches and treatment strategies. Examples of treatments used for 
paediatric OCD included psychodynamic therapy, pharmacotherapy, cognitive-
behavioural therapy (CBT), hypnosis, family therapy, immunotherapy, and 
homeopathy. Study 1 comprised the first known meta-analysis of randomised, 
controlled treatment trials (RCTs) for paediatric OCD. Included studies were limited 
to RCTs as they are the most scientifically valid means for determining treatment 
efficacy and provide a more accurate estimate of treatment effect by removing error 
variance associated with confounding variables. The literature search identified 13 
RCTs containing 10 pharmacotherapy to control comparisons (N = 1016) and 5 CBT 
to control comparisons (N = 161). Random effects modelling yielded statistically 
significant pooled effect size (ES) estimates for pharmacotherapy (ES = 0.48, 95% 
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CI = 0.36 to 0.61, p < .00001) and CBT (ES = 1.45, 95% CI = 0.68 to 2.22, p =.002). 
The results support the efficacy of CBT and pharmacotherapy, and confirm these 
approaches as the only two evidence-based treatments for paediatric OCD. 
Implications and suggestions for future research are discussed.  
The effectiveness of CBT provided impetus to further examine this treatment. 
Group CBT is an understudied treatment modality among children with OCD. It was 
hypothesised that group CBT would possess efficacy because of the effectiveness of 
individual CBT for children with OCD, the demonstrated effectiveness of group 
CBT among adults with OCD, the practical and therapeutic advantages afforded by a 
group treatment approach, and the embeddedness of the approach in robust 
psychological theory. The aim of the second study was to evaluate the efficacy of 
group CBT. The study comprised the largest known conducted randomised, placebo-
controlled trial of group CBT for paediatric OCD. Twenty-two children and 
adolescents with a primary diagnosis of OCD were randomly assigned to a 12-week 
program of group CBT or a credible psychological placebo. Children were assessed 
at baseline, end of treatment, and at 1 month follow-up. Outcome measures included 
the Children’s Yale-Brown Obsessive-Compulsive Scale, global measures of OCD 
severity, Children’s Depression Inventory, and parent- and child-rated measures of 
psychosocial functioning. An intention-to-treat analysis revealed that children in the 
group CBT condition had statistically significantly lower levels of symptomatology 
at posttreatment and follow-up compared to children in the placebo condition. 
Analysis of clinical significance showed that 91% of children that received CBT 
were ‘recovered’ or ‘improved’ at follow-up, whereas 73% of children in the placebo 
condition were ‘unchanged’. Effect size analysis using Cohen’s d derived an effect 
of 1.14 and 1.20 at posttreatment and follow-up, respectively. These effects are 
comparable to results from studies of individual CBT. This study supported group 
CBT as an effective treatment modality for paediatric OCD and demonstrated that 
the effect extends beyond placebo and nonspecific treatment factors.  
In addition to treatment efficacy, the inherent worth of a treatment lies in its 
adoption by the relevant clinical population. Children with OCD are known to be 
secretive and embarrassed about symptoms, and there is often a long delay between 
onset of symptoms and treatment-seeking (Simonds & Elliot, 2001). An important 
observation during the course of conducting the RCT was that a high rate (39%) of 
eligible families declined participation. This led to the question, “What barriers 
 13
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prevent participation in group CBT for paediatric OCD?” Qualitative methodology 
was employed to address this research question. Eligible families that had declined 
participation in the RCT were contacted and invited to participate in semi-structured 
interviews that explored reasons for non-participation and positive and negative 
perceptions of group CBT. The average time between non-participation and 
interview was 1.33 years (SD = 3 months). Data were collected from nine families 
and thematic analysis methodology was utilised to identify emergent themes. Failure 
to participate was predicted by practical and attitudinal barriers. Practical barriers 
included a lack of time, distance, severity of OCD symptoms, financial, and child 
physical health. Attitudinal barriers included child embarrassment about OCD 
symptoms, child belief that therapy would be ineffective, fear of the social aspect of 
the group, lack of previous success with psychology, lack of trust in strangers, 
parental concern about the structure of the group, denial of a problem, and ‘not being 
ready for it’. Attitudinal barriers more frequently predicted treatment non-
participation. Positive and negative perceptions of this treatment modality were 
informative. Parents showed no differences in preference for individual or group 
CBT. An important finding was that 56% of the children had not received treatment 
since parental expression of interest in the group CBT program. Application of the 
findings to methods that promote service utilisation is discussed.
 Chapter 1 
 
Introduction 
                                                                                     
 
“What lies behind us and what lies before us are tiny matters compared to what lies within 
us”, Ralph W. Emerson. 
    
This research is about helping young people with obsessive-compulsive 
disorder (OCD) to manage their lives successfully, void of the constraints imposed 
by the monster that is OCD. OCD can be a chronic and debilitating condition that 
can rob an individual of friendships, security, time, self-understanding, and an 
existence that others take for granted. A driving force behind my foray into child 
clinical psychology stems from a personal philosophy that every child deserves the 
right to a happy, healthy childhood. During the course of this research I met many 
children with OCD at various levels of severity. I met a young male housebound 
with his symptoms, a six-year old girl with dermatitis on her hands and abnormal 
bleeding around her bottom from excessive washing and wiping, and a boy who 
performed mathematics calculations five times over even during school tests. I met 
children afraid to have sleepovers, children that feared death of loved ones by doing 
things out of a prescribed order, children that expended tremendous energy hiding 
rituals from peers, and children that felt alien to other children. This research is for 
these children, and the countless others, that live or have lived under the tyranny of 
OCD. Thousands of researchers and clinicians worldwide are banded together 
towards the common goal of improving the lives of these children, and there is much 
hope now for children affected by OCD. I am privileged to have been a part of the 
advancement of knowledge in this field. It is with this sentiment that I offer my 
humble contribution to the field of child clinical psychology – the research that is 
presented to you in this thesis. The primary aim of my research was to expand 
knowledge of evidence-based treatments for paediatric OCD. I hope that this 
knowledge will, in some way, lesson the burden experienced by these children. 
I will briefly outline the structure of my thesis. Chapter 1 commences with a 
broad overview of paediatric OCD including diagnostic criteria, clinical 
presentation, prevalence, course, comorbidity, assessment, and etiology. Chapter 2 
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 Chapter 1 
explores existing treatments for paediatric OCD, and summarises the results and 
methodology of key studies. Many different treatments, ranging from cognitive-
behavioural therapy (CBT) to hypnosis, medication to psychodynamic therapy, and 
homeopathy to transcranial magnetic therapy, are discussed. With such an array of 
treatments, clinicians need to know which treatments are effective in order to confer 
the most benefit to families. Chapter 3 addresses this issue, presenting the findings of 
a meta-analysis of RCTs of treatments for paediatric OCD (Study 1). The overall aim 
of this study was to enhance knowledge of evidence-based treatments for paediatric 
OCD. A secondary benefit of meta-analysis methodology is that comparative 
efficacy of treatments can be assessed because treatment effectiveness is quantified 
using a standardised methodology. Findings from this study inform the direction for 
the next part of the thesis. Chapter 4 identifies the understudied nature of group 
CBT. Practical and therapeutic benefits of this treatment modality are described, and 
a rationale for its proposed effectiveness within the paediatric OCD population is 
offered. The chapter concludes by recognising the lack of controlled trials that have 
been conducted on group CBT for paediatric OCD, and the gains in knowledge of 
the effectiveness of this treatment that could be achieved should more controlled 
trials be conducted. Chapter 5 introduces Study 2, which comprises a randomised, 
placebo-controlled trial of group CBT for paediatric OCD. The study involved 22 
children/adolescents randomly allocated to a 12-week program of group CBT or a 
credible placebo therapy control. Measures employed include the Children’s Yale-
Brown Obsessive-Compulsive Scale, global indices of OCD severity, Children’s 
Depression Inventory, and the parent version of the Child Obsessive Compulsive 
Scale. Posttreatment and brief follow-up results, effect sizes, and clinical 
significance analyses are presented. During the course of conducting Study 2, a high-
rate of non-participation in group CBT among families that expressed initial interest 
was observed. This resulted in the germination of Study 3 (presented in Chapter 6), 
which explores barriers to treatment access. Individuals with OCD frequently delay 
help-seeking and children may be secretive and embarrassed about symptoms. 
Families that met the screening criteria for the group CBT trial but declined 
participation were contacted and invited to participate in a study about the reasons 
for non-participation. The aim of this study was to determine the types of barriers, 
practical and attitudinal, that contributed to non-participation. Consenting parents 
participated in semi-structured interviews. Data were analysed using thematic 
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analysis methodology. Implications of the findings are discussed in the context of 
facilitating treatment accessibility and participation. The thesis concludes with a 
general discussion in Chapter 7.   
 17
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Chapter 1 
Paediatric Obsessive-Compulsive Disorder 
                                                                                     
 
 
In 1875 Legrand du Saulle referred to OCD as folie du doute, or the “disease 
of doubt”. Increasing awareness led to the recognition that children can suffer from 
the disorder. Janet’s publication in 1903 comprised the first report of a child with 
obsessive-compulsive symptoms. He presented the case of a 5-year-old boy, writing 
“No reassuring satisfies: the patient must be forever verifying his honesty, 
cleanliness, sanity, perceptions, and what he did last” (Mayo, 1948, p. 253). Freud’s 
famous case, “rat man”, experienced an onset of obsessions at six years of age. Mayo 
(1948, p. 253) commented “they are experts in an arduous rethinking of the 
obvious”. These reports and others encouraged awareness of the problem 
contemporarily referred to as paediatric OCD.  
Since Janet’s seminal publication, our understanding of paediatric OCD has 
significantly advanced. This chapter overviews OCD in children, including a review 
of the diagnosis, epidemiology, phenomenology, and course of the disorder. 
Relevant issues such as differential diagnosis, comorbidity, assessment, and etiology 
are discussed. Heretofore, the term “children” refers to individuals under the age of 
18 years, unless otherwise indicated and childhood OCD refers to individuals aged 
below18 years that meet formal diagnostic criteria for OCD.  
 
Diagnosis 
 
OCD is characterised by recurrent obsessions and/or compulsions that 
consume more than one hour a day and cause marked distress or functional 
impairment (American Psychiatric Association, 2000). The diagnostic criteria for 
childhood OCD are identical to adults with the exception that children do not have to 
 18
 Chapter 1 
display insight into their disorder. Younger children may lack the abstract thinking 
skills required to identify OCD-related behaviours as atypical and senseless.     
A primary characteristic of OCD is the experience of obsessions. Obsessions 
are persistent thoughts, impulses, or images that are anxiety provoking and perceived 
as difficult to control. Obsessions differ from worry, which is apprehensive 
expectation about a real-life event and is experienced ego-syntonic. Individuals with 
OCD recognise obsessions as originating from their own mind, and not from an 
external source, such as in psychotic illnesses. Individuals with OCD often attempt 
to ignore or suppress the unwanted thoughts, images, or impulses, or to neutralise 
them with some other thought or action. 
Compulsions are repetitive behaviours or cognitions that a person performs 
to reduce the anxiety associated with the occurrence of an obsession, or according to 
rules that must be applied rigidly. Although compulsions are designed to reduce the 
anxiety associated with a dreaded event they are not normally logically connected to 
the event, or are undoubtedly excessive. Approximately 90% of children with OCD 
report the experience of both obsessions and compulsions, though the presence of 
both symptoms is not required for a diagnosis (Foa et al., 1995). A diagnosis of OCD 
is ascribed if the symptoms cannot be better accounted for by a general medical 
condition or substance that has affected the central nervous system.  
 
Epidemiology 
 
An early study reported that 0.3% of children met criteria for “mixed 
obsessional/anxiety disorders”, and no cases had pure obsessive-compulsive 
symptoms (Rutter, Tizard, & Whitmore, 1970). Recent epidemiological evidence 
suggests that OCD is more common than once thought (Thomsen, 1998). Among 
adults, it is the fourth most common psychiatric disorder, ranking after phobias, 
substance abuse disorders, and major depressive disorder (Rasmussen & Eisen, 
1992). Factors thought to have influenced the upward revision in prevalence rate 
include increased clinician education, improved diagnostic methods, and increased 
knowledge of the disorder among referrers (doctors, teachers, etc). An outline of 
epidemiological studies of childhood OCD is presented below.  
Flament and colleagues (1988) screened 5,596 United States students aged 14 
to18 years for OCD symptomatology using the Leyton Obsessional Inventory – 
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Child Version (Berg, Whitaker, Davies, Flament, & Rapoport, 1988). Follow-up 
diagnostic interviews were administered to 356 students. Eighteen obtained a 
diagnosis of OCD. The weighted lifetime prevalence rate of the disorder was 1.9% 
and the weighted current prevalence rate was 1.0%.  
Zohar and colleagues (1992) examined OCD symptomatology in 562 male 
and female Israeli army inductees aged 16 to 17 years. Over 95% of the national 
cohort of youths this age was screened via induction centres. A diagnostic interview 
determined OCD status. The point prevalence rate for OCD was 3.6%. Apter and 
colleagues (1996) utilised a similar methodology and sampling frame. They 
examined the prevalence of OCD symptomatology among 861 male and female 16-
year old Israeli army inductees. Screening involved the use of a self-report 
questionnaire (the Hebrew version of the Schedule for Tourette’s Syndrome and 
Other Behavioral Syndromes; (Pauls & Zohar, 1991) and a structured diagnostic 
interview with a child and adolescent psychiatrist. Twenty cases of OCD were 
identified, representing a current prevalence of 2.3%. In a separate study, Zohar 
(1999) reported that the lifetime prevalence of OCD among a sample of 861 17-year 
old Israeli army inductees was 2.8%. 
Reinherz and colleagues (1993) examined OCD symptomatology among a 
sample of late adolescents in the United States. The mean age of the sample of 386 
participants was 17.9 years. Trained lay interviewers conducted diagnostic 
interviews. Eight adolescents met the criteria for OCD, suggesting a 2.1% lifetime 
prevalence.  
Lewinsohn and colleagues (1993) examined the prevalence of OCD in the 
United States in a sample of 1,710 high school students. Three cohorts of high 
school students aged 14 to 18 years were recruited in 1987, 1988, and 1989. 
Demographic characteristics of the sample were equivalent to 1980 census data. 
Each student received a diagnostic interview. The current prevalence of OCD was 
0.06% and the lifetime prevalence was 0.53%. A 14-month follow-up was conducted 
on 1,508 participants in the original sample. The current prevalence of OCD at time 
two was zero and the lifetime prevalence was 0.60%. No new cases of OCD were 
identified between time one and time two, indicating that the incidence of OCD was 
negligible. These findings differ from other studies, where higher prevalence and 
incidence rates have been reported. Results may have been biased by a high 
nonresponse rate of 48% among the first cohort. No efforts were made to recruit 
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adolescents that had dropped out of high school or been placed in psychiatric 
institutions. The interrater reliability of diagnoses for current and lifetime anxiety 
disorders was low (KS = .60 and .63, respectively), which may have comprised an 
additional source of bias. 
Valleni-Basile et al. (1994) reported a 12-month OCD point prevalence of 
2.9% among a sample of 3283 United States students. Students ranged in age from 
12 to 15 years. The study was originally designed to assess depressive 
symptomatology. Each student was administered the Center for Epidemiologic 
Studies Depression Scale (CES-D; Radloff, 1977). The CES-D is a screening 
questionnaire for depression. A subsample of these students was selected to undergo 
diagnostic evaluation. The subsample included children who had received elevated 
scores on the screening instrument, students who submitted questionnaires with 
missing data, as well as a random sample of children. The authors reported that cases 
with OCD symptomatology were likely to be identified during this stage as the CES-
D demonstrates proficiency in screening for alternative disorders (Garrison, Addy, 
Jackson, McKeown, & Waller, 1991). Trained psychiatric nurses administered 
diagnostic interviews to students and their mothers. Twenty-six children met the 
criteria for OCD. A follow-up study of this sample (Valleni-Basile et al., 1996) 
revealed that the weighted 1-year incidence of OCD was 0.7%. Subclinical OCD did 
not predict a diagnosis of OCD at follow-up.  
A community-based study conducted by Verhulst and colleagues (1997) 
examined the prevalence of psychiatric disorders in a Dutch sample of adolescents. 
In the first phase of the study, a representative sample of 853 13- to 18-year olds was 
screened using the parent, self-report, and teacher versions of the Child Behavior 
Checklist (Achenbach, 1991). Parent and child versions of the Diagnostic Interview 
Schedule for Children, version 2.3 (DISC; National Institute of Mental Health, 1992) 
were administered to a subsample of these children. The subsample comprised 200 
children that obtained a mean z score above the 75th percentile on the CBCL, and 
112 randomly selected children that obtained a z score below the 75th percentile on 
the CBCL. The six-month weighted prevalence of OCD in the Netherlands was 0.2% 
and 0.9%, according to the parent and child versions of the DISC, respectively. No 
significant gender differences were detected.  
In the largest study undertaken, Heyman and colleagues (2003) investigated 
OCD symptomatology among a sample of 10,438 children in the United Kingdom. 
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The sampling frame from which participants were drawn comprised an estimated 
90% of the population of five to fifteen year-olds in the United Kingdom. Parents of 
children aged 10 years and below and children aged over 11 years were administered 
a diagnostic interview. The interviews were conducted by trained lay interviewers. 
Twenty-five children received a diagnosis of OCD with both Diagnostic and 
Statistical Manual (American Psychiatric Association, 2000) and the Tenth Revision 
of the International Classification of Disease (ICD-10-DCR; World Health 
Organisation, 1993) criteria. This equated to a weighted current prevalence rate of 
0.25%. Significant age differences were detected, with older children more likely to 
meet diagnostic criteria than younger children. No significant gender differences 
were found. The prevalence rate reported in this study is lower than that reported in 
previous studies. This may be due to the use of the ICD-10-DCR, which 
underdiagnoses cases of OCD by more than 50% relative to the DSM-IV criteria 
(Steinberger & Schuch, 2002). The main limitation of ICD-10-DCR OCD criteria is 
that diagnostic stability is highly dependent upon age, and older children are more 
likely to meet diagnostic criteria than younger children. This bias is evident in the 
above, and may have attenuated the prevalence rate.  
Guerrero and colleagues (2003) reported a current prevalence rate of 12% in 
a sample of 619 Hawaiian adolescents. Ages ranged from 13 to 19 years, with a 
mean age of 15.8 (SD = 1.23) years. The DISC (National Institute of Mental Health, 
1992) was administered to each participant by a lay, trained interviewer. Seventy-
four cases of OCD were identified. Environmental and genetic risk factors were 
provided as explanations for the elevated prevalence rate. Hawaiian individuals have 
a greater risk of developing a group A β–hemolytic streptococcal infection. The 
auto-immune response associated with this infection has been linked to the 
development of obsessive-compulsive symptomatology, thus accounting for the 
higher prevalence rate (Garvey, Giedd, & Swedo, 1998; Swedo, 1994). 
These results suggest that the current prevalence rate of OCD in children is 
between approximately 0.25% and 2.3%, with the exception of Hawaiian children. 
The lifetime prevalence of childhood OCD is approximately 2.8%, and the 1-year 
incidence of OCD in children is approximately 0.7%. The variability in the 
prevalence rates can be attributed to the heterogeneity of the measures employed. 
Cross-cultural differences in the prevalence of OCD are uncommon, yet have been 
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reported (Guerrero et al., 2003). Research has yet to determine whether there are 
cross-cultural differences in the incidence of OCD.  
 
Phenomenology 
 
Many different types of obsessions and compulsions encompass the clinical 
presentation of OCD. The most common symptoms are outlined in this section.  
 
Obsessions 
 
Types of Obsessions 
Contamination. Many children with OCD experience obsessions related to 
the theme of contamination. Contamination obsessions typically concern germs, dirt, 
or excrements. They may be highly specific to vague and poorly defined (American 
Academy of Child and Adolescent Psychiatry, 1998). For instance, one child with 
contamination obsessions might experience intrusive thoughts about a particular 
cleaning fluid or disease (e.g., meningococcal disease), whereas another child may 
experience obsessions about “sticky” or “dirty” objects.     
Children with contamination obsessions may believe that contact with a 
contaminated object will cause them to feel ill, catch a disease, or even die. March, 
Franklin, and Foa (2003) reported the case of a 10-year-old boy who had primary 
obsessions involving contact with bodily fluids, such as saliva or faeces. He believed 
that contact with these stimuli would trigger illness. Consequently, he avoided 
contact with objects that had been touched by others and became distressed when he 
was near items associated with public bathrooms or sick people.  
Children with contamination obsessions may worry that they will 
contaminate others and cause them to feel ill. Harris and Weibe (1992) presented a 
case illustration of a 15-year-old boy who experienced repetitive, intrusive thoughts 
that he had caught a disease (e.g., AIDS, cancer) and that contact with other people 
would facilitate transmission of the disease.  
Aggressive. Aggressive obsessions involve a fear that harm will come to 
oneself or others. Children with aggressive obsessions may worry that they will do 
something to hurt themselves or other people. Typical obsessions include a fear that 
they will act upon unwanted impulses, such as stabbing the self, a close friend or 
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stealing items, fearing that they will uncontrollably express obscenities or insults, or 
fearing that they will commit an embarrassing act. Children with OCD may 
experience violent images. Shafran and Somers (1998) described a 14-year-old boy 
with intrusive thoughts that he would poison himself or someone he loved. The boy 
also believed that he might accidentally steal items that he touched.  
Symmetry. Intrusive urges regarding the need for symmetry and order 
comprise another common type of obsession. Children with symmetry obsessions 
may experience the overwhelming urge to align objects in a particular way. They 
may demonstrate an abnormal preoccupation with the neatness of their personal 
appearance or aspects of their environment. Owens and Piacentini (1998) described 
an 8-year-old boy with symmetry obsessions regarding tactile sensations. Specific 
sensations, such as someone touching him on the shoulder, would trigger thoughts 
that the sensations had to be “evened out”. 
Hoarding/saving. Some children experience hoarding or saving obsessions in 
which they feel driven to collect objects of useless or limited value. They may 
demonstrate difficulty discarding the items that they have collected. Leonard, 
Swedo, and Rapoport (1991) discussed a 6-year-old boy that experienced the urge to 
collect items he walked past. These included sticks, rocks, and paper. He retained 
useless household items, such as used toothpaste tubes and newspapers, and found it 
extremely difficult to resist these urges.  
Magical. Children with OCD may have obsessions that contain magical or 
superstitious content. They may experience intrusive thoughts relating to lucky or 
unlucky numbers, colours or words. Children with magical obsessions may feel 
compelled to count in their mind, or to count objects, such as windows or tiles, until 
they have reached a number with special significance. 
Scrupulosity. Scrupulosity or religious obsessions can take several forms. 
Children with these obsessions may present with an excessive concern or fear of 
offending religious figures. They may have an extreme preoccupation with morality 
and right or wrong. Leonard, Swedo, and Rapoport (1991) described a 17-year-old 
boy that ruminated excessively about past deeds. He spent prolonged amounts of 
time retrospectively examining his activities to determine if he had engaged in sinful 
behaviours. Children with religious obsessions may have a preoccupation with being 
truthful. They may avoid answering questions with a direct “yes” or “no” statement, 
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in case their answers reveal a lie. Responses may be punctuated with “maybe”, 
“don’t know” or “possibly”.  
Sexual. Some children with OCD have obsessions involving sexual content. 
The image or urge that comprises the obsession is experienced as unwanted and 
anxiety provoking. The thoughts may involve forbidden or perverse images or 
impulses, and can sometimes contain themes of homosexuality. Obsessions may 
involve committing an aggressive sexual act on another person. Sexual obsessions 
may be extremely difficult for a child to articulate due to shame and embarrassment, 
although they are more commonly seen in adults with OCD rather than children.  
 
Prevalence of Obsessions 
Several studies have identified the prevalence of different types of obsessions 
in childhood OCD samples. Some obsessions are experienced more frequently than 
others. In an Australian clinical sample comprising 77 children with a primary 
diagnosis of OCD the most common obsessions were contamination obsessions 
(75%) and aggressive obsessions (62%) (Barrett, Healy-Farrell, & March, 2004). 
Primary obsessions reported in a United States clinical sample of 70 adolescents 
included contamination obsessions (40%), aggressive obsessions (24%), scrupulosity 
(13%) and forbidden thoughts (4%) (Swedo, Rapoport, Leonard, Lenane, & 
Cheslow, 1989). Children in a United States clinical sample most commonly 
experienced contamination obsessions (73%), aggressive obsessions (53%), and 
symmetry obsessions (33%) (Last & Strauss, 1989). Hanna (1995) found that the 
most common obsessions reported in a United States clinical sample were 
contamination obsessions (87%), aggressive obsessions (81%), symmetry obsessions 
(64%), hoarding/saving obsessions (36%), magical obsessions (26%), sexual 
obsessions (26%), religious obsessions (23%), and somatic obsessions (10%). These 
studies suggest that contamination obsessions are the most common obsessions 
reported by children with OCD, followed by aggressive obsessions. No cross-
cultural differences are apparent.   
 
Compulsions 
 
Compulsions are performed to alleviate the anxiety associated with the 
experience of an obsession. In rare cases a child may present with compulsions only, 
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though it is unclear whether the reason is because obsessions are not present or the 
child is not able to identify or articulate the obsessional content. In these instances, 
the compulsions are enacted according to specific “rules” that the child has 
developed. Compulsions can be either overt or covert. Overt compulsions are actions 
that are potentially observable by another person. Covert compulsions involve 
mental activity such as counting or rehearsing sentences in one’s mind.  
 
Types of Compulsions  
Washing. Some children with OCD exhibit washing compulsions. These 
compulsions usually occur in response to contamination obsessions. A child may 
have an obsession related to germs or contamination and feel compelled to eliminate 
the threat by washing parts of his/her body. They may engage in lengthy, elaborate, 
washing rituals multiple times a day. The presence of negative affect and the 
frequency and intensity of the washing behaviour differentiates compulsions from 
normal washing. Observational markers of compulsive washing include excoriation 
(particularly on the hands) and excessive use of cleaning agents such as soaps and 
detergents.      
Checking. Checking compulsions generally occur in response to aggressive 
obsessions. The source of the checking may vary greatly from child to child. Some 
children check excessively that the door is locked, whereas other children may check 
the kitchen stove. Common items or objects that children with checking compulsions 
examine include windows, toys, light switches, water faucets, electrical outlets, and 
appliances. Some children with OCD recheck tasks or activities to make sure that 
they have not made a mistake, and others retrace parts of their route to ensure that 
they have not hurt anyone (Thomsen, 1998). Kearney and Silverman (1990) 
described a 14-year-old male with a severe case of OCD. He repeatedly checked 
windows in his house to ensure that no bats were present. Checking compulsions 
occurred on a near-continual basis, thousands of times a day. A 13-year old girl 
experienced an intrusive urge to place the child she was baby-sitting in a microwave 
oven (Wagner, 2003). This obsession triggered a checking compulsion, whereby she 
relieved her anxiety by checking the microwave and/or baby’s crib repeatedly to 
ensure that she had not acted on her urge. A 14-year-old boy with OCD had 
obsessions that he would poison someone. To relieve his anxiety he checked food to 
make sure that he had not put poison in it (Shafran & Somers, 1998). 
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Arranging. Arranging or ordering compulsions usually occur in response to 
symmetry obsessions. Children with arranging compulsions engage in elaborate 
ordering routines. They may manipulate aspects of their environment in a highly 
stereotyped and rigid manner. The arranging compulsion is discontinued when the 
individual achieves a subjective feeling that things are “just right”. Some children 
with arranging compulsions may need to ensure that objects or body actions are 
“even”. In the case example reported by Owens and Piacentini (1998), an 8-year old 
boy experienced intrusive urges to even out his or others’ tactile sensations. When 
his mother touched a table with one forearm he became extremely agitated and 
yelled at her to touch the table with her other forearm. He attempted to physically 
force her to place her opposite forearm on the table when she did not comply with 
his demand. An 11-year-old girl spent three hours a day straightening items in each 
drawer and closet in her bedroom (Leonard, Swedo, & Rapoport, 1991). The 
compulsions increased in frequency and severity until she refused to go into her 
room, and had to sleep on the floor outside her bedroom. Family members were 
prevented from accessing her room in case they disturbed the order of her items. 
Arranging compulsions can be precipitated by aggressive obsessions. Children may 
arrange objects until they are “just right” in order to avert harm befalling a loved one 
(Evans, Milanak, Medeiros, & Ross, 2002). 
Repeating. Repeating compulsions can be triggered by aggressive obsessions. 
Children may repeat certain phrases, words, or activities. They may walk in and out 
of doorways, repeatedly put on shoes, or re-write sections of homework until the 
action or outcome feels “just right”. Some of these behaviours may be mistaken for 
boredom by an observer. Leonard et al. (1991) reported the case of a 17-year old boy 
that repeatedly retraced his steps from his family’s car into the house. When he was 
interrupted or prevented from performing his compulsion he got extremely upset and 
agitated. He spent 20 minutes traversing a distance that took his family members 
seconds. This kind of behaviour is often associated with the term “obsessional 
slowness”, whereby individuals with OCD may have trouble completing tasks in a 
timely fashion due to their preoccupation with their compulsion. Last and Strauss 
(1989) described a girl and a boy with repeating compulsions. The girl repeatedly 
produced extensive lists of the names of friends and family members, and the boy 
repeated particular actions, such as taking the milk in and out of the refrigerator two 
consecutive times.  
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Counting. Counting compulsions may be triggered by magical or aggressive 
obsessions. Children with OCD sometimes feel compelled to count certain objects in 
a setting (e.g., tiles), words in a written sentence, or syllables during oral 
communication. Some children may have to count to a “safe” number to prevent a 
dreaded event from occurring, such as a fatal car accident. Counting compulsions 
often interfere with task completion. 
Touching. Some children perform touching compulsions, whereby they 
repeatedly touch items until they feel that they have touched them “just the right 
way”. It may take hours until this subjective feeling occurs. Items that children with 
touching compulsions may be concerned with include walls, doors, furniture, and 
personal possessions. Leonard and colleagues (1991) described a 13-year-old girl 
who compulsively touched the corners of chairs, refrigerators, walls, and doors to 
such an extent that she developed calluses on her hands. She would only discontinue 
her ritual if she felt that items had been touched “the right way”. She engaged in the 
performance of these compulsions two hours per day. Another girl touched the left 
and right sides of doorways she passed through in order to ‘prevent harm’ from 
coming to her family (Grayson, 2003). 
Hoarding. A hoarding compulsion is generally precipitated by an obsession, 
such as concern that the item would be needed if discarded. The individual feels an 
irresistible urge to retain a particular item, despite its apparent limited economic or 
personal value. Individuals with hoarding compulsions may display great difficulty 
parting with the items that they have collected. Objects that individuals with 
hoarding compulsions collect are not used for hobbies and are not retained for 
sentimental worth. They are items that most would consider ‘junk’ or rubbish. 
Examples include newspapers, rocks, food wrappers, and magazines. In the example 
provided by Leonard and colleagues (1991) a 6-year-old boy compulsively collected 
objects such as sticks, stones and newspapers, despite having no particular use for 
them. His room became so full of rubbish that his parents were concerned it had 
become a health hazard. The boy refused to part with the objects he had collected 
and had to be physically restrained when his parents entered his room to clean it up.   
Reassurance-seeking. Reassurance-seeking compulsions can be triggered by 
an array of obsessions, including aggressive, contamination, and scrupulosity. 
Reassurance-seeking is a compulsion that often involves other people. Parents or 
teachers may be asked the same question repeatedly to alleviate the anxiety 
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associated with an obsession. A 6-year-old boy experienced intrusive obsessions 
regarding blood and “bugs” (Wagner, 2003). These obsessions were particularly 
problematic during mealtimes. He alleviated his anxiety by repeatedly asking his 
family for reassurance that his food did not contain these items.  
 
Prevalence of Compulsions 
The most common compulsions reported in an Australian clinical sample of 
77 children were washing (57%) and reassurance seeking (57%) (Barrett, Healy-
Farrell, & March, 2004). In a clinical sample of 31 children from the United States 
the most common compulsions were washing (84%), checking (64%), repeating 
(64%), arranging (61%), touching (58%), counting (42%), and hoarding (42%) 
(Hanna, 1995). No gender differences in the frequency of obsessive-compulsive 
symptoms were apparent. March, Mulle, and Herbel (1994) reported that washing 
(53%) and checking (60%) were the most common compulsions in a United States 
clinical sample of 15 children. In another United States clinical sample the most 
common compulsions were washing (64%), checking (27%), counting (14%), 
touching (11%), and ordering (11%) (Allsopp & Verduyn, 1990). Among a 
community sample of 3,283 adolescents 26 were identified as meeting diagnostic 
criteria for OCD (Valleni-Basile et al., 1994). The most common compulsions were 
arranging (56%), counting (41%), collecting (38%), washing (17%) and checking 
(12%). Similar results have been obtained in other studies (Last & Strauss, 1989; 
Swedo et al. 1989). 
These results suggest that the most common compulsive symptoms 
experienced by children with OCD are washing and checking. These results parallel 
those obtained in adult studies (Rasmussen & Tsuang, 1986). No differences in 
compulsive phenomenology are apparent across cultures or gender.   
 
Pattern of Symptom Presentation 
 
Children with OCD usually present with multiple obsessions and 
compulsions. Barrett and colleagues (2004) reported that the majority of children in 
an Australian clinical sample presented with two or more obsessions and three or 
more compulsions. Hanna (1995) reported that the mean number of current and 
lifetime obsessions in a United States clinical sample was 3.5 (SD = 2.4) and 4.0 (SD 
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= 1.6; range 1 to 8), respectively. The mean number of current and lifetime 
compulsions was 4.1 (SD = 2.0, range 1 to 9) and 4.8 (SD = 1.7, range 2 to 9), 
respectively. In 90% of cases, the presenting symptom constellation changes over 
time, with no clear progression in the pattern of symptoms (Hanna, 1995; Rettew, 
Swedo, Leonard, Lenane, & Rapoport, 1992). 
 
Disability and Functional Impairment in OCD 
 
The World Health Organisation has ranked OCD as the tenth leading cause of 
disability in the world (Murray & Lopez, 1996). Childhood OCD is accompanied by 
significant impairments in academic, social, and family functioning. Piacentini, 
Bergman, Keller, and McCracken (2003) attributed the broad range of impairment to 
the heterogeneous nature of OCD symptoms. Counting or superstitious compulsions 
may interfere with a child’s ability to read, listen, or communicate, by impairing 
concentration and attention. Contamination rituals may prevent children from 
visiting places outside the family home, for fear of catching a disease from an 
unfamiliar bathroom or alien eating utensils. Contamination obsessions and 
compulsions may preclude the possibility of sleepovers at friends’ houses or family 
visits to restaurants. Repeating, checking, or just-right compulsions may contribute 
to school lateness and parent-child conflict.      
Clinical observations have provided the main source of evidence that OCD is 
associated with significant functional impairment. Allsopp and Verduyn (1990) 
conducted a review of the case notes of 44 consecutive child OCD patients referred 
to an adolescent mental health clinic in the United Kingdom. OCD was associated 
with intermittent or non-attendance at school in 36% of cases. School was noted as a 
precipitating factor for the development of OCD symptomatology in 9% of cases, 
suggesting that school difficulties were secondary to OCD. Particular problems 
noted included difficulty concentrating, social withdrawal, and lengthy rituals that 
precluded timely attendance. OCD was associated with impaired social functioning. 
Seventy-five percent of the children had no close friendships, with boys more likely 
to have fewer social contacts than girls.  
Toro, Cervera, Osejo, and Salamero (1992) conducted a study using a similar 
design. They reviewed the case notes of 72 children with a DSM-III (American 
Psychiatric Association, 1980) diagnosis of OCD. Results were compared with a 
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comparison group of 72 clinical cases that did not meet the criteria for OCD. 
Primary diagnoses in the comparison condition included elimination disorder, 
anxiety disorder, affective disorder, and schizophrenia, as examples. Children with 
OCD demonstrated a higher rate of social withdrawal (65%) compared to children in 
the comparison condition (25%). Approximately 60% of children with OCD 
experienced a decline in academic performance following the onset of OCD. They 
also experienced considerable parent-child conflict (36%), although this rate did not 
differ significantly from the comparison condition (27%).  
Piacentini, Bergman, Keller, and McCracken (2003) used a survey design to 
investigate the frequency with which OCD symptoms caused interference to aspects 
of a child’s life. Advantages of this study included the use of structured diagnostic 
interviews and psychometrically sound outcome measures. OCD-related functional 
impairment was assessed across school, social, and home domains. Participants 
comprised 151 children with a primary diagnosis of OCD and their parents. The 
mean age of the children was 11.8 years. Convergence between parent and child 
reports was examined. Children most commonly reported experiencing significant 
interference due to OCD in the following areas: concentrating on schoolwork (37%), 
doing homework (32%), doing household chores (30%), being with a group of 
strangers (28%), and getting ready for bed at night (28%). Parents most commonly 
reported significant problems due to OCD in the following areas: concentrating on 
schoolwork (48%), doing homework (47%), getting ready for bed at night (42%), 
bathing/grooming in the morning (36%), and getting along with parents (36%). 
Parents and children reported a greater frequency of OCD-related home and school 
problems, compared to OCD-related social problems. Parents were more likely to 
report significant problems in all three domains. Most children (88% according to 
parent report, 85% according to child report) demonstrated a significant problem in 
at least one of the three domains of functioning, providing further evidence for the 
negative impact of OCD upon a child’s life. The results are consistent with the 
results of an earlier study by Piacentini and colleagues (1999).  
Sukhodolsky and colleagues (2005) found that children with OCD were more 
impaired in areas of adaptive functioning and emotional adjustment than children in 
an unaffected comparison group. Social functioning was indexed by number of 
friends, time spent with friends, interactions with others, and play. School 
competence was measured in terms of parental report of child grades, school 
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problems, and participation in special education classes. Daily living skills sampled 
personal habits, behaviour in the community, and domestic task performance. They 
had impairments in all three domains, higher levels of internalising symptomatology, 
and a lower number of activities (e.g., hobbies, club and sport participation). These 
studies suggest that childhood OCD is associated with significant disability and 
burden for the child, and can interfere with academic, social, and family functioning.  
 
Course 
 
Age at Onset 
 
The mean age at onset of childhood OCD in United States clinical samples is 
between 7 and 11 years of age (Geller, Beiderman, Griffin, Jones, & Lefkowitz, 
1996; Hanna, 1995; Last & Strauss, 1989; Piacentini, Bergman, Jacobs, McCracken, 
& Kretchman, 2002; Scahill, Riddle, McSwiggin-Hardin et al., 1997; Swedo, 
Rapoport et al., 1989; Thienemann, Martin, Gregger, Thompsen, & Dyer-Friedman, 
2001). A study conducted in Denmark reported congruent findings (Thomsen & 
Mikkelson, 1995). The mean age at onset of childhood OCD in this sample was 10.6 
years, providing some support for the generalisability of findings from the United 
States. In an epidemiological United States sample the age at onset ranged from 7 to 
18 years, with a mean age at onset of 12.8 years (Flament et al., 1988). No 
epidemiological studies have examined the age at onset of childhood OCD in an 
Australian sample.  
A number of studies have suggested that boys have an earlier age of onset 
than girls (Flament et al., 1985; Hanna, 1995; Last & Strauss, 1989). Boys tend to 
have a prepubertal onset while girls are more likely to have a pubertal onset. A study 
by Scahill and colleagues (Scahill, Riddle, McSwiggin-Hardin et al., 1997) failed to 
support these findings. They reported that the average age at onset of OCD for boys 
and girls was 9.3 years and 8.9 years, respectively. This discrepancy in age of onset 
between genders may be spurious. Small sample sizes and ascertainment bias may 
have attenuated the reliability of the data. Although the above studies have 
researched age of onset, results should be interpreted cautiously due to design 
limitations. All of the studies relied on retrospective reports, which lack reliability.  
 
 32
 Chapter 1 
Gender Differences 
 
Some researchers have argued that OCD in children is more common in boys 
than girls (Hollingsworth, Tanguay, Grossman, & Pabst, 1980; Rapoport, 1989; 
Swedo, Rapoport et al., 1989). This claim has been challenged by alternative 
research (Flament et al., 1988; Riddle, Scahill et al., 1990), where it has been 
suggested that the overrepresentation of males may be due to an earlier age of onset 
(Flament et al., 1985; Last & Strauss, 1989) or to greater severity of the disorder in 
males during childhood (Flament et al., 1988). Some researchers believe that OCD 
may be more common in males than females prior to adolescence, and that the 
gender ratio becomes equivalent in adolescence (Rapoport, 1989; Valleni-Basile et 
al., 1994). In adults, the gender ratio is approximately equal (Weissman et al., 1994). 
 
Prognosis 
 
A meta-analysis examining the long-term morbidity of children diagnosed 
with OCD indicated that OCD is a chronic and persistent illness (Stewart et al., 
2004). Follow-up periods of the 18 studies reviewed ranged from 1 to 15.6 years. 
Pooled mean persistence rates for full OCD and full or subthreshold OCD were 40% 
and 61%, respectively. Predictors of long-term morbidity included an earlier age of 
onset, inpatient versus outpatient status, and increased OCD duration. A limitation of 
the study was that the impact of treatment upon OCD status at follow-up was not 
examined or statistically controlled for. The authors reported that participants in 15 
of the studies received treatment, participants in one study received no treatment, and 
information on treatment receipt was not reported in two studies. The rates of 
untreated OCD persistence may be significantly higher. 
Wewetzer and colleagues (2001) examined psychiatric morbidity among a 
sample of adults who had an onset of OCD in childhood. Participants had presented 
to a treatment clinic a decade earlier. The mean age at onset of OCD was 12.5 years 
and the mean follow-up time was 11.2 years. At follow-up, 36% of participants met 
criteria for OCD. Of these, 70% met criteria for an additional clinical disorder. The 
most frequent comorbid disorders were obsessive-compulsive personality disorder 
(40%), social phobia (35%), avoidant personality disorder (35%) major depressive 
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disorder (25%), and paranoid personality disorder (25%). OCD appears to be a 
persistent condition without treatment.  
 
Differential Diagnosis  
 
Differential diagnosis is useful for distinguishing childhood OCD from other 
disorders. This section describes the differential diagnosis of childhood OCD in 
relation to normal childhood development and other psychiatric conditions. 
Many children engage in ritualistic behaviours as part of a normal course of 
development. Young children may have elaborate bedtime rituals, a desire for 
sameness in their environment, rigid likes and dislikes, concerns about symmetry, or 
a need to have things done “just so”. Leonard and colleagues (1990) noted that OCD 
symptoms could be reliably differentiated from benign childhood routines on the 
basis of timing, content, and severity. Whereas OCD symptoms usually have a mean 
age of onset of 7 to 12 years, normative childhood rituals usually begin at age two 
and disappear by age eight (Evans et al., 1997; Gesell, Ames, & Ilg, 1974; Thomsen, 
1998). They occur most frequently between two and four years of age (Evans et al.). 
Normal childhood rituals are generally experienced as pleasurable and assist in the 
facilitation of the child’s mastery over his/her environment. Conversely, OCD 
symptoms are accompanied by significant distress and dysfunction (March & 
Leonard, 1998). 
In an anxiety disorder due to a medical condition the obsessions and 
compulsions are judged to be the product of a general medical condition. This 
judgment is based upon a review of the concordance between the course and onset of 
the medical condition and OCD, and any atypical features associated with the 
presentation of the condition (e.g., an unusual age of onset). A substance-induced 
anxiety disorder is distinguished from OCD in that obsessions and compulsions are 
attributed to the physiological effects of a drug of abuse, a medication, or exposure 
to a toxin. OCD onset has been reported to occur with carbon monoxide poisoning, 
Sydenham’s chorea, tumors, and postviral encephalitis (American Academy of Child 
and Adolescent Psychiatry, 1998). 
Generalised anxiety disorder (GAD) and OCD require differential diagnosis 
as both involve an anxiety response that is excessive, disproportionate to a real-life 
threat, and perceived as difficult to control. Important differences distinguish the two 
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disorders. GAD-related anxiety tends to be more reality-based, such as worry about 
hurting a friend’s feelings or failing a subject (Albano, March, & Piacentini, 1999). 
The content of obsessions does not usually consist of real-life problems, and is often 
identified by the individual as excessive and inappropriate. Individuals with GAD do 
not tend to perceive their worry as intrusive, and do not feel the need to resist their 
worries or to perform compulsions to relieve their anxiety. Individuals with GAD are 
more likely to be able to identify internal or external triggers for their worry than 
individuals with OCD (Turner, Beidel, & Stanley, 1992). 
Recurrent, intrusive thoughts and activities may be observed in the context of 
many psychological disorders, particularly those involving deficits in impulse 
control. Some individuals experience intrusive, recurrent thoughts regarding a defect 
in their appearance, and will repeatedly check their appearance in the mirror. This 
type of symptom can be better accounted for by body dysmorphic disorder. Other 
individuals experience the repeated urge to pull out their hair, and may be diagnosed 
with trichotillomania. Some children have intrusive thoughts and worries regarding 
specific objects or social situations, which can indicate specific phobia and social 
phobia, respectively. OCD shares similarities with eating disorders, as both involve 
excessive worry and preoccupation with certain stimuli. In eating disorders, the 
content of the thoughts is not neutralised with a compulsion, and other unique 
diagnostic features are present.  
Many children with OCD experience obsessions related to contamination or 
illness. These types of thoughts are present in hypochondriasis and sometimes 
specific phobia. Children with hypochondriasis misinterpret benign physical cues as 
indicating that they have a serious medical illness. A diagnosis of OCD should only 
be made if the child experiences additional obsessions and compulsions that are 
unrelated to illness. Some children may be plagued by recurrent fears that they will 
be exposed to a disease. In this case a diagnosis of specific phobia of illness should 
be considered.  
OCD should be distinguished from major depressive disorder. Major 
depressive disorder shares similarities with OCD in that both can involve excessive 
rumination about unpleasant current or future events. However, depressive thoughts 
are not experienced by the individual as inappropriate or ego-dystonic, and tend to be 
accompanied by dysphoric affect rather than anxious affect.  
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OCD shares similarities with schizophrenia. Both conditions involve 
repetitive behaviours that are socially and culturally inappropriate, and perceived as 
strange by other people. OCD differs from schizophrenia in that children with OCD 
usually realise that their behaviours are not normal. OCD behaviours are functional 
in that they are designed to alleviate anxiety, whereas schizophrenic behaviours are 
not intended to serve a purpose. OCD and schizophrenia share the feature of 
intrusive, irrational thoughts. Children with OCD are more likely to recognise that 
the thoughts originate from their own mind, rather than from an external source as in 
thought insertion.  
OCD symptoms may appear similar in presentation to symptoms of a tic 
disorder. Tic disorders involve repeated vocal or motor tics. Tics are sudden, rapid, 
stereotyped movements or vocalisations. Compulsions in OCD are distinguishable 
from tics as compulsions are performed to relieve anxiety, whereas tics are not. 
Compulsions are aimed at neutralising an obsession, whereas a tic is not preceded by 
the experience of a distressing thought.  
 
Comorbidity 
 
OCD is highly comorbid, with most studies suggesting that approximately 
80% of children meet diagnostic criteria for at least one other psychiatric disorder 
and nearly 50% have multiple diagnoses (Swedo et al., 1992; Zohar, 1999). The 
most common comorbid conditions will be outlined in this section.  
Anxiety disorders frequently co-occur with OCD in child and adult samples. 
In an Australian study using a clinical sample of children with OCD the prevalence 
rate for GAD was 60% (Barrett et al., 2004). Results of an epidemiological study 
suggested that 30% of children that met diagnostic criteria for OCD also met 
diagnostic criteria for social phobia (Swedo, Rapoport et al., 1989). In clinical 
samples, the rate of comorbidity for social phobia is slightly lower, ranging between 
14% and 20% (Barrett et al., 2004; Last & Strauss, 1989; Thienemann et al., 2001; 
Waters, Barrett, & March, 2001). Specific phobia was diagnosed in 17% of cases of 
children with OCD in a community sample (Swedo, Rapoport et al., 1989). This is 
consistent with the rates found in clinical studies, which have ranged between 6% 
and 43% (Barrett et al., 2004; Hanna, 1995; Last & Strauss, 1989; Thienemann et al., 
2001; Waters et al., 2001). The prevalence of separation anxiety disorder among 
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children with OCD in community samples ranges between 7% and 34% (Swedo, 
Rapoport et al., 1989; Valleni-Basile et al., 1994; Waters et al., 2001). In clinical 
samples the comorbidity rate is between approximately 6% and 29% (Barrett et al. 
2004; Benazon, Ager, & Rosenberg, 2002; Hanna, 1995; Last & Strauss, 1989; 
Waters et al. 2001).  
Mood disorders are common in children with OCD. Approximately 26% to 
45% of children with OCD in community samples meet diagnostic criteria for major 
depressive disorder (Swedo et al. 1989; Valleni-Basile et al. 1994). In a clinical 
sample, approximately 73% of children met criteria for a comorbid mood disorder 
(Gellar et al. 1996).  
Childhood OCD is frequently comorbid with tic disorders. Geller and 
colleagues (2001) found that Tourette’s disorder was present in 25% of children and 
9% of adolescents. Other studies using clinical samples of individuals aged 18 or 
younger have reported that the rate of co-occurrence is between 6% and 13% 
(Hanna, 1995; Thienemann et al., 2001). Children with comorbid OCD and 
Tourette’s disorder are more likely to have an earlier age of onset of OCD symptoms 
than children with OCD only (Leonard, Swedo, Rettew, Gershon, & Rapoport, 
1992). Hanna (1995) found that 13% of a clinical sample of children with OCD had 
comorbid transient tic disorder. 
Comorbidity of childhood OCD and attention-deficit hyperactivity disorder 
(ADHD) is also common. Between 16% and 33% of children with OCD in clinical 
samples meet diagnostic criteria for ADHD (Gellar et al. 1996; Hanna, 1995). The 
rate of comorbidity reported in a community-based study was 10% (Swedo, 
Rapoport et al., 1989). Geller and colleagues (2002) conducted a study to determine 
whether ADHD symptomatology in children with OCD represented a by-product of 
OCD symptoms (e.g., intrusive, obsessional thoughts, anxiety) or a distinct comorbid 
disorder. They concluded that ADHD symptomatology reflects a true comorbid state 
and is not merely induced as a result of OCD symptoms.  
Oppositional defiant disorder is prevalent among children with OCD. In a 
community-based study the rate of co-occurrence was 11%, while clinical studies 
report a rate of between 16% and 43% (Hanna, 1995; Swedo, Rapoport et al., 1989). 
Geller and colleagues (2001) examined the relationship between age and 
onset and comorbidity. An earlier age of onset predicted increased risk for simple 
phobia, Tourette’s disorder, ADHD, agoraphobia, and multiple anxiety disorders. 
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Age of onset did not predict the onset of mood or psychotic disorders, although these 
disorders were associated with chronological age.  
These results suggest that children with OCD are likely to have a comorbid 
disorder. An earlier age of onset of OCD is a significant risk factor for the 
development of additional disorders. The most common comorbid disorders are 
generalised anxiety disorder, specific phobia, major depressive disorder, and 
separation anxiety disorder.  
 
Assessment 
 
Many different assessment strategies have been utilised to assess OCD 
symptomatology in children. These assessment strategies serve numerous functions. 
Some instruments assist diagnosis and others assist treatment planning and 
evaluation. A summary of commonly used, psychometrically sound assessment 
strategies for childhood OCD appears next.  
 
Diagnostic Assessment 
 
Diagnosing OCD in children is crucial to the development of an appropriate 
treatment plan. Other disorders may accompany or resemble OCD, hence, 
differential diagnosis is required to determine the nature of the disorder and which 
disorder causes the most disruption and distress. Many semi-structured interviews 
have been developed to serve this purpose.  
One of the most commonly used semi-structured interview methods is the 
Anxiety Disorders Interview Schedule for DSM-IV: Child and parent versions 
(ADIS-C/P; Silverman & Albano, 1996). The ADIS-C/P are separate, semistructured 
interviews that assist in the differential diagnosis of anxiety, affective, and 
externalising disorders as defined by the DSM-IV. Additional items that screen for 
learning disorders, somatoform disorders, psychosis, substance abuse, and eating 
disorders, are present. Each diagnosis obtained by the child is ascribed a Clinician’s 
Severity Rating, which ranges from 0 to 8. Higher scores indicate greater levels of 
distress and disruption. This rating is useful for establishing a principal diagnosis and 
any additional diagnoses. The interviews can be used with children aged 6 to 18 
years. The child and parent versions of the ADIS have good interrater reliability, 
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test-retest reliability, and concurrent validity (Silverman, Saavedra, & Pina, 2001; 
Wood, Piacentini, Bergman, McCracken, & Barrios, 2002).  
The Schedule for Affective Disorders and Schizophrenia for School-Age 
Children: Present and Lifetime version (Kaufman et al., 1997) interview is a 
semistructured diagnostic interview for children aged 7 to 17 years. It can generate 
32 DSM-III-R and DSM-IV Axis I diagnoses, spanning multiple diagnostic 
categories. It assesses current and lifetime symptomatology. The administration time 
for the parent and child interviews in clinical settings is approximately 1.25 hours 
each. It has good reliability and validity (Kaufman et al.).  
The Diagnostic Interview for Children and Adolescents Version IV (Reich, 
2000) is a semi-structured interview used to diagnose a range of disorders in children 
aged 6 to 17. It contains a parent and child version. The interview provides an 
assessment of current and lifetime DSM-IV and ICD-10 diagnoses. The 
administration time ranges between one and two hours. Lay, highly trained 
interviewers can administer the interview, although only appropriately qualified 
professionals should assign clinical diagnoses. In addition to enquiring about 
psychiatric morbidity, this interview also contains a perinatal section, a psychosocial 
module, and questions on risk and protective factors. Earlier versions of the 
instrument demonstrate reliability and validity. Data are beginning to emerge that 
support the reliability and validity of the present version. 
The Diagnostic Interview Schedule for Children Version IV (DISC-IV; 
Shaffer, Fisher, Lucas, Dulcan, & Schwab-Stone, 2000) can assess a range of 
disorders using DSM-IV and ICD-10 criteria. It contains two parallel versions: the 
DISC-P for parents of 6 to 17-year-olds and the DISC-Y for children aged 9 to 17 
years. The DISC-IV assesses for the presence of disorders occurring within the past 
12 months and past month. Diagnostic categories include anxiety, mood, substance 
use, schizophrenia, and miscellaneous disorders. Administration time in clinical 
samples is approximately 90 to 120 minutes. It can be administered by trained, lay 
interviewers. Previous versions of the DISC demonstrate good reliability. Further 
studies will need to be conducted to examine the psychometric properties of the 
current version.  
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Treatment Planning and Monitoring 
 
Several assessments have been developed to facilitate the planning and 
evaluation of treatment strategies. These vary in structure, form, and practicality. An 
interviewer-based measure that is considered the “gold standard” for clinical trials of 
OCD ( et al., 1999) is the Children’s Yale-Brown Obsessive Compulsive Scale 
(CYBOCS; Goodman, Price, & Rasmussen, 1989a, 1989b; Scahill et al., 1997). 
The CYBOCS assesses symptom phenomenology and severity. It allows the 
clinician to generate a rich description of the types of obsessions and compulsions 
the child experiences. Ten core items are used to generate a Total score, an 
Obsessions score, and a Compulsions score. The Obsessions and Compulsions 
subscales are identically structured, containing five items that assess 
duration/frequency, interference, distress, resistance, and degree of control over 
symptoms. The Total score ranges from 0 to 40, with higher scores indicating a 
greater severity of OCD symptomatology. The CYBOCS has demonstrated good 
reliability and validity. Internal consistency for the total and subscale scores is high 
(>.9; McKay et al., 2003; .8; Scahill et al., 1997). Interrater reliability for each of the 
scales is good to excellent (Scahill et al.). Convergent validity for the Total score has 
been demonstrated with the Leyton Survey Total score (Scahill et al.) and the 
obsessions, compulsions and total impairment scores on the parent-completed 
children’s Obsessional Compulsive Inventory (CHOCI; Shafran et al., 2003) and the 
child-completed CHOCI (Shafran et al.). Correlations between the Total CYBOCS 
score, the standardised Revised Children’s Manifest Anxiety Scale Total score 
(Reynolds & Richmond, 1987) and the raw Children’s Depression Inventory score 
(Kovacs, 1985) suggest sufficient discriminant validity. Scale scores are sensitive to 
treatment effects (Scahill et al.). 
The CYBOCS possesses great clinical utility. Information from the symptom 
check-list provided with the measure can be used to generate the OCD hierarchy that 
is devised in CBT programmes. An OCD hierarchy identifies a particular symptom 
cluster and ranks situations associated with that symptom cluster according to the 
amount of anxiety they produce. An OCD hierarchy usually contains approximately 
ten items. The hierarchy is useful for planning, implementing, and evaluating 
exposure-based interventions. Clients begin their exposure program with the least 
anxiety-provoking stimulus in their hierarchy then proceed to a more anxiety-
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provoking stimulus once mastery of the preceding item has been achieved. Clients 
may have several OCD hierarchies as more than one OCD symptom cluster is 
usually present.  
The Leyton Obsessional Inventory: Child Version (LOI-CV; Berg, Whitaker, 
Davies, Flament, & Rapoport, 1988) is a 20-item self-report measure that assesses 
the phenomenology and interference of current OCD symptomatology. It is useful 
for formulating baseline symptomatology and monitoring treatment change over 
time (Grados & Riddle, 1999), although research suggests that it may not be as 
sensitive to treatment response as other instruments (Gellar et al., 2003). Responses 
to each item are presented in a yes/no format. If a child chooses the “yes” option 
he/she is then required to rate the interference of the item on a 4-point Likert scale. 
Higher scores indicate a greater level of interference. The LOI-CV has good 
psychometric properties, including high internal reliability, specificity, and 
sensitivity (Berg et al., 1988; Flament et al., 1988). It has adequate test-retest 
reliability for children aged 11 years and older (King, Inglis, Jenkins, Myerson, & 
Ollendick, 1995).  
The National Institute of Mental Health Global Obsessive-Compulsive Scale 
(NIMH-GOCS; Insel et al., 1983) is a single item measure of global diagnostic 
severity ranging from 1 (minimal symptoms or within normal range) to 15 (very 
severe). Severity levels are clustered into five main groups (i.e., ratings of 1-3, 4-6, 
7-9, 10-12, and 13-15), with detailed descriptions for each cluster. A score of 7 or 
higher indicates clinical OCD. The NIMH-GOCS shows adequate test-retest 
reliability (Kim, Dysken, & Kuskowski, 1992; Kim, Dysken, Kuskowski, & Hoover, 
1993). Convergent validity has been demonstrated with the Symptom Checklist-90 
(Derogatis, Lipman, & Covi, 1973), the Yale-Brown Obsessive-Compulsive Scale 
Total score (Goodman, Price, & Rasmussen, 1989a, 1989b), a physician global 
rating scale, and a patient global rating scale (Kim et al., 1992). The scale is sensitive 
to treatment effects (Barrett et al., 2004; Piacentini et al., 2002; Piacentini, Gitow, 
Jaffer, Graae, & Whitaker, 1994). 
The NIMH Clinical Global Impairment Scale (Guy, 1976) is a clinician-rated 
device that provides a global rating of severity ranging from 1 (not at all ill) to 7 
(extremely ill). The NIMH Clinical Global Improvement Scale is a clinician-rated 
measure of global improvement. Ratings range from 1 (very much improved) to 7 
(very much worse), with 4 indicating no change. These scales are sensitive to 
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treatment effects (Barrett et al., 2004; Piacentini et al., 2002; Piacentini et al., 1994; 
Waters et al., 2001). March and Mulle (1998) recommend using these scales 
throughout the treatment phase to track changes in OCD status. These scales are 
highly practical and time-efficient, although they lack the reliability and diagnostic 
utility afforded by alternative measures. 
 
Etiology 
 
The etiology of childhood OCD is not clearly understood. Many theories 
have been proposed to account for the development of OCD in children. These 
theories have received mixed empirical support in the literature, and no single theory 
affords a comprehensive explanation, which would ideally cover neurophysiological, 
behavioural, and cognitive domains. A brief review of the current knowledge of the 
etiology of childhood OCD follows.  
 
Genetic Studies 
 
Heredity plays a significant role in the etiology of OCD. Twin studies have 
found that the rate of concordance of OCD symptoms ranges between 53% and 87% 
for monozygotic twins and 22% and 47% for dizygotic twins (Alsobrook & Pauls, 
1998; Carey & Gottesman, 1998; Rasmussen & Tsuang, 1986). Researchers have 
speculated that a single gene is likely to be implicated in the development of OCD, 
rather than a complex array of multiple genes (Risch, 1990). Family studies have 
found that approximately 18% of parents of children with OCD meet diagnostic 
criteria for the disorder (Lenane et al., 1990; Riddle, Scahill et al., 1990). Fathers 
appear more likely to have OCD than mothers (Lenane et al.). These results provide 
support for the genetic transmission of OCD. Children that develop OCD tend to 
have different patterns of symptoms than relatives with OCD, providing evidence 
against a social learning theory of OCD transmission (Leonard, Rapoport, & Swedo, 
1997). The particular genetic mechanisms that contribute to pathogenesis have not 
been clearly identified, although important findings in this area are beginning to 
emerge.  
Preliminary research by Walitza and colleagues (2002) documented an 
association between OCD in children and a sequence variant of a serotonergic 
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receptor gene (A-allele of the 5-HT2A-receptor promoter polymorphism -1438G/A). 
Fifty-five children with OCD were compared to 223 control children. Statistically 
significant differences in genotype and allele frequencies were found between 
children with OCD and the control children. This genetic phenotype may comprise a 
risk factor for the early development of OCD. Similar findings have been 
documented among female adults with OCD, but not male adults (Enoch, Greenberg, 
Murphy, & Goldman, 2001).  
 
Family Factors 
 
Family factors have been implicated in OCD development and maintenance. 
The literature in this area is inchoate. Waters and Barrett (2000) provide a summary  
of the family factors hypothesised to play a role in OCD development.  
Social learning theory proposes that individuals reproduce observed 
behaviours through vicarious learning (Bandura, 1977). These behaviours are then 
maintained through operant conditioning. Although advocates of genetic accounts of 
OCD argue that it is unlikely that OCD behaviours are socially transmitted, this 
statement has been met with some contention. Other scientists argue that those 
typically assess symptoms at a single point in time, and do not investigate past 
symptomatology (Waters & Barrett, 2000). OCD tends to display a waxing and 
waning course, with the pattern of symptoms changing over time. It is possible that 
symptoms were initially socially transmitted but that the phenomenology of the 
disorder changed over time. However, evidence for a modeling account of OCD is 
limited.  
Expressed emotion (EE) has been defined as a parenting style characterised 
by criticism, hostility, and/or overinvolvement (Hibbs et al., 1991). Early research 
among schizophrenic patients demonstrated that 76% of individuals with 
schizophrenia who were discharged from hospital and returned to high-EE 
households relapsed within 9 months, compared to 28% of patients returning to low-
EE households (Brown, Monck, Carstairs, & Wing, 1962). Hibbs and colleagues 
(1991) compared the families of three sets of children; children with OCD, 
disruptive behaviour problems (DB), or normal controls. Higher-EE was found in the 
families of the OCD and DB children compared to the control children. There was 
no significant difference in EE between the OCD and DB children. Eighty-eight 
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percent of the DB, 82% of the OCD, and 41% of the control families were of high-
EE status. Leonard and colleagues (1993) reported the elevated presence of high-EE 
in OCD families in a separate study, although no other groups were examined. 
Research has supported the notion that perceived criticism is associated with relapse 
following behavioural treatment for OCD (Renshaw, Chambless, & Steketee, 2003). 
Although explanations have been proposed to account for the maintenance and 
exacerbation of OCD symptomatology in a high-EE environment (e.g., Steketee, 
1993), cohesive etiological accounts have not been specified to account for the 
pathophysiological origin of OCD. One theory suggests that the relationship between 
EE and symptom onset may be mediated by psychophysiological reactivity (Hibbs, 
Zahn, Hamburger, Kruesi, & Rapoport, 1992). The correlational nature of EE 
research means that confidence cannot be placed in this parenting style as a cause of 
OCD.  
A parenting style characterised by excessive control and overprotectiveness 
has been hypothesised to play a role in anxiety development in children. Rapee 
(1997, p. 62) posited that “excessive protection from a parent may help to provide 
information to the child that the world is a dangerous place  and may also reduce the 
child’s opportunities for learning otherwise”. Children may be encouraged to avoid 
potentially difficult situations, which may reinforce maladaptive behavioural and 
emotional responses, and cognitive overestimations of threat. There is an association 
between an overcontrolling parenting style and anxiety in children (Barrett, Shortt, & 
Healy, 2002; Dumas, LaFreniere, & Serketich, 1995; Krohne & Hock, 1991; 
Siqueland, Kendall, & Steinberg, 1996). This research is only associational at this 
stage and does not explain the specificity of disorders or symptoms within anxiety 
disorders for individuals.  
 
Autoimmunity Theory 
 
Recent research has suggested that some children with OCD develop the 
disorder in the context of an autoimmune response to a group A β–hemolytic 
streptococcal (GABHS) infection. This condition is described under the acronym 
PANDAS, which refers to paediatric autoimmune neuropsychiatric disorders 
associated with streptococcal infections. It occurs when the immune system 
generates antibodies in response to streptococcal bacteria, and the antibodies cross-
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react with the basal ganglia of a genetically vulnerable child, prompting the 
development of OCD or a tic disorder (Garvey et al., 1998; Swedo, 1994). PANDAS 
is characterised by a sudden onset or exacerbation of symptoms following GABHS 
infection. Identification of this condition is based upon the following working 
criteria: (1) the presence of OCD or tics; (2) pre-pubertal onset of symptoms; (3) 
episodic course of severity of symptoms; (4) onset or exacerbation of symptoms 
associated with GABHS infections; and (5) association with neurological 
abnormalities, such as abnormal motor activity (Swedo et al., 1998). 
The post-streptococcal autoimmune theory has its roots in Tourette’s disorder 
and Sydenham’s chorea investigations. Researchers noted that these conditions 
frequently co-occurred with OCD. It was known that these disorders were related to 
abnormalities in basal ganglia functioning. OCD symptoms tended to develop in the 
context of Sydenham’s chorea, and remit after the condition was treated (Asbahr, 
Ramos, Negrao, & Gentil, 1999; Swedo et al., 1993). Sydenham’s chorea is 
hypothesised to develop through the same mechanism as OCD, whereby anti-
GABHS antibodies cross-react with caudate neural tissue, initiating the onset of 
symptoms (Husby, van de Rijn, Zabriskie, Abdin, & Williams, 1976). The onset of a 
tic disorder following GABHS infection has been noted (Kiessling, Marcotte, & 
Culpepper, 1994). As yet, the prevalence or incidence of OCD due to GABHS 
infections is unknown. Limitations of this theory are evident. Research suggests that 
the serum of 20 to 40% of normal children contain similar antibodies, yet these 
children do not have OCD.  
 
Neuroanatomical Abnormalities 
 
Neuroanatomical abnormalities have been implicated in the etiology of OCD. 
Brain imaging studies have highlighted dysfunction in the orbitofrontal cortex and 
basal ganglia circuitry (Insel, 1992; Wise & Rapoport, 1989). Baxter et al. (1987) 
used position emission tomography to measure neuroanatomically localised cerebral 
glucose metabolic rates. Three groups of adult participants were compared: adults 
with OCD, normal controls, and adults with unipolar depression. Glucose metabolic 
rates in the cerebral hemispheres, caudate nuclei, and orbital gyri, were significantly 
elevated among individuals with OCD, compared to individuals in the control 
conditions. Similar results have been obtained in subsequent studies (Baxter et al., 
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1988; Mindus, Nyman, Mogard, Meyerson, & Ericson, 1989; Nordahl et al., 1989; 
Swedo, Schapiro et al., 1989) but refuted in others (Martinot et al., 1990). 
Three studies using single photon emission computed tomography (SPECT) 
have demonstrated significantly greater perfusion in certain structures of the brain in 
adults with OCD compared to normal controls (Harris, Hoehn-Saric, Lewis, 
Pearlson, & Streeter, 1994; Machlin et al., 1991; Rubin, Villanueva-Meyer, Ananth, 
Trajmar, & Mena, 1992). Adams, Warneke, McEwan, and Fraser (1993) detected 
support for these findings, although did not utilise a comparison group in the study, 
making it difficult to interpret the results. Implicated brain structures include the 
frontal cortex, orbital gyri, and cerebellum. Molina and colleagues (Molina et al., 
1995) examined cerebral perfusion in a previously untreated adult with OCD before, 
during, and 6 weeks after treatment with clomipramine. The patient’s symptoms 
remitted while on medication then returned following medication discontinuation. At 
baseline, SPECT scans indicated that there was a high perfusion ratio in the bilateral 
orbitofrontal, anterior cingular, frontotemporal and right caudate regions. This ratio 
normalised during clomipramine treatment and then increased, although not 
uniformly, at follow-up.  
These results are consistent with an etiological explanation of 
neuroanatomical abnormalities, however, they do not confirm that there is a causal 
relationship between neuroanatomical abnormalities and OCD. The studies were 
cross-sectional in design, therefore only an association between brain structure 
abnormalities and OCD can be posited at this stage. Further studies have shown 
results inconsistent with those reported in the above studies, casting doubt on the 
applicability of this theory (Edmonstone et al., 1994; Lucey et al., 1995).  
The series of investigations linking OCD to the basal ganglia was 
precipitated by a number of findings. Some children with OCD experience 
coexisting choreiform movements consistent with the presentation of Sydenham’s 
chorea (Presta et al., 2003). An increased rate of OCD has been documented in 
several illnesses involving the basal ganglia, including Tourette’s disorder, 
Sydenham’s chorea, Huntington’s chorea, and postencephalitic Parkinson’s disease 
(Cummings & Cunningham, 1992; Pauls, Towbin, Leckman, Zahner, & Cohen, 
1986; von Economo, 1931). Scientists have compared the structure of the basal 
ganglia in individuals with OCD to normal controls. Cottraux and Gérard (1998) 
provided a summary of the research in this area. They reported that 15 of the 26 
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studies conducted demonstrated involvement of the basal ganglia in cases of OCD, 
yet the hemisphere concerned, the direction of change following treatment, and the 
type of functioning (hyper-functioning or hypo-functioning) varied. Research 
implicating the basal ganglia in the etiology of OCD is inconsistent. 
 
Neurotransmitter Dysregulation 
 
Dysfunction in serotonin neurotransmission has been proffered as a 
mechanism underlying OCD development (Barr, Goodman, Price, McDougle, & 
Charney, 1992). Evidence for this theory is derived from multiple sources. 
Individuals with OCD respond well to selective and non-selective serotonin reuptake 
inhibitors, OCD is associated with abnormalities in serotonin function, and 
behavioural and physiological changes coincide with the administration of serotonin 
receptor agonists in individuals with OCD (Simpson et al., 2003). The utility of the 
evidence for a serotonergic model is hampered by a lack of ability to infer causality. 
It is possible that primary deficits in the serotonergic system are associated with 
OCD pathophysiology, although it is equally plausible that the serotonergic system 
is involved because serotonin neural pathways modulate dysfunction in other brain 
regions. Current experimental research in the field has not resolved this ambiguity. 
Nonetheless, the serotonergic theory remains a leading explanation of the etiology of 
OCD.  
Researchers have implicated the dopaminergic system in the etiology of 
OCD. Evidence for this putative involvement comes from research into Tourette’s 
disorder. Tourette’s disorder is thought to be linked to a dysregulation in the 
dopaminergic neurotransmitter system due to the effectiveness of haloperiodol and 
other dopamine antagonists in its treatment (Shapiro, Shapiro, & Eisenkraft, 1983). 
Tourette’s disorder frequently co-occurs with OCD (Pauls et al., 1995). A genetic 
relationship between the disorders has been proposed (Billet, Richter, & Kennedy, 
1998). Evidence for the involvement of the dopaminergic system in the etiology of 
OCD has been provided by research linking OCD to the basal ganglia. The 
dopaminergic system interacts with this region of the brain. OCD has demonstrated 
responsiveness to clomipramine and fluoxetine. These medications may block the 
reuptake of dopamine (Austin et al., 1991; Lipinski, Mallya, Zimmerman, & Pope, 
1989). Although these results suggest that the dopaminergic neurotransmitter system 
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may play a role in OCD symptomatology the direction and mechanism of causality 
has not been elucidated. A significant problem with this type of research is that it 
cannot illustrate causal relationships. Successful treatment of a disorder does not 
provide evidence of causality. Hence, research linking the dopaminergic system to 
the development of OCD is inchoate, albeit potentially promising. 
Theories of neurotransmitter dysregulation are limited by their inability to 
account for the specificity of OCD symptoms. For instance, these theories cannot 
explain why some individuals with OCD develop aggressive obsessions and 
checking compulsions, while other individuals display an excessive concern with 
contamination. They are also unable to explain why similar neurochemical 
imbalances produce depression in one instance and OCD in another.  
 
Learning Theory 
 
Mowrer (1947; 1960) advanced a two-factor theory of fear and avoidance 
behaviour in anxiety disorders. He proposed that anxiety towards a stimulus 
develops in the context of a classically conditioned response. Operant conditioning 
processes then maintain this anxiety. Initially, individuals avert or relieve anxiety by 
escaping the aversive stimulus. Later, anxiety is averted by implementing avoidance 
behaviours. These behaviours reinforce the avoidance response by providing relief 
from anxiety or by preventing a dreaded event from occurring. Avoidance 
behaviours prevent extinction of the classically conditioned anxious response.  
Evidence for this theory was derived from experimental research with 
animals (Metzner, 1963). These studies suggested that animals could learn to avoid 
aversive stimuli in a compulsive-like fashion. The avoidance behaviours became so 
“fixated” that they were often resistant to extinction. Research in the 1980s 
highlighted limitations in this theory. Most people with OCD could not recall a 
traumatic event that coincided with symptom onset (Steketee, 1993). In up to 40% of 
cases, no precipatory fear-inducing event is associated with OCD onset (Barlow, 
2002). The theory tends to explain the onset of obsessions and phobic states in a 
similar manner. Converse to phobic responses, many obsessions are not precipitated 
by the presence of environmental cues, signifying a further limitation to this theory’s 
explanatory power (Jakes, 1996). Rachman (1990) attempted to compensate for this 
limitation by suggesting that the classically conditioned response could emerge in 
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the context of a cognitive, as opposed to an environmental, event. Heightened fear 
responses (e.g., concerns about contamination, the consequences of leaving the door 
unlocked) could arise through observational learning or through abstract learning 
(e.g., learning that a friend or neighbour was robbed or has become ill). The 
individual uses new information to mentally associate the conditioned stimulus (e.g., 
thoughts that the door is unlocked, “contaminated” objects) with the unconditioned 
stimulus (e.g., illness, danger). Although this theory may be plausible for some 
symptom presentations it fails to explain the full spectrum of OCD symptom 
development. Clinical reports suggest that many obsessions appear spontaneously, 
and are not precipitated by the learning of new information. Unlike many phobic 
responses, obsessions are often not logically connected to sources of danger (e.g., 
repeating, touching urges) so initial pairing of a conditioned stimulus and an 
unconditioned seems unlikely.  
Mowrer’s theory failed to account for the limited range of stimuli that could 
become the theme of an individual’s obsession. The theory predicts that any stimulus 
could potentially come to elicit a conditioned response via pairing with an aversive 
stimulus. In OCD, obsessive concerns tend to focus on a specific, non-random 
distribution of objects. Examples include germs, locks, stoves, and numbers, and not 
other items which may be more associated with traumatic, anxiety-inducing 
experiences, such as cars from car accidents, or knives from attacks. Although 
learning theory has not provided an adequate account of the etiology of OCD, it can 
explain the maintenance of OCD symptoms. Learning principles underlie the 
rationale for current exposure-based interventions.  
 
Psychodynamic Theory 
 
Classical psychodynamic theory proposed that obsessions develop from 
repressed id impulses (Freud, 1894, 1895). The id was conceptualised as a part of the 
unconscious mind. It was believed to operate on the pleasure principle. If reality 
permitted, immediate gratification was sought. The id was thought to be organised 
around primitive, instinctual impulses such as sexuality and aggression. Individuals 
that had undergone trauma in childhood or who were socialised to become moral, 
conventional individuals were considered more likely to develop repressed id 
impulses (Bruno, 1993). Freud (1895) argued that in obsessional neurosis obsessions 
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were not replaced by another idea or thought, but instead by urges or actions 
deployed as mechanisms of discharge or protection (Mahony, 1986). These actions 
or compulsions were instigated to relieve the anxiety associated with the underlying 
conflict. If the conflict was not resolved, the obsessions and compulsions would 
recur.  
Psychodynamic theorists believed that OCD developed when an individual 
became fixated in the anal stage of development (18 months to 3 years), perhaps due 
to punitive toilet training methods or sexual trauma during this stage. OCD 
symptoms were thought to provide a means for expressing unresolved, repressed 
thoughts or feelings. Fixation at the anal stage of development was believed to lead 
to a desire for control, perfectionism, and order.  
The psychodynamic theory of OCD has been discredited (March, Franklin, 
Leonard, & Foa, 2004). It does not offer a convincing account of the etiology of 
OCD and empirical support for the theory is lacking. Psychodynamically-oriented 
therapies, such as psychoanalysis, are ineffective in treating individuals with OCD 
(Jenike, 2001; Kaplan & Sadock, 1995). Recent advances in genetic and 
neurobiological research provide a more compelling account of the etiology of OCD.  
 
Cognitive Theory 
 
Cognitive theory proposes that catastrophic misinterpretations of intrusive 
thoughts differentiate individuals with OCD from individuals without OCD. This 
theory is derived from Beck’s (1976) cognitive specificity hypothesis. Beck 
proposed that pathological anxiety results from one or more of the following 
cognitive errors: (1) overestimating the probability of a feared event, (2) 
overestimating the severity of a feared event, (3) underestimating one’s personal 
coping resources, and (4) underestimating external factors that could alleviate the 
threat.  
The cognitive theory of OCD proposes that individuals with OCD appraise 
intrusive thoughts in a substantively different way from individuals without OCD. 
The appeal of the cognitive model comes from research that has documented that 
80% to 88% of individuals experience intrusive thoughts and that normal obsessions 
do not differ in content from obsessions in OCD (Freeston, Ladouceur, Thibodeau, 
& Gagnon, 1991; Niler & Beck, 1989; Rachman & de Silva, 1978; Salkovskis & 
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Harrison, 1984). This finding illuminates the potential role of cognitive processes in 
the pathogenesis of the disorder.  
Carr (1974) was the first individual to develop a cognitive model of OCD. He 
proposed that individuals with OCD overestimate the probability of unfavourable 
outcomes relative to individuals without OCD. Since Carr’s original formulation, 
researchers have sought to establish the key cognitive processes underlying OCD 
etiology. Cognitive processes suggested have included an inflated perception of 
responsibility, overestimation of the probability and severity of harm, thought-action 
fusion, intolerance of uncertainty, overimportance of thoughts, and metacognitive 
beliefs.  
Salkovskis (1989) proposed that individuals with OCD can be differentiated 
from individuals without OCD by the way in which they appraise personal 
responsibility for the content of intrusive thoughts. Individuals with OCD are more 
likely to appraise intrusive cognitions as evidence that they will be responsible for 
harm to themselves or others unless they take action to avert it (Salkovsks, 1989). 
Salkovskis and colleagues defined responsibility as:  
 
The belief that one has the power which is pivotal to bring about or prevent 
subjectively crucial negative outcomes. These outcomes are perceived as 
essential to prevent. They may be actual, that is, having consequences in the 
real world, and/or at a moral level (Salkovskis, Richards, & Forrester, 1995, p. 
285)  
 
This model predicts that an inflated responsibility appraisal increases the level of 
distress experienced by the individual (Salkovskis, 1989). An individual with OCD 
alleviates this distress by performing a compulsion. Support has been found for this 
model among adults with OCD (Freeston, Ladouceur, Gagnon, & Thibodeau, 1993). 
A significant relationship between responsibility appraisals and obsessive-
compulsive symptoms has been reported in non-clinical children (Magnúsdóttir & 
Smári, 2004).  
Rachman (1997) proposed that obsessions are caused by catastrophic 
misinterpretations of the significance and importance of intrusive thoughts. An 
individual with OCD is more likely to believe that negative intrusive thoughts 
indicate something significant about his/her self (e.g., “I am weird, deviant, 
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horrible”) or that the thoughts convey highly important information that must be 
attended to (Thordarson & Shafran, 2002). Individuals with OCD are more likely to 
appraise intrusive thoughts as personally meaningful, attributing special significance 
to their intrusive thoughts. This appraisal may occur along one of two dimensions. 
The individual may overemphasise the importance of intrusive thoughts due to the 
frequency of their occurrence in conscious awareness, or the individual may 
overemphasise the importance of intrusive thoughts as a result of the content of the 
thought. Catastrophic misinterpretations about the importance of intrusive thoughts 
can lead to distress, increased obsessions, and the utilisation of neutralisation and 
thought suppression strategies. However, thought suppression strategies are futile 
and have the paradoxical effect of increasing the frequency of the occurrence of 
intrusive thoughts. This is referred to as the “white bear” effect based upon 
experiments by Wegner and colleagues (Wegner, Schneider, Carter, & White, 1987). 
Adults with OCD tend to overemphasise the importance of intrusive thoughts 
relative to individuals without OCD. Studies have not investigated this cognitive 
processing bias among children with OCD. 
Intolerance of uncertainty has been cited as a cognitive process underlying 
the maintenance of anxiety disorders. Individuals with anxiety disorders tend to have 
greater difficulty tolerating uncertainty that could possibly signal threat, finding this 
uncertainty more distressing and upsetting than non-clinical individuals. Mancini 
and colleagues (2002) proposed a definition based upon Kruglansky’s (1990) work 
on decision-making and cognitive closure. They defined intolerance of uncertainty as 
involving the desire for “an answer on a given topic, any answer…compared to 
confusion and ambiguity” (p. 403). Freeston and colleagues (1994) regarded 
intolerance of uncertainty as a cognitive bias that affects how an individual appraises 
and responds cognitively, affectively, and behaviourally, to uncertain situations. It 
involves: 
 
 (B)ehavioral attempts to control the future and avoid uncertainty, inhibition of 
action based on uncertainty, emotional reactions such as frustration and distress, 
and cognitive interpretations that being uncertain reflects badly on a person 
(Freeston et al., 1994, p. 799).  
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Although Mancini’s conceptualisation emphasises the need for cognitive 
closure, recent research has shown that intolerance of uncertainty may be more 
related to decreased confidence in one’s memory or cognitive abilities. Individuals 
with OCD appear to desire more vivid memories (Constans, Foa, Franklin, & 
Mathews, 1995) and have less confidence in their memory (Hermans, Martens, De 
Cort, Pieters, & Eelen, 2003) than non-anxious individuals. No differences in actual 
memory function are evident (Hermans et al., 2003).This discrepancy between 
perceived memory ability and desired memory ability may result in difficulty 
tolerating uncertainty (Tolin, Abramowitz, Brigidi, & Foa, 2003). Individuals with 
poorer perceived memory or cognitive confidence are likely to exhibit greater 
pathological doubting and greater intolerance of uncertainty. Whereas early literature 
discussed intolerance of uncertainty as a symptom of OCD and other anxiety 
disorders, the focus has shifted to examining the role of beliefs about uncertainty as a 
causal factor in OCD. Research has only recently begun to examine the relationship 
between intolerance of uncertainty and OCD among adults, and no known published 
research exists among children with OCD. Among adults, intolerance of uncertainty 
is significantly related to worry and obsessive-compulsive symptoms in clinical and 
non-clinical samples (Dugas, Gosselin, & Ladouceur, 2001; Steketee, Frost, & 
Cohen, 1998). 
Rachman (1993) stated that individuals with OCD may fuse thoughts and 
actions. Thought-action fusion is a form of metacognitive processing. Thought-
action fusion (TAF) is: 
 
“…the belief that (one’s) specific intrusive thoughts can directly 
influence the relevant external event and/or the belief that having these 
intrusive thoughts is morally equivalent to carrying out a prohibited 
action” (Rachman & Shafran, 1999, p. 139). 
 
This definition highlights the two forms of TAF. Probability or likelihood 
TAF refers to the belief that thoughts can directly influence external environmental 
stimuli. Individuals with this type of cognitive distortion fear that thinking about a 
dreaded event, such as a relative dying in a car accident, increases the likelihood that 
the event will occur. Morality TAF refers to the belief that having an intrusive 
thought is morally equivalent to performing the event depicted in the obsession. 
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Individuals may believe that intrusive thoughts about performing sexual acts on a 
minor, or stabbing a friend, are as repulsive and evil had the individual actually 
performed these acts. These irrational beliefs have been documented for over a 
century. Maudsley (1895) wrote that a patient like this “…is constrained to think of 
doing an indecent act and is in fright lest he should someday do it” (p. 184). Bleuler 
(1934) noted that “patients also fear that they might destroy their beloved ones 
through a thought (‘omnipotence of thought’)” (p. 561). This cognitive appraisal 
style can influence the development of clinically significant obsessions by increasing 
the frequency of occurrence of intrusive thoughts and a person’s corresponding level 
of distress (Berle & Starcevic, 2005). 
TAF is related to obsessionality/OCD in adults (Amir, Freshman, Ramsey, 
Neary, & Brigidi, 2001; Coles, Mennin, & Heimberg, 2001; Emmelkamp & 
Aardema, 1999; Hazlett-Stevens, Zucker, & Craske, 2002; Muris, Meesters, Rassin, 
Merckelbach, & Campbell, 2001; S. Rachman, Thordarson, Shafran, & Woody, 
1995; E.  Rassin, Merckelbach, Muris, & Spaan, 1999; Eric Rassin, Muris, Schmidt, 
& Merckelbach, 2000; Shafran, Thordarson, & Rachman, 1996). Experimental 
research has indicated that TAF beliefs can precede and cause symptom onset 
(Rassin et al., 1999). Zucker and colleagues (2002) showed that psychoeducation 
was effective at correcting TAF beliefs among a non-clinical adult sample. 
Barrett and Healy (2003) examined TAF beliefs among a sample of children 
with a primary diagnosis of OCD. Children with OCD had significantly higher 
ratings of TAF than non-clinical children. There were no significant differences in 
TAF ratings among children with OCD and children with an alternative anxiety 
disorder. Libby and colleagues (2004) reported that children with OCD displayed 
stronger TAF beliefs than children diagnosed with an alternative anxiety disorder or 
non-clinical children. Muris and colleagues (2001) found that TAF was significantly 
related to obsessionality among a sample of non-clinical adolescents, and that it was 
also associated with symptoms of other anxiety disorders and depression. TAF may 
be a phenomenological feature characteristic of many anxiety disorders  
Wells and Matthews (1994) proposed a prototypcal metacognitive model of 
emotional disorders. They incorporate aspects of earlier cognitive theories into their 
model, but added the additional tier of metacognition. They regard beliefs about 
cognitions and cognitive processes as central to the etiology of emotional disorders, 
including OCD. For instance, individuals with OCD are more likely to believe that 
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thinking about an event is related to the probability of the event’s occurrence 
(thought-action fusion). When an intrusive, ego-dystonic cognition occurs 
individuals with thought-action fusion beliefs are more likely to overestimate the 
probability of harm, to experience greater distress, and to engage in a greater 
frequency of neutralising behaviours. Individuals with OCD are more likely to 
believe that they need to control their thoughts. Thought control strategies such as 
suppression often have the paradoxical consequence of increasing the frequency of 
intrusive thoughts. Individuals with emotional disorders are more likely to believe 
that worrying or intrusive thoughts are dangerous and uncontrollable. They are more 
likely to believe that worrying is associated with positive consequences and to 
display poorer confidence in their memory abilities.  
Many aspects of the cognitive model have been supported by empirical 
examination in adult OCD samples (Turner, 2006), but research among children is 
lacking. Two studies illustrated that children with OCD displayed bias in cognitive 
processing relative to normal and anxious control children (Barrett & Healy, 2003; 
Libby, Reynolds, Derisley, & Clark, 2004). Matthews and colleagues (2007) found 
that inflated responsibility, thought-action fusion, and meta-cognitive beliefs 
accounted for 35% of the variance in obsessive-compulsive symptoms in 223 non-
clinical adolescents. Williams and colleagues (2002) observed that OCD symptoms 
covaried with reduction in responsibility appraisals during CBT treatment. Muris and 
colleagues (2001) found associations between implicated cognitive biases and 
obsessive-compulsive symptoms in a non-clinical adolescent sample. This 
preliminary research suggests that the cognitive model may play a role in the 
etiology and maintenance of paediatric OCD. The scope and methodology of this 
research area clearly needs to be expanded. 
 
Chapter Summary 
 
OCD is characterised by the experience of repetitive, intrusive obsessions 
and/or compulsions that consume more than one hour a day and cause marked 
distress or impairment. Approximately 1 in 100 children meet standardised 
diagnostic criteria for OCD. Primary symptoms experienced by children include 
contamination and aggressive obsessions, and washing and checking compulsions. 
OCD is frequently accompanied by disturbances in psychosocial functioning, 
 55
 Chapter 1 
 56
including significant interference in the home, academic and social domains. 
Untreated OCD may lead to significant adult morbidity, including OCD, other 
anxiety disorders, personality disorders, and impaired social functioning.  
The assessment of OCD should comprise a differential diagnosis and 
determination of related problems. OCD in children is most frequently comorbid 
with other anxiety disorders, mood disorders, and tic disorders. The etiology of 
childhood OCD remains to be determined, yet is likely to be multifactorial. 
Etiological accounts have implicated genetic factors, neurochemical abnormalities, 
neuroanatomical abnormalities, a post-streptococcal autoimmunity response, and 
cognitive factors. 
 Chapter 2 
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Treatments for Paediatric Obsessive-Compulsive Disorder 
                                                                                     
 
 
Recent epidemiological evidence suggests that between 0.25% and 2.3% of 
children and adolescents have OCD (Apter et al., 1996; Douglass, Moffitt, Dar, 
McGee, & Silva, 1995; Flament et al., 1989; Flament et al., 1988; Heyman et al., 
2003; Thomsen & Mikkelsen, 1993; Valleni-Basile et al., 1994; Zohar et al., 1992). 
OCD in childhood is associated with deterioration in school performance (Toro et 
al., 1992), poor peer relationships (Allsopp & Verduyn, 1990) and psychological 
distress. It is a persistent condition, and is a potential risk factor for future morbidity. 
Without intervention, children are at a greater risk of experiencing further 
psychopathology in adulthood, including continued OCD, personality disorders, 
social phobia, depression, and poor social adjustment (Wewetzer et al., 2001). Adults 
with OCD have lower employment, poorer academic achievement and lower marital 
rates compared to non-OCD adults (Hollander et al., 1996; Koran, 2000; Lensi et al., 
1996; Steketee, 1993). As the disorder is accompanied by significant impairment, 
and has an onset in childhood in two-thirds of all adult cases, it is of paramount 
importance to identify and disseminate effective treatments early in the course of the 
disorder. Over the past few decades, a significant treatment literature has accrued 
documenting an array of techniques for paediatric OCD. This extensive literature is 
described and reviewed in this chapter.  
 
Psychological Interventions 
 
Psychological interventions for paediatric OCD are many and involve 
numerous mechanisms of change. CBT and behavioural therapy are the most 
extensively studied treatments in the literature. Family therapy targets family 
systems and family functioning as the mechanism of change in treatment. 
Psychodynamic therapy has been used to enhance the functioning of the ego, while 
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anxiety management training teaches stress management techniques. Meta-cognitive 
therapy is the most recent psychological treatment to emerge in the paediatric OCD 
literature, and involves targeting unhelpful beliefs about worry and thoughts, that 
maintain OCD symptoms. Hypnotherapy has been used as an adjunctive treatment, 
and one case report has examined bibliotherapy.  
 
Cognitive-Behavioural Therapy 
 
     CBT refers to a collection of techniques aimed at modifying unhelpful 
thoughts and behaviours that maintain emotional disorder. CBT programs for 
paediatric OCD usually have a duration of 12 to 20 weeks. The two core techniques 
used in the CBT for paediatric OCD are exposure and response prevention (ERP) 
and cognitive therapy. Adjunctive techniques sometimes employed in CBT programs 
include behavioural experiments and operant learning procedures.  
Exposure and response prevention. ERP involves exposing the client to 
his/her feared stimulus (e.g., asking a client with contamination fears to touch a dirty 
plate) while refraining from performing his/her associated compulsion (e.g., hand-
washing). ERP is based on the exposure principle, which supposes that prolonged 
exposure to an anxiety-provoking stimulus will lead to autonomic habituation to 
anxiety. With repeated exposures, physiological reactivity to the stimulus decreases 
and the obsession becomes less distressing. Opportunities for negative reinforcement 
associated with anxiety reduction, through the execution of compulsions or 
avoidance behaviours, are removed. The lack of “pay-off” facilitates the extinction 
of compulsions. Exposure is delivered in two common ways that are referred to as 
flooding and graded. Flooding begins with exposure to a highly anxiety-provoking 
stimulus and the individual is continuously exposed until habituation occurs. The 
individual undergoes repeated exposures to this stimulus over the course of therapy, 
and generalisation of gains to related less anxiety-provoking stimuli occur. Graded 
exposure begins with the least anxiety-provoking stimulus of a person’s hierarchy of 
feared stimuli. The individual proceeds to the next stimulus on the hierarchy when 
the preceding stimulus no longer provokes anxiety. While flooding can produce 
improvement more quickly than graded exposure, it is rarely used due to the high 
level of discomfort associated it and the risk it poses to therapy engagement and 
premature withdrawal from therapy.  
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An example of an ERP application might pertain to a child with obsessions 
about a robber breaking into her bedroom, family home, and family boat at 
nighttime. These obsessions are accompanied by a marked increase in anxiety and 
urge to ritualise. Ritualising occurs in the form of checking, having things arranged 
in a certain way, and reassurance-seeking from parents. Thoughts about a break-in to 
the boat are the least anxiety-provoking. Usual rituals following this thought are to 
check that the boat is locked up before bed, ask parents whether the boat is still 
locked, and look outside the window to check that no robber is present. The next 
most disturbing obsession involves thoughts about the robber breaking into the 
family home. Rituals include checking the front and back door are locked, and 
repeatedly leaving bed to ask his parents if the doors are locked. Bedroom rituals 
include making sure the window is locked, making sure curtains are closed (so the 
robber won’t observe a young, vulnerable child inside and consider the house a 
satisfactory target), and making sure the bedroom door is closed (so that the opening 
of the door by a potential robber would be heard to give some prior warning that it is 
necessary to hide). The child and therapist used a shared metric, the subjective units 
of distress (SUDS) scale to communicate about the anxiety associated with having an 
obsession and then failing to perform associated rituals. This scale may range from 0 
to 10, or some therapists prefer 0 to 100, where the lowest rating is ‘no anxiety’ and 
the highest rating is ‘most anxious you have ever been in your life’. The therapist 
collects the child’s ratings of each scary situation and, consistent with a graded 
method of exposure delivery, hierarchically ranks these situations. The child then 
commences ERP with the least-anxiety provoking situation, for instance, the child 
refrains from asking her parents if the boat is locked up at nighttime (or if a less-
distressing version of this task is required the therapist and child may agree to delay 
the question for a period of time, or for the child to aim to ask for reassurance about 
the boat fewer times in a night than usual). This ERP exercise is repeated at 
nighttimes until the task is no longer anxiety-provoking. When this has been 
achieved the child and therapist progress to the next item on the exposure hierarchy. 
Therapy is continued until all the items on the exposure hierarchy do not provoke 
anxiety or, as a less rigorous criterion, until the symptoms are no longer of clinical 
significance.  
Cognitive therapy. Cognitive therapy targets the cognitions and unhelpful thinking 
styles that precede the increase in anxiety following the occurrence of an intrusive 
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thought. Cognitions and beliefs potentially implicated in paediatric OCD were 
discussed in Chapter 1 in the context of the cognitive theory of OCD. Some 
cognitive therapy techniques that may be used in the treatment of paediatric OCD 
will now be described.  
Most cognitive therapy techniques are referred to under the umbrella term 
‘cognitive restructuring’. The idea behind cognitive restructuring is that unhelpful 
thoughts that maintain emotional symptoms are challenged and replaced with 
thoughts containing more realistic and helpful content. Overestimation of the 
probability of harm was one thought bias discussed in Chapter 1 that can be 
challenged through cognitive restructuring. The child is asked to generate a realistic 
estimate of the probability that the sequence of events leading to his/her dreaded 
event will occur. For example, if a child experiences intrusive thoughts that his 
house will burn down if the oven is left on, the therapist and the child objectively 
investigate the likelihood of this occurrence. Each event that could potentially lead to 
the dreaded outcome is enumerated. The child may decide that the probability that 
the oven will cause a house fire is 1 in 100, the probability that no-one in the house 
will notice and extinguish the fire is 1 in 10, the probability that no-one in the 
neighbourhood will notice the fire and alert the firestation is 1 in 1000, and that the 
probability that firefighters will not extinguish the fire is 1 in 10. The therapist and 
child compute the actual likelihood of the dreaded outcome by multiplying the 
probabilities of each step. The child and therapist compare the realistic estimate to 
the probability “generated” by OCD. The probability "generated” by OCD’ is 
regarded as 100%, as OCD “makes” the child behave as though the event will occur 
100% of the time. The child reappraises the actual likelihood of the event occurring 
as significantly lower, thereby provoking less anxiety and ritualising. This technique 
is more suitable for adolescents due to the cognitive capacities required.  
Inflated and faulty responsibility appraisals can be challenged using the 
technique of ‘pie-charting’. First, the content of the child’s intrusive thought and the 
nature of the dreaded event are elucidated. Children are asked to identify potential 
causes of the dreaded event and to assign the percentage of responsibility attributable 
to each cause. For example, a child may have intrusive thoughts that her father will 
be badly injured while working at a building construction site. The pie chart is 
constructed to highlight the relative level of responsibility attributable to each 
potential cause (see Figure 1).  
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27%
40%
20%
13% Injury due to faulty machinery
Falls from a high place
Heavy materials fall on him
Traffic accident at the site
 
 
Figure 1. Pie chart of perceived responsibility for a dreaded event. 
 
The child reattributes responsibility for her father’s safety from internal factors 
to external, uncontrollable factors. After completing this task she may recognise that 
she will be less than 1% responsible for her father experiencing an injury at work, as 
opposed to her previous estimate of 100%. By reducing the child’s tendency to 
overemphasise personal responsibility for dreaded events Salkovskis’ (1995) theory 
predicts that affective discomfort, and subsequent ritualising, will be reduced. 
Catastrophic misinterpretations about the importance of intrusive thoughts can 
result in distress, increased obsessions, and the utilisation of neutralisation and 
thought suppression strategies. Cognitive therapy aims to facilitate the benign 
interpretation of intrusive thoughts, images, or impulses by deemphassing the 
importance of the thoughts. Some clinicians use Wegner and colleagues (1987) 
“white bear” paradigm as a clinical tool. Wegner and colleagues instructed study 
participants to suppress the image of a white bear. Participants had difficulty 
adhering to this instruction and reported experiencing an increase in the frequency of 
intrusion of this image. Shafran and Somers (1998) reported a series of case studies 
in which participants overemphasised the significance of intrusive thoughts. A 14-
year-old male presented with intrusions concerning harm to himself and loved ones. 
He experienced intrusive thoughts that he might accidentally poison or stab himself 
or others. He interpreted these thoughts as indicating that he was weird and 
dangerous. He believed that the thoughts were important and occurring for a reason. 
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His clinician challenged his beliefs by asking him if there was any other reason why 
he thought the obsessions might be occurring so frequently. After failing to generate 
an alternative reason the client was told by the clinician that they would perform an 
experiment. The client was asked not to think about a white bear. Immediately, the 
client smiled and reported that he was now thinking about a white bear. The client 
realised that trying to suppress his intrusive thoughts had the counteractive effect of 
increasing the frequency of these thoughts. The therapist explained to the client that 
approximately 90% of the population experience intrusive thoughts. These strategies 
helped the client to replace his beliefs with benign interpretations. His OCD 
symptoms abated. These results were replicated in a second case using this same 
technique. It is not clear what the relative efficacy of this treatment was as E/RP was 
also employed during therapy and the study lacked experimental control. 
Another cognitive therapy technique used to alter the importance and meaning 
of intrusive thoughts is the detachment cultivation (Söchting & March, 2002). 
Detachment cultivation involves externalising OCD symptoms so to create a 
‘personal’ distance between the child and OCD. Children are asked to give OCD a 
nasty nickname such as ‘germy’, ‘dragon’, or ‘baddie’. The child, parents, and 
therapist ally against the enemy in a mutual battle, seeking to gain control over OCD 
territory. March and Mulle (1998) present the cause of OCD to the parents and child 
as neurobehavioural, and describe obsessions as a form of “brain hiccup”. 
Obsessions are portayed as intrusive and annoying, but of no real significance - 
much like a sneeze. Framing the disorder within a neurobehavioural framework 
cultivates detachment from the disorder. Clients attribute the experience of 
symptoms to neurochemical disturbances or to a “brain malfunction” rather than 
erroneously interpreting the symptoms as evidence that they are bad people.  
Psychoeducation encourages the client to adopt a benign appraisal of the 
significance of an intrusive thought. Clients are informed that over 90% of the 
population experience intrusive thoughts, and that the form and content of these 
thoughts does not differ from clinical obsessions. Printed lists outlining intrusive 
thoughts experienced by the general population are presented to the client. Clients 
learn that the experience of obsessions is not rare, and that the experience does not 
imply that the individual is deranged or mentally ill (Rachman, 1997).  
Cognitive restructuring may be undertaken to improve the indiividual’s ability 
to tolerate uncertain situations. Grayson (2003) advocates informing the client that 
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certainty in life is not achievable. No person can perfectly predict future events, no 
matter how minor. Most people are comfortable with everyday uncertain situations, 
yet individuals with OCD lack tolerance for uncertainty. For instance, most people 
cannot remember turning the oven off the previous night at dinner, or they might not 
know if their spouse is unharmed at a specific point in time, when the couple is apart. 
Yet, most people are able to tolerate this uncertainty. Individuals with OCD would 
seek to establish certainty by performing compulsions (e.g., checking that the oven is 
off, ringing home to determine if spouse is unharmed). The feeling of certainty 
attained is only temporary. Individuals with OCD need to understand and accept that 
no individual can ever be completely certain of a future event. Even though some 
events may seem impossible, they are not improbable.  
Whitall and O’Neill (2003) describe using surveys to challenge OCD 
individuals’ catastrophic interpretations of uncertain situations. For instance, a client 
with checking compulsions may be asked to survey ten people to determine if those 
people recall locking their front door. The majority of people will not explicitly 
remember doing so, yet, despite the uncertainty they will be sure the door is locked. 
This experiment seeks to normalise the experience of uncertainty and illustrate that 
just because a person does not remember completing a task does not mean that it is 
not done.  
Cognitive therapy techniques and behavioural experiments can be used to test 
the validity of TAF beliefs. Clark (2000) reported the use of this technique in the 
treatment of an adult with OCD. This individual believed that thinking about getting 
sick would increase the likelihood that she would become sick. Clark instructed her 
to test this belief by repeatedly thinking about becoming sick. She was asked to keep 
a record of her intrusive thoughts and the perceived probability that she would 
become ill. This technique helped her to modify her faulty beliefs regarding the 
contingency between her thoughts and real-life events. The cognitive therapy 
techniques listed above may be incorporated into treatment plans if the clinician 
deems the cognitive content to be a maintaining mechanism of the client’s disorder.  
Behavioural experiments. Behavioural experiments are a cognitive therapy technique 
whereby the client and therapist contrive a scenario that will enable evaluation of a 
dysfunctional cognition. Williams and colleagues (2002) reported using behavioural 
experiments with a 14-year old girl whose obsessions indicated that someone in her 
family would die unless household objects were aligned in fours. In therapy she 
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evaluated the “OCD hypothesis” and alternative “non-OCD hypothesis” via a 
behavioural experiment. The non-OCD hypothesis was that harm would not befall 
her family if she deliberately left objects misaligned. Although behavioural 
experiments resemble exposure, they are different in that they are designed to target 
dysfunctional cognitions, and are terminated as soon as an outcome to the 
“experiment” has occurred. The efficacy of this treatment technique in isolation from 
other CBT components has not been studied. 
Operant conditioning procedures have been utilised in many paediatric OCD 
studies. Positive punishment (removal of a pleasant stimulus) and negative 
punishment (application of an aversive stimulus) have been documented in the 
treatment literature. Negative punishment has consisted of an aversive tactile 
experience or the removal of privileges (Apter, Bernhout, & Tyano, 1984; Lyon, 
1983). Punishment is not condoned in current psychological practice as it is 
unethical and may have the counterproductive effect of increasing resistance to 
treatment (March, 1995). Operant conditioning procedures were utilised in a small 
number of studies to manage comorbid oppositional behaviour, with the goal of 
increasing treatment compliance (e.g., Owens & Piacentini, 1998). Current CBT 
protocols favour operant techniques, such as positive reinforcement, as a means of 
increasing compliance with ERP. In March and Mulle’s (1998) treatment manual, 
rewards for achieving difficult exposure tasks are planned collaboratively by the 
child, therapist, and family. 
Over 60 treatment studies have evaluated CBT. Four of these were RCTs. 
Himle and colleagues (2003) conducted a trial with 10 children comparing group 
CBT to a placebo control. Children received a programme containined ERP and 
cognitive therapy. Children receiving CBT showed an average 40% reduction in 
symptoms at posttreatment, while children in the placebo group showed an average 
22%. Barrett, Healy-Farrell, and March (2004) compared changes in OCD 
symptomatology among 77 children randomly assigned to an individual CBT, group 
CBT, or wait-list control condition. Three main components were employed in the 
CBT programme; (1) psychoeducation, anxiety management, cognitive therapy, (2) 
ERP, and (3) relapse prevention. Component 1 was delivered across weeks 1 to 5, 
component 2 across weeks 6 to 10, and component 3 across weeks 11 to 14. The 
programme lasted 14 weeks and treatment contained an extensive family component.  
Sessions were held once weekly, with approximately 50 minutes allocated to work 
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with the child and 30 minutes with the parent and/or siblings. It was desirable for 
siblings to attend a prespecified eight treatment sessions, with partial session content 
focusing on sibling anxiety management, support for siblings, sibling 
accommodation of symptoms, and discussion of the impact of OCD on siblings. 
Siblings mostly saw the treating therapist one-on-one, or within a group of other 
siblings for the group programme. Children in the active treatment conditions 
showed significantly lower symptom severity (64% and 61%) at posttreatment than 
children in the wait-list condition, who worsened by 5%. The improvement was 
maintained at six months and three years follow-up (Barrett, Farrell, Dadds, & 
Boulter, 2005). 
The Pediatric OCD Treatment Study Team (2004) evaluated the efficacy of 
CBT alone among a sample of 28 children using a randomised, placebo-controlled 
design. The CBT regimen comprised a 14-session programme of psychoeducation, 
cognitive therapy, and ERP. The mean reduction in symptom severity was 46%. The 
rate of clinical remission (defined as a mean CYBOCS score of 10 or less at 
posttreatment) was 39%. CBT was significantly more effective than pill placebo at 
reducing OCD symptom severity. 
Bolton and Perrin (in press) compared ERP only to waitlist-control among 20 
children in a randomised design. Symptom severity of children receiving ERP 
decreased an average 44% compared to 2% for waitlisted children.  
 
Other Behavioural Techniques 
 
Satiation. Satiation, or ‘massed practice’, involves prolonged exposure to 
obsessional content. This is achieved by playing a prerecorded monologue of the 
obsession on a closed-loop audiotape, repeating obsessions verbally, or writing out 
the obsession.  
Satiation has been used in the treatment of paediatric OCD (Campbell, 1973; 
Friedmann & Silvers, 1977; Green, 1980; Kellerman, 1981; O'Connor, 1983; Taylor, 
1985). These case reports reported positive outcomes, yet it is difficult to assess the 
effectiveness of satiation because most reports used a combination of treatment 
techniques, such as medication and behavioural therapy, and all used uncontrolled 
methodology. It is inconclusive whether this technique is beneficial.  
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Thought Stopping. Thought stopping involves an attempt to eliminate an intrusive 
thought from conscious awareness by executing a verbal command (e.g., “stop!”) or 
behaviour (e.g., snapping a rubber band on the wrist) upon emergence of the thought. 
Thought stopping has been used, usually as an adjunctive technique, in many 
paediatric OCD studies (Campbell, 1973; Frare & Lebel, 1996; Friedmann & 
Silvers, 1977; Kellerman, 1981; Ownby, 1983; Taylor, 1985). These studies tended 
to support the efficacy of the technique, although they were uncontrolled and usually 
included other treatment components, making it difficult to discern treatment 
efficacy. Researchers have not validated the efficacy of this technique within a 
paediatric OCD population in a controlled design, perhaps because a) thought 
stopping has shown little efficacy in adult OCD populations b) procedures contradict 
the implementation of ERP techniques and c) cognitive theory does not justify its use 
(Rachman, 2003). Rachman (1997) claimed that this technique was an ad hoc 
method, because it attempted to control the problem after it had taken place, rather 
than correcting the underlying dysfunctional cognitions responsible for distress. The 
technique has been criticised for contradicting recent evidence that attempting to 
suppress an intrusive thought may increase the frequency of intrusion (Salkovskis, 
1996). This outcome was noted in one case report of the technique (Wilhelm, 2003).  
 
Metacognitive Therapy 
 
Metacognition has been proposed as a central mechanism of change in the 
treatment of OCD. Metacognition refers to “the psychological structures, knowledge, 
events and processes that are involved in the control, modification and interpretation 
of thinking itself” (Wells & Cartwright-Hatton, 2004, p. 386). At its simplest level, 
metacognition can be understood as ‘thinking about thinking’ or beliefs about mental 
events and cognitive processes (Clark & Purdon, 1993; Janeck, Calamari, Riemann, 
& Heffelfinger, 2003).  
Metacognitive therapy for OCD alters metacognitive processes implicated in 
the maintenance of OCD, such as beliefs that one’s memory is excessively fallible or 
thought-action fusion beliefs. Though-action fusion beliefs are thoughts about a 
dreaded event that an individual with OCD catastrophically interprets as increasing 
the likelihood that the dreaded event will occur. Simons and colleagues (2006) 
presented a case series of 10 children randomly assigned to receive a 20-week 
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program of ERP or metacognitive therapy. An example of one of the metacognitive 
techniques was thought experiments to test thought-action fusion beliefs. For 
instance, one female child had obsessions about dying, and interpreted these 
thoughts as indicating that she would soon die. To counter the anxiety generated by 
this obsession, her compulsions centered on generating counteractive thoughts that 
she wanted to live. She was instructed to practice thinking certain thoughts, such as 
winning the lottery, and to examine whether the outcome occurred. OCD severity in 
the metacognitive group decreased an average 78%, compared to a 95% reduction in 
the ERP-treated children. Metacognitive therapy shows promise for paediatric OCD 
and requires evaluation through controlled designs and analysis of clinically 
significant change. Although it has lower efficacy than ERP therapy, it may be an 
acceptable alternative psychotherapy for children reluctant to undertake ERP, and 
may result in significant clinical change. 
 
Anxiety Management Training 
 
Anxiety management training (AMT) has occasionally been included as a 
supportive component of CBT (e.g., Lyon, 1983; March et al., 1994; Waters et al., 
2001). AMT techniques include progressive muscle relaxation, breathing retraining, 
visualisation, isometric relaxation, and stress reduction methods. AMT has not been 
tested as a treatment for paediatric OCD, perhaps because it has been found to be 
ineffective in treating adult OCD. One study sought to ascertain whether ERP 
without AMT techniques was effective, and found an average 67% decrease in 
symptom severity at posttreatment (Franklin et al., 1998). The authors concluded that 
AMT does not seem to be a necessary part of treatment. Himle (2003a) used AMT as 
a placebo control in a group CBT-control comparison, and found that AMT reduced 
symptoms by an average of 22% (compared to 40% for CBT), however, symptoms 
returned to approximately baseline at the 6-month follow-up for the AMT group. 
The CBT group maintained treatment gains. The sample was very small so it is 
unclear how generalisable these findings are. Some therapists believe that AMT may 
support CBT treatments by lowering the peak level of anxiety, thereby reducing the 
difficulty of challenging exposure tasks. This may increase the tolerability of CBT to 
children (March, 1995). However, anxiety management strategies are generally not 
recommended as they may interfere with core mechanisms in ERP – habituation and 
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cognitive change (Maltby & Tolin, 2003). There is no evidence that AMT in 
isolation is an effective treatment for paediatric OCD.  
 
Bibliotherapy 
 
Tolin (2001) used bibliotherapy to treat a 5-year old boy with obsessive-
compulsive symptoms. The child was given a story about a tiny obnoxious flea, O. 
C. Flea, that annoys his friends by telling them that things are dangerous, urging 
them to perform bizarre behaviours to prevent danger. Events transpire that preclude 
the animals from performing their rituals, and they learn that no dangerous 
consequences result. The animals begin changing their behaviour to banish O. C. 
Flea. While not comprising a strict ERP or CBT procedure, the mechanisms 
underlying this therapy appear to be cognitive (externalising OCD via metaphors and 
reinterpreting obsessive thoughts) and behavioural (resisting compulsions). It is 
unclear whether this technique is effective. Although the child’s symptoms 
decreased by 96%, this study was a case study, and the technique of blocking 
reassurance about germs from others in the child’s environment was simultaneously 
employed. Further research needs to be undertaken.  
 
Family Therapy 
 
Family therapy alters patterns of interaction between family members in 
order to increase family functioning or to reduce emotional disturbance in one family 
member. Many suggestions have been proffered on targets for OCD family therapy 
intervention, including high expressed emotion, reassurance-seeking, 
communication, conflict resolution, problem-solving, OCD accommodation by 
family members, and family difficulties that impede successful implementation of 
CBT (Freeman, Garcia, Fucci, Miller, & Leonard, 2003; Hibbs et al., 1991; March, 
Leonard, & Swedo, 1995). A number of studies have reported the use of family 
therapy (Barrett et al., 2004; Dalton, 1983; Fine, 1973; Hafner, Gilchrist, Bowling, & 
Kalucy, 1981; Hand, 1988; O'Connor, 1983; Scott, 1966; Van Noppen, Steketee, 
McCorkle, & Pato, 1997; Waters et al., 2001). A problem with these studies is that 
the targets of intervention were highly diverse. In most to all cases designs were 
uncontrolled, additional interventions (particularly behavioural) were employed, 
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valid outcome measures were not utilised, and studies were limited to few cases. 
There is no evidence to support the efficacy of family therapy. It may be a promising 
avenue to pursue as an adjunct to CBT treatment.   
 
Psychodynamic Therapy 
 
 Psychodynamic therapy has not featured markedly in child OCD treatment 
studies, probably because of poor results obtained in adult treatment studies and 
substantial problems with the theoretical model governing treatment. A common 
drawback of psychoanalysis in general is that it may take a long time to achieve 
improvement. McGehee (2005) presented the case study of a 10-year-old boy. 
Therapy was biweekly for three months. No improvement in symptoms led the 
therapist to increase sessions to four-times weekly. Symptom remission was 
observed at the end of a two-year treatment period. The author did not report on the 
method used to diagnose OCD or include outcome measures, making interpretability 
impossible. There is no evidence to support the efficacy of psychodynamic therapy 
for childhood OCD.  
 
Hypnotherapy 
 
Two studies have examined hypnosis as an adjunctive component of 
treatment (Kellerman, 1981; Taylor, 1985). These studies reported a reduction in 
obsessive-compulsive symptomatology. Other techniques were utilised, OCD 
diagnosis was not standardised, and uncontrolled methodology was used, hence, it is 
not possible to draw conclusions about the efficacy of this intervention.  
 
Biological Interventions 
 
Biological interventions target biological mechanisms of change, such as 
deficiencies in serotonin or dopamine neurotransmitter functioning, brain structures, 
and immunological deficiencies. Pharmacotherapy has received the most attention in 
the literature, particularly the SSRIs. Other biological interventions for paediatric 
OCD include immunological treatments for the PANDAS subgroup and 
homeopathy.  
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Pharmacotherapy 
 
Clomipramine 
Clomipramine is a tricyclic antidepressant and was the first medication to be 
studied among children with OCD. Treatment guidelines suggest that clomipramine 
should generally be administered for a 12-week period at a dosage of 3 mg/kg per 
day (American Academy of Child and Adolescent Psychiatry, 1998). Dosages in 
excess of 5 mg/kg per day or 250 mg per day should not be administered due to risks 
such as seizures, toxicity, and electrocardiographic changes (American Academy of 
Child and Adolescent Psychiatry). 
Six studies on clomipramine treatment for paediatric OCD have been 
conducted (de Haan, Hoogduin, Buitelaar, & Keisjers, 1998; DeVeaugh-Geiss, 
Moroz, & Biederman, 1992; Flament et al., 1985; Hanna, Yumiler, & Cantwell, 
1993; Leonard et al., 1989; Rapoport, Elkins, & Mikkelsen, 1980). Length of 
treatment ranged between 8 to 12 weeks. Three of the studies were RCTs, which 
reported an average improvement in symptoms ranging from 37% to 51%, and 
significantly lower posttreatment symptom severity than the control groups. De Haan 
compared clomipramine to behaviour therapy and found that children in the 
clomipramine condition improved an average 26% compared to 58% in the CBT 
condition.  
Leonard and colleagues (1991) sought to determine whether treatment gains 
were maintained following clomipramine discontinuation. Twenty-six children who 
had participated in a previous clomipramine-desipramine double-blind crossover 
study (Leonard et al., 1989) received maintenance clomipramine treatment at follow-
up. The mean length of clomipramine treatment prior to entry into the maintenance 
study was 17 months. Twenty children completed the 8-month maintenance phase. 
Eight (89%) of the nine participants in the substitution desipramine hydrochloride 
condition and two (19%) of the 11 participants in the nonsubstitution clomipramine 
condition relapsed during the two-month comparison period. These results suggest 
that OCD symptoms return following withdrawal of clomipramine. 
Fifty-four probands comprising consecutive participants in earlier studies 
(Flament et al., 1985; Leonard et al., 1993) were followed up two to seven years 
after receiving five weeks of clomipramine treatment (Leonard, Swedo, & Lenane, 
1993). The mean age of the participants at follow-up was 17 years (SD = 3.0 years, 
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range = 10 to 24 years) and the mean follow-up period was 3 years (SD = 1.0 years, 
range = 1.9 to 7.3 years). At follow-up, 43% of participants met criteria for OCD and 
18% were classified as “subclinical OCD”.  
The average improvements in outcome in Leonard and colleagues’ (1993) 
study cannot be attributed solely to previous treatment with clomipramine, due to 
limitations in the study’s design. Children were not excluded from the study if they 
had received interim treatments. Most of the children that participated in the follow-
up had received further, multiple, treatments. The interim treatments comprised 
medication (96%), behavioural therapy (33%), individual psychotherapy (54%), and 
family therapy (20%). Many of the participants were receiving treatment for OCD at 
the time of follow-up. The most common current pharmacological treatments were 
clomipramine (37%), fluoxetine (24%), and fluvoxamine (4%). No participant was 
receiving CBT at follow-up. Due to the absence of internal validity in the study’s 
design, the long-term effects of clomipramine on OCD symptomatology are not 
interpretable. However, the findings indicate that despite multiple treatments for 
OCD, a significant proportion of children continue to meet diagnostic criteria.  
Clomipramine appears to be an efficacious treatment for children with OCD. 
However, treatment effects are not durable following medication discontinuation and 
approximately one third of children with OCD do not respond to the treatment. A 
limitation of clomipramine treatment, and other pharmacotherapies, is that it has 
been associated with the experience of adverse events. An adverse event is a clinical 
or physical change experienced by a participant during the course of a treatment, 
whether or not the treatment is considered to be responsible for that event. Adverse 
events include side effects, diseases, and changes to cognitive and affective 
functioning. Adverse events associated with the use of clomipramine include 
palpitations, sweating, tremor, drowsiness, weight gain, increased seizure risk, and 
arrhythmias (DeVeaugh-Geiss et al., 1992; Leonard et al., 1988; Liebowitz et al., 
2002). Clomipramine has a more hazardous side effect profile compared to treatment 
with SSRIs. This is because clomipramine is not as selective for serotonin reuptake. 
Clomipramine inhibits the neuronal reuptake of serotonin, dopamine, and 
noradrenaline, and acts as an antagonist at cholinergic, adrenergic, histaminergic, 
and dopaminergic receptors. This non-selectivity produces greater neurobiological 
disturbance than that produced by SSRIs, which is restricted to blocking the reuptake 
of serotonin. The seriousness of the adverse events associated with clomipramine, 
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and innovations in pharmacological treatments for depression, prompted the 
investigation of the efficacy of the SSRIs (Liebowitz et al.). 
 
Fluvoxamine 
Fluvoxamine is an SSRI and has been evaluated in two open studies (Apter et 
al., 1994; Yaryura-Tobias, Grunes, Walz, & Neziroglu, 2000), one RCT (Riddle et 
al., 1996; Riddle et al., 2001), and one follow-up study (Walkup et al., 1999) and is a 
first-line pharmacological agent for children with OCD. Riddle and colleagues 
conducted a 10-week multicenter, randomised, double-blind, placebo-controlled trial 
(50-200 mg/day). Of the 120 children that participated in the study, 44 withdrew 
prematurely. Reasons cited included a lack of improvement (22 placebo, 9 
fluvoxamine), side effects (3 fluvoxamine, 1 placebo) and ‘other’ reasons. An 
intention-to-treat, last-observation-carried forward analysis revealed that children in 
the fluvoxamine condition had a significantly lower level of symptom severity than 
children in the placebo condition at posttreatment. The mean reduction in OCD 
symptom severity from pretreatment to posttreatment was 25% for the fluvoxamine-
treated children and 14% for the placebo-treated children. This difference was 
statistically significant. Treatment response was defined by the researchers as a 25% 
decrease in symptom severity from baseline to endpoint. Twenty-four (42%) 
participants in the fluvoxamine condition and 17 (26%) participants in the placebo 
condition were treatment responders.  
The long-term efficacy of fluvoxamine was evaluated in a 52-week trial with 
99 children (Walkup et al., 1999) who had participated in the above study. 
Medication dose was titrated to 20 mg per day during the first three weeks of 
treatment. The children that had been treated with fluvoxamine in the original study 
(N = 34) experienced a 31% reduction in symptoms in the original study and an 
additional 16% in the extension phase. Continued medication management may be 
useful for improving treatment response and for preventing relapse. The risks 
associated with long-term medication use are unknown.  
The results of Riddle’s (1996) study support the efficacy of fluvoxamine as a 
short- and long-term treatment for childhood OCD. The results of the open trials are 
consistent with the RCT. Research has not shown that the effects are durable when 
medication is withdrawn. Adverse events associated with fluvoxamine use among 
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children with OCD include headaches, insomnia, infection, abdominal pain, and 
nausea (Riddle, 1996, 2001). 
 
Sertraline 
The efficacy and safety of the SSRI sertraline has been examined in two 
randomised, placebo-controlled trials (March et al., 1998; Pediatric OCD Treatment 
Study Team, 2004), one uncontrolled trial (Alderman, Wolkow, Chung, & Johnston, 
1998; Johnston et al., 1996), one case study series (Procter, McNicholas, & Baird, 
2001), and one extension trial (Cook et al., 2001).  
March and colleagues (1998) conducted a 12-week, multicenter, randomised, 
double-blind, placebo-controlled trial among 187 children. Children treated with 
sertraline (200 mg/day) showed significantly greater improvement on outcome 
measures. Average reduction in symptom severity was 29%. Children receiving 
sertraline were significantly more likely to experience adverse events, such as 
insomnia, nausea, agitation, and tremor, and were more likely to discontinue the 
study as a result of adverse events than children in the placebo condition. 
Approximately 13% children treated with sertraline and 3% of placebo-treated 
children discontinued treatment prematurely. 
The Pediatric OCD Treatment Study Team evaluated the efficacy of 
sertraline, CBT, and CBT and sertraline combined (POTS, 2004). The study 
employed a randomised, placebo-controlled design and was conducted across three 
treatment sites in the United States. Ninety-seven of 112 participants completed the 
full 12 weeks of treatment. Intention-to-treat analyses revealed a statistically 
significant advantage for sertraline compared with placebo. Clinical remission was 
defined as a CYBOCS score less than or equal to 10. The rate of clinical remission 
for participants treated with sertraline only was 21% compared to 4% for placebo. 
Sertraline-treated participants experienced a greater number of treatment-emergent 
adverse events than participants in the placebo condition. The most commonly 
experienced adverse events were stomachache and nausea. No serious adverse events 
accompanied sertraline use.  
Cook and colleagues (2001) conducted a 52-week extension study with 137 
participants from March and colleagues’ (1998) trial. Of these, 62 completed the 52-
week extension phase. All participants began the extension study within three days 
of completing the 12-week treatment phase. Participants were treated in dosages of 
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50-200 mg per day. Efficacy analyses were conducted on 132 evaluable participants. 
The average decrease in symptoms was 25% between baseline and endpoint of the 
original study (from 0 to 12 weeks of treatment), 36% between baseline and endpoint 
of the extension study (from 12 to 52 weeks of treatment), and 53% between 
baseline of the original study and endpoint of the extension study (between 0 and 64 
weeks of treatment). Significant incremental improvements were demonstrated on all 
outcome measures from the baseline of the extension phase to endpoint. At endpoint, 
67% of the participants were classified as treatment responders. Of those who 
completed the 52-week extension phase, 85% that were responders to sertraline in 
the initial 12-week phase of the study remained responders at the endpoint of the 
extension phase. Forty-three percent of children who did not meet the criteria for 
treatment response to sertraline in the initial 12-week phase were treatment 
responders at the endpoint of the extension phase. The incidence of treatment-
emergent adverse events in the extension phase was 77%. The most common adverse 
events were headache, insomnia, nausea, diarrhoea, somnolence, abdominal pain, 
hyperkinesia, nervousness, and vomiting. These findings complement the 
recommendations of practice guidelines, which suggest that medication should be 
continued for a further 9 to 18 months after an acceptable acute response has been 
demonstrated (Grados, Scahill, & Riddle, 1999; March, Frances, Carpenter, & Kahn, 
1997; Thomsen, 2000). Shortcomings in the methodological design of the study limit 
the extent to which the findings can be considered valid. The limitations represent 
the practical and ethical constraints of conducting research with this population. 
Children in the study were not excluded if they received concomitant psychotherapy. 
No information was collected on psychotherapy, therefore, it is not possible to 
determine the extent to which this confounded treatment outcome. Some children 
received CBT, which is an efficacious treatment for children with OCD. The lack of 
a comparison condition means that a placebo response may have accounted for 
improvements in symptomatology. Outcome measures were administered by 
clinicians who were not blind to the treatment. Hence, results of the extension study 
are promising but must be interpreted with caution.  
Sertraline appears to be an efficacious treatment for paediatric OCD, 
although there is no evidence to suggest that improvement is maintained when 
sertraline is withdrawn.  
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Fluoxetine 
Fluoxetine is an extensively studied SSRI agent. Seven uncontrolled trials 
(Baysal & Ünal, 1996; Bouvard & Dugas, 1993; Como & Kurlan, 1991; Geller, 
Biederman, Reed, Spencer, & Wilens, 1995; Liebowitz, Hollander, Fairbanks, & 
Campeas, 1990; Riddle, Hardin, King, Scahill, & Woolston, 1990; Semerci & Unal, 
2001) and three RCTs (Geller, Hoog et al., 2001; Liebowitz et al., 2002; Riddle et 
al., 1992) have been published. Riddle and colleagues examined the efficacy of 
fluoxetine (20 mg/day) among a sample of 14 children with OCD in the United 
States. They employed a 20-week randomised, double-blind, placebo-controlled 
design with a crossover at eight weeks. The first agent was administered for eight 
weeks, and the second agent was administered at 12 weeks. This discrepancy in 
timing was implemented to allow for the long half-life of fluoxetine and its 
metabolite, norfluoxetine. Plasma fluoxetine levels were monitored to evaluate 
compliance with the treatment. Due to a small sample size, analyses on the primary 
outcome measures were conducted on the data obtained at baseline and at eight 
weeks. OCD severity decreased by an average of 44% between baseline and the 
initial 8 weeks for the fluoxetine condition, compared to 27% for the placebo 
condition. Change score analyses revealed that there was a statistically significant 
difference favoring fluoxetine on a global OCD measure, but not on the two other 
frequently used OCD severity measures. Interpretability of the study is difficult, due 
to methodological shortcomings and low power. The statistical analyses employed 
by Riddle and colleagues had unacceptably high Type I error rates. Inflation of the 
familywise error rate, which occurs when multiple analyses are conducted on a 
single data set, was not controlled. The familywise error rate for the study was 30 
times the acceptable level. An acceptable per test alpha level using the Bonferroni 
correction procedure is .0017. Only one result was statistically significant at this 
alpha level, namely, the change in global OCD severity from pretreatment to the first 
eight weeks in the fluoxetine condition. No statistically significant differences in 
OCD symptom severity, anxiety symptoms, depressive symptoms, or obsessive-
compulsive symptoms were observed from pretreatment to eight weeks for either of 
the conditions, or between the conditions at eight weeks, at the corrected per test 
alpha level. Effect size calculation on change scores revealed a small and non-
significant effect (.18, 95% CI = -.92 to 1.27). The large confidence interval suggests 
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that the treatment effect could be as small as negligible or as voluminous as large, 
rendering study results difficult to interpret.  
Geller and colleagues examined the efficacy of fluoxetine (20-80 mg/day) 
among 103 children with OCD. A 13-week, randomised, placebo-controlled, double-
blind design was employed. Twenty-two participants (31%) in the fluoxetine 
condition and 12 participants (37%) in the placebo condition withdrew from the 
study prematurely, although this difference was not statistically significant. The 
groups did not differ significantly at baseline in demographic characteristics, patient 
characteristics or symptom severity. Intention-to-treat analyses were conducted using 
the last-observation-carried-forward approach. Those receiving fluoxetine improved 
an average 39%, compared to 19% in the placebo condition. In the fluoxetine 
condition, 35 of 71 children (49%) were classified as treatment responders, 
compared to 8 of 32 children (25%) in the placebo condition. Eighty children (78%) 
reported at least one treatment-emergent adverse event. There were no significant 
differences between the conditions in the number of children that reported adverse 
events.  
Liebowitz and colleagues conducted a randomised, double-blind, placebo-
controlled trial to assess the efficacy of fluoxetine (20-80 mg/day). Forty-three 
children received eight weeks of treatment followed by an eight week maintenance 
phase. Due to attrition, only eighteen children completed the maintenance phase. 
Treatment group did not predict the rate of attrition. Intention-to-treat analyses were 
conducted using the last-observation-carried-forward approach. The fluoxetine and 
placebo condition demonstrated significantly lower OCD severity at eight weeks, 
although the study was slightly underpowered. More fluoxetine-treated children 
(51%) were classified as treatment responders than placebo-treated children (32%), 
although this difference was not statistically significant. Post hoc analyses 
controlling for baseline scores were conducted on all study entrants to examine 
treatment efficacy at week 16. The fluoxetine-treated condition had lower average 
symptom severity. A high rate of adverse events was reported. All children in the 
fluoxetine condition and 86% of participants in the placebo condition reported 
experiencing at least one adverse event. The majority of these events were treatment-
emergent. The most common adverse events experienced by children in the 
fluoxetine condition were headaches (52%), fatigue (47%), abdominal pain (43%), 
drowsiness (38%), difficulty staying asleep (38%), decreased appetite (38%), weight 
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loss (33%), nausea (33%), and muscle ache (33%). The most common adverse 
events experienced by children in the placebo condition were headaches (36%), 
fatigue (32%), and nausea (32%). The extent of adverse events attributable to the 
medication is unclear, as between-groups differences in comorbid psychopathology 
existed. The fluoxetine condition had a significantly higher level of depressive 
symptomatology at baseline than participants in the placebo condition. Depression is 
often associated with sleeping difficulties, physical symptoms, and changes in 
appetite, including weight loss. No follow-up studies examining the long-term 
efficacy of fluoxetine for children with OCD have been published.  
A concern in the use of fluoxetine is the risk of increased frequency of 
suicidal ideation or behaviour. King and colleagues (1991) studied a sample of 42 
children treated with fluoxetine for depression or OCD and observed this 
phenomenon in six children. A pooled analysis of adult clinical OCD trials showed 
no single incident of suicidality among fluoxetine-treated individuals (Beasley et al., 
1992). Results are currently inconclusive.  
 
Paroxetine 
Paroxetine is an SSRI agent that has been studied in two RCTs (Geller, 
Stewart, Farrell, & Emslie, 2003; Geller et al., 2004) and two open trials (Diler & 
Avci, 2000; Rosenberg, Stewart, Fitzgerald, Tawile, & Carroll, 1999). Geller and 
colleagues (2004) conducted a 10 week, multisite, randomised, placebo-controlled 
study of paroxetine (10-50 mg/day). The intention-to-treat sample comprised 203 
children. Mean reduction in symptoms was 36% and 21% for the paroxetine and 
placebo groups, respectively. This represented a change from severe OCD 
symptomatology to mild OCD symptomatology in the paroxetine group. Analyses 
using the last-observation-carried-forward technique revealed a statistically 
significant difference in OCD symptom severity at endpoint, favouring paroxetine.  
Geller (2003) used a randomised controlled withdrawal design to examine 
paroxetine efficacy. Children (N = 193) that responded to a 16-week paroxetine 
treatment phase were randomised to a 16-week extension trial of paroxetine versus 
placebo. Children in the paroxetine condition displayed an average 36% worsening 
of symptoms compared to an average worsening of 72% in the placebo condition. 
Geller reported that the differential relapse rates were 44% and 35%, though this 
difference was not statistically significant, despite the study being overpowered.  
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The two open trials have reported favourable results, noting reductions in 
symptoms between 29% and 57%. The side effect profile for paroxetine appears 
reasonable, with fewer than 10% of the sample reporting adverse events such as 
decreased appetite, vomiting, diarrhoea, and so forth. The durability of paroxetine 
outcome has not been investigated.   
 
Immunotherapy and PANDAS Treatment 
 
Immunotherapy has been studied among children with the PANDAS subtype 
of OCD. PANDAS-related disorders are indirectly triggered by streptococcal 
infection, leading researchers to propose that treatments that alter immune function 
may be of benefit. Current methods investigated have included plasmapheresis, 
intravenous immunoglobulin, penicillin prophylaxis, or prednisone (Allen, Leonard, 
& Swedo, 1995; Garvey et al., 1999; Giedd, Rapoport, Leonard, Richter, & Swedo, 
1996; Grados, Scahill, & Riddle, 1999; Nicolson et al., 2000; Perlmutter et al., 
1999). Surgical treatments, such as adenotonsillectomy have also been reported in 
the treatment of PANDAS OCD (Heubi & Shott, 2003). The PANDAS subtype of 
OCD is believed to be a unique subtype of OCD with specificity in characteristics. A 
review of the PANDAS area is outside the scope of this thesis.  
 
Homeopathy 
 
Case reports have suggested that homeopathic remedies may assist children 
with OCD (Reichenberg & Ullman, 1998, 1999, 2000; Reichenberg-Ullman & 
Ullman, 2002). These reports are of poor methodological quality. OCD was not 
diagnosed using standardised methods and assessments were not administered. There 
is no evidence confirming homeopathy as an efficacious treatment method.  
 
Combination Treatments 
 
Empirical evidence indicates that combined treatment is superior to treatment 
with CBT alone or sertraline alone (POTS, 2004). The POTS team evaluated the 
relative efficacy of CBT, sertraline, and combined CBT and sertraline, in a 
randomised, placebo-controlled study. The clinical implications of this study are 
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significant. Intention-to-treat analyses revealed that treatment with CBT alone (p = 
.003), sertraline alone (p = .007), and combination treatment (p = .001) was 
significantly superior to a placebo. Combination treatment was statistically superior 
to CBT or sertraline alone. The rate of clinical remission was 54% for combined 
treatment, 39% for CBT alone, 21% for sertraline alone, and 4% for placebo. The 
effect size was 1.4 for combination treatment, 0.97 for CBT alone, and 0.67 for 
sertraline alone.  
Open-label case series reports have suggested that a clomipramine-SSRI 
combination may be useful (e.g., Figueroa, Rosenberg, Birmaher, & Keshavan, 
1998; Simeon, Thatte, & Wigins, 1990). Methodological limitations do not permit 
conclusive interpretations regarding efficacy.  
 
Other Treatments 
 
Neurosurgery and electroconvulsive therapy have been suggested as potential 
treatments among adults with severe, treatment refractory OCD and comorbid 
depression. Several procedures have been reported, including capsulotomy, 
cingulotomy, limbic leucotomy, and central lateral thalamotomy with anteromedial 
pallidotomy, executed by radiosurgery or radiofrequency thermolesions (Polosan, 
Millet, Bougerol, Olie, & Devaux, 2003). Electroconvulsive therapy involves the 
induction of a bilateral tonic clonic seizure by passing a brief electrical current 
through the brain. The mechanism of action has not been identified, though is 
thought to be related to neurotransmitter functioning.  
Neurosurgery and electroconvulsive therapy are proscribed for children with 
OCD, due to the risk of irreversible consequences such as seizures, and structural 
and cognitive damage. OCD is known to remit without treatment in a third of 
paediatric cases. Developmental changes such as increased cognitive capabilities 
may overcome previous non-response to a specific type of treatment. Legal and 
ethical challenges present concerns in the consent required for such procedures. 
These considerations mean that neurosurgery and electroconvulsive therapy for child 
OCD are unlikely to be examined for treatment efficacy.  
Transcranial magnetic stimulation is a noninvasive technique whereby 
powerful magnetic fields are used to excite neurons in the cortex. It is currently 
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being studied among adults, but not children. A review of available adult trials 
suggested that there are insufficient data to conclude that transcranial magnetic 
stimulation is efficacious and more research is needed to investigate this treatment 
technique (Martin, Barbanoj, Pérez, & Sacristán, 2006).   
Further medications that have been highlighted in case reports or open-label 
trials, but not studied within RCTs, include sumatriptan, buspirone, and citalopram 
(Fitzgerald, Stewart, Tawile, & Rosenberg, 1999; Pathak, Cottingham, & 
McConville, 2003; Simeon et al., 1994; Thomsen, Ebbesen, & Persson, 2001). A 
NIMH sponsored trial is currently underway to assess the efficacy of riluzole, a 
glutamate receptor blocker. It is likely that new pharmacological treatments and 
augmenting treatments for paediatric OCD will continue to be investigated. 
  
Integrating the Literature 
 
The diversity in literature and lack of a coherent picture of etiology (as 
outlined in Chapter 2) and maintaining mechanisms presents a potential hindrance 
navigating treatment options by consumers, clinicians, and researchers. Most 
published studies report results favouring the treatment modality presented, yet there 
is great variety in quality of methodology, statistical techniques, and patient samples 
that makes interpretation of outcomes problematic. To optimise outcome for children 
with OCD evidence-based treatments require distinction from non-evidence based 
treatments and insight into comparative effectiveness is required.  
 
Chapter Summary 
 
Many different treatment strategies relying on heterogeneous theoretical 
mechanisms of change have been applied to the treatment of paediatric OCD. 
Psychological interventions have included CBT, behavioural therapy, 
psychodynamic therapy, family therapy, bibliotherapy, AMT, metacognitive therapy, 
and hypnotherapy. Biological interventions have comprised pharmacotherapy with 
clomipramine and the SSRIs, immunotherapy for PANDAS, and homeopathy. The 
paediatric OCD treatment literature would benefit from systematic integration to 
identify evidence-based treatments and determine the relative effectiveness of 
treatment modalities.     
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Chapter 3 
Study 1: Meta-Analysis of Randomised, Controlled Treatment 
Trials for Paediatric Obsessive-Compulsive Disorder       
                                                                                
 
 
OCD affects approximately 1 in 100 children. It can substantially disable 
children’s functioning at home, school, and with peers (Piacentini et al., 2003) and 
increase the risk of psychological problems in adulthood, including continued OCD, 
clinical anxiety and depression, personality disorders, and social maladjustment 
(Wewetzer et al., 2001). OCD was previously thought to be a psychiatric condition 
extremely refractory to treatment (Kobak, Greist, Jefferson, Katzelnick, & Henk, 
1998). The past two decades has witnessed a surge of clinical and research literature. 
Treatment discourse has covered a diverse array of approaches, including 
pharmacotherapy, CBT, psychodynamic therapy, hypnotherapy, AMT, family 
therapy, bibliotherapy, metacognitive therapy, and immunotherapy.  
Expert Consensus Guidelines (March, Frances, Kahn, & Carpenter, 1997) 
recommend CBT as the first-line treatment of choice for all prepubertal children with 
a primary diagnosis of OCD, and for adolescents with mild to moderate symptoms. 
A combination of CBT and pharmacotherapy is recommended for adolescents with 
severe symptoms. The expert recommendations were based largely on extrapolations 
from adult treatment trials and the belief that OCD in children is “virtually identical” 
in clinical presentation to OCD in adults (O'Kearney, Anstey, & von Sanden, 2006, 
p. 2). In recent years many treatment trials have emerged, including several RCTs. 
RCTs are the “gold standard” for determining whether a cause-effect relation exists 
between a treatment and an outcome. They control for all factors, known and 
unknown, that could influence treatment response (Kraemer, 2002). Systematic 
integration of these trials could enhance understanding of the treatment of paediatric 
OCD. 
A treatment effect becomes more probable when findings from multiple 
studies are consistent. Meta-analysis is a statistical technique that pools the results of 
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multiple, separate studies and quantifies the effectiveness of an intervention in terms 
of a standardised treatment effect (Glass, 1976). Meta-analytic results provide 
greater evidence of the reliability of a treatment effect, and have more statistical 
power than individual studies, which reduces the Type II error possibility. Findings 
provide external validity through inclusion of samples with varied practitioner, 
patient, and geographical characteristics. An advantage of meta-analysis is that it 
allows indirect comparison of the effectiveness of different types of treatments 
through the utilisation of a common metric.  
Five known studies have provided meta-analytic summaries of treatments for 
paediatric OCD (Abramowitz, Whiteside, & Deacon, 2005; Freeman et al., 2007; 
Geller et al., 2003a; Guggisberg, 2005; Phillips, 2003). All but one pooled results 
from RCTs and non-RCTs (study results are summarised in Table 1). A limitation 
with pooling results from non-RCT trials is that the true treatment effect is likely to 
be significantly inflated, because the effect includes error from threats to validity.  
 
Table 1  
Results of Previous Meta-Analyses Including RCTs and non-RCTs for Paediatric 
OCD 
 
First author Year Treatment Included 
studies 
Effect 
size 
95% CI n 
Freeman  2007 CBT 3 RCT 
9 non-RCT 
1.55 1.12-1.97 12 
Abramowitz 2005 Pharmacotherapy 7 RCT 
4 non-RCT 
1.13 .82-1.25 11 
     CBT 1 RCT 
9 non-RCT 
1.98 1.40-2.56 10 
Phillips  2003 Pharmacotherapy 9 RCT 
10 non-RCT 
.95 .68-1.25 19 
  CBT 1 RCT 
10 non-RCT 
1.68 .95-1.46 11 
Guggisberg  2003 Pharmacotherapy 
& CBT trials 
12 RCT 
20 non-RCT 
1.32 1.01-1.62 32 
 
 
Patients often present for treatment when symptoms are most severe, therefore 
improvement unrelated to treatment is expected merely with time. Other factors, 
such as the therapeutic alliance and patient expectations, may autonomously 
influence treatment outcome. These effects are not partialled out when non-RCTs are 
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pooled, leading to a potentially biased and misleading estimate of treatment 
effectiveness.  
This meta-analysis offers a unique contribution to previous research as it 
includes RCTs only (i.e., not uncontrolled or active comparator trials), no duplicated 
data (e.g., subtrials), and is not restricted to a specific treatment modality. Results 
from important recent trials, such as the POTS (2004) trial, are included.  
 
Method 
 
Data Sources 
 
A comprehensive literature search was conducted for treatment studies of 
paediatric OCD. Systematic searches of MEDLINE (1966-), PSYCINFO (1887-), 
and CURRENT CONTENTS (2005-) from 1st available year of coverage to January 
2007 were conducted using the terms “obsessive compulsive disorder”, “treatment”, 
“child”, and “therapy”. A manual search of the contents of Journal of the American 
Academy of Child and Adolescent Psychiatry, Archives of General Psychiatry, 
JAMA, and Journal of Child and Adolescent Psychopharmacology was conducted. 
Bibliographies of previous meta-analyses cited in the introduction to this chapter 
were searched. Citations from relevant articles were searched iteratively for further 
possible studies.  
 
Study Selection 
 
Studies were included if they (a) included participants aged 19 or under with 
a DSM or ICD primary diagnosis of OCD (b) included a control comparison 
(waitlist, placebo pill, or placebo therapy) (c) employed randomisation (d) used a 
reliable and valid primary outcome measure (e) were published in English and (f) 
presented sufficient information to enable calculation of effect sizes, including 
means or SDs, t or F values, change scores, and probability values. Duplicate 
publications were omitted, as were publications reporting on subsample results when 
another publication using the full sample existed. 
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Statistical Analysis 
 
Effect Size Calculation 
 
Standardised mean difference was used to represent effect size (d). Where 
available, effect sizes were calculated using change scores. Change scores increase 
the precision of effect size estimators by controlling for pretreatment group 
differences on dependent measurements. The formula used to obtain d is provided 
below, where MTΔ  is the mean change in the treatment group from pretreatment to 
posttreatment, MCΔ  is the mean change in the control group from pretreatment to 
posttreatment, and σpooledΔ is the pooled change SD: 
 
Δ
ΔΔ −=
pooled
CT MMd σ  
 
When change scores were not provided, effect size was determined by subtracting 
the mean posttreatment control group score from the mean posttreatment treatment 
group score, and dividing by the pooled posttreatment SD. The pooled SD was 
computed using the equation below, where NC and NT are the number of observations 
in the control and treatment conditions respectively, and σC and σT are the 
posttreatment SDs of the control and treatment conditions, respectively.  
 
( )( ) ( )( )
2
11 22
−+
−+−=
CT
CCTT
pooled NN
NN σσσ  
 
The above procedure has been used previously (Kobak et al., 1998). In some studies, 
more than one treatment condition was compared to a control condition. When 
computing effect sizes, the number of participants in the control condition was 
evenly divided across the treatment conditions, so that each subject was included 
once only per meta-analysis. Hedge’s small-sample correction was applied as d is 
known to overestimate the population effect size when the sample size is small. 
Effect sizes were standardised so that a positive result indicated that the treatment 
condition performed better than the control condition.  
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Pooled Effect Size Calculation 
 
A random-effects model (REM) was employed to compute mean effects sizes 
across sets of studies. A REM includes a variance component that accounts for 
between-study variance, or uncontrollable differences between studies that may have 
influenced treatment effect. A REM is indicated when heterogeneity is likely to be 
present between comparison samples, or when the researcher wishes to generalise 
REM results to treatment conditions that do not exactly match those included in the 
data analysis. A fixed effects model (FEM) assumes that samples are homogenous 
and treatment conditions are similar across studies. Although the FEM has greater 
statistical power, recent research suggests that the REM is preferable (Field, 2003; 
Hunter & Schmidt, 2000). 
Individual effect sizes were weighted, because effect sizes with smaller 
variances (derived from studies with larger Ns) are more precise estimators of effect. 
Weight in a REM needs to take into account within-study variance (vi) and between-
study variance (η2). Within-study variance was calculated using the formula:  
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d
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Between-study variance was calculated using the formula: 
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Weighted effect sizes were averaged across a given group of studies to determine a 
pooled effect size. To test whether pooled effect sizes differed from zero, 95% 
confidence intervals were calculated: 
 
95% confidence interval
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The confidence limits are therefore: 
confidence limits =  
)(2
2
2
CTCT
CT
NN
d
NN
NNd ++×
+±  
 
If the interval did not include zero, the hypothesis that the true pooled effect size 
equaled zero was rejected at the .05 significance level.  
 
Publication Bias Estimation 
 
As only published studies were included, effect sizes may have been inflated 
due to publication bias, or the ‘file drawer problem’ (Rosenthal, 1979). Such a 
problem occurs if studies reporting significant findings are published (large effect 
sizes) and studies reporting null results (small effect sizes) are not. Publication bias 
was investigated using funnel plots and Egger’s unweighted regression asymmetry 
test. The fail-safe N estimated the number of unpublished studies producing null 
results that would need to exist to negate an observed pooled effect size (Orwin, 
1983; Rosenthal, 1979). It is computed using the formula: 
 
Fail-safe N = ( ) ( )[ ]706.2706.2/ 2 −kZkk  
 
where k is the number of studies in the meta-analysis and z is the standard normal 
deviate corresponding to the one-tailed p value of the effect. An analysis is 
considered resistant to the file-drawer problem if the fail-safe N exceeds 5k plus 10 
(Rosenthal, 1979). 
 
Heterogeneity Analysis 
 
Heterogeneity in a meta-analysis is undesirable and implies that treatment 
outcome varies across studies. This may be due to diversity in patients, interventions, 
trial methodology, or statistical heterogeneity (differences in random error among 
trials). Trials may be unsuitable for pooling. Sources should be explored using meta-
regression (given at least 10 trials per meta-analysis and sufficient moderator 
variable data) or subgroup analysis (Higgins, 2005). 
 86
Chapter 3: Study 1 
 87
 The I2 statistic was used to index degree of heterogeneity. This method is 
unaffected by sample size and has greater power than other heterogeneity tests 
(2002; Higgins, Thompson, Deeks, & Altman, 2003). I2 ranges from 0% to 100%, 
and values above 50% are considered problematic (Higgins, 2005). I2 was calculated 
using the formula:  
 [ ]
∑
∑
−
−−×= 2
2
2
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%100
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dfddw
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ii
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Additional chi square tests of significance of heterogeneity were conducted to 
increase rigor.  
 
Sensitivity Analysis 
 
Sensitivity analysis increases the validity of a meta-analysis by investigating 
how results differ when the criteria for including studies is modified. Subgroup 
analysis was performed and interpretation was based on inspection of the magnitude 
of the pooled effect size and statistical significance of the confidence intervals for 
each subgroup, and heterogeneity between subgroups. Deeks (2001) methodology 
for conducting a chi-square test of heterogeneity between subgroups was employed. 
Qint represents the test statistic and is evaluated at a .10 alpha level due to the 
underpowered nature of the test (Higgins, 2005).  
 
Results 
 
Study Characteristics 
 
The search identified 127 reports documenting the treatment of paediatric 
OCD. Types of treatments are shown in Table 2. Thirteen studies, containing 15 
treatment comparisons, met inclusion criteria for the meta-analysis. The studies are 
summarised in Table 3. There were five control comparisons (N = 161) and ten 
pharmacotherapy to control comparisons (N = 1016). All studies utilised the 
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Table 2  
Publications Reporting the Use of a Treatment for Paediatric OCD 
 
Treatment Studya 
 Uncontrolled design     RCT design 
Psychological treatments       
CBT Weiner (1967) 
Fine (1973) 
Mills (1973) 
Rosen (1975) 
Lindley (1977) 
Yamagami (1978) 
Ong (1979) 
Harbin (1979) 
Stanley (1980) 
Hafner (1981) 
Ownby (1983) 
Zikis (1983) 
Morelli (1983) 
Bolton (1984) 
Hand (1988) 
Wilmuth (1988) 
Mehta (1990) 
Kearney (1990) 
Thornicroft (1991) 
Nicolau (1991) 
Harris (1992) 
Piacentini (1994)  
March (1994) 
March (1995)  
Knox (1996) 
Scahill (1996)  
Van Noppen (1997) 
Owens (1998)  
Fischer (1998)  
de Haan (1998)  
Franklin (1998) 
Gold-Steinberg (1999) 
Neziroglu (2000)  
Rosenberg (2000) 
Woods (2000)  
Thienemann (2001) 
Franklin (2001)  
Tolin (2001) 
Waters (2001)  
Detweiler (2001) 
Benazon (2002) 
Lumpkin (2002) 
Williams (2002)  
Piacentini (2002) 
Benazon (2003)  
Himle (2003) 
Cannon (2003)  
Freeman (2003) 
Turner (2004) 
Piacentini (2004)  
Sallinen (2004) 
Asbahr (2005) 
Lewin (2005) 
Martin (2005) 
Fernandez (2006) 
Storch (2006) 
Tobias (2006) 
Michael (2006) 
Whiteside (2006) 
Valderhaug (2007) 
Storch (in press) 
  (2003a) 
Barrett (2004) 
POTS (2004) 
Bolton (in press)   
 
 
 
 
 
 
 
 
 
Behavioural (non-ERP) therapy Hallam (1974) Queiroz (1981) Lyon (1983) Francis (1988)   
Meta-cognitive therapy Simons (2006)       
Family therapy Scott (1966) Dalton (1983) O’Connor (1983)    
Psychodynamic therapy McGehee (2005)      
Hypnosis Kellerman (1981) Taylor (1985)     
 
Biological treatments 
      
Pharmacotherapy       
   Buspirone Simeon (1994)      
   Citalopram Thomsen (1997) Thomsen (2001) Mukaddes (2003)    
   Clomipramine Rapoport (1980) 
 
Leonard (1989)  
 
March (1990)  
 
Hanna (1993) de Haan (1998) Flament (1985) 
DeVeaugh-Geiss (1992)  
   Fluoxetine Liebowitz (1990) 
Riddle (1990) 
Como (1991) 
Bouvard (1993) 
 
Geller (1995) 
Baysal (1996)  
Semerci (2001)  Riddle (1992) 
Geller (2001) 
Liebowitz (2002) 
   Fluvoxamine Apter (1994) Riddle (1996) Walkup (1999) Yaryura-Tobias (2000)  Riddle (2001) 
   Paroxetine Rosenberg (1999) 
 
Diler (2000)  
 
Gilbert (2000)  
  
 Geller (2003b) 
Geller (2004) 
   Sertraline Johnston (1996)  
 
Alderman (1998)  
 
Procter (2001) 
 
Asbahr (2005) 
 
 March (1998) 
POTS (2004) 
   Sumatriptan Pathak (2003)      
Homeopathy Reichenberg (1998) Reichenberg (1999) Reichenberg (2000) Reichenberg (2002)   
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Treatment 
 
Studya 
 Uncontrolled design     RCT design 
Immunotherapy Allen (1995)  
Giedd (1996) 
Perlmutter (1999) 
Garvey (1999) 
Grados (1999) 
Nicolson (2000) 
Heubi (2003) 
 
  
Combination treatment       
Pharmacotherapies Simeon (1990) Figueroa (1998) Thomsen (1999) Fitzgerald (1999)   
Pharmacotherapy and CBT Wever (1997)     POTS (2004) 
Note. RCT = Randomised, controlled trial, POTS = Pediatric OCD Treatment Study Team, ERP = Exposure and response prevention 
a First author of study reported only 
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Table 3 
Characteristics of Studies Included in the Meta-Analysis 
 
First 
author 
Year Location Condition Design Type Time 
(weeks) 
Diagnostic 
system 
N Mean 
age  
(years) 
Male 
(%) 
Pretest 
M 
Pretest 
SD 
Posttest 
M  
Posttest 
SD 
Change 
in score 
M 
Change 
in score 
SD 
Bolton  In press UK CBT - individual Parallel ITT 5a DSM-IV 10 13.0 60.0 24.00 4.78 13.90 10.74 -10.10 NR 
   Wait-list control     10 13.4 80.0 22.00 8.25 21.10 5.90 -.90 NR 
Barrett  2004 Australia CBT - individual Parallel COM 14 DSM-IV 22 10.75b 50.0b 23.64 4.30 8.36 6.93 -15.28 NR 
   CBT - group     29 12.9 44.83 21.38 5.62 8.28 7.33 -13.10 NR 
   Wait-list control     24 11.7 54.17 22.95 5.49 24.04 4.14 1.09 NR 
POTS  2004 USA CBT - individual Parallel ITT 12 DSM-IV 28 11.4 50.0 26.00 4.60 14.0 9.5 -12.00 NR 
   Sertraline     28 11.7 50.0 23.50 4.70 16.50 9.10 -7.00 NR 
   Placebo - pill     28 12.3 50.0 25.20 3.30 21.50 5.40 -3.70 NR 
Geller  2004 USA/  Paroxetine Parallel ITT 10 DSM-IV 98 11.3 54.1 24.40 4.95 15.10 8.60 -9.30 NR 
  Canada Placebo - pill     105 11.3 61.0 25.30 5.05 19.40 8.20 -5.90 NR 
Himle  2003 USA CBT - group Parallel ITT 10 DSM-IV 5 14.4c 50.0 c 24.10 2.66 14.40 3.56 -9.70 NR 
   Placebo - therapy     5 14.4 c 50.0 c 22.20 4.15 17.40 5.98 -4.80 NR 
Geller  2003b USA Paroxetine Withdrawal ITT 16 DSM-IV 95 11.8 49.5 9.90 6.53 13.50 NR 3.60 9.0 
   Placebo - pill     98 11.6 59.2 9.60 6.04 16.50 NR 6.90 8.5 
Liebowitz  2002 USA Fluoxetine Parallel ITT 16 DSM-III-R 21 13.0 52.4 22.50 4.16 12.76 10.00 -9.74 NR 
   Placebo - pill     22 12.3 63.6 23.82 5.77 19.68 10.61 -4.14 NR 
Riddle  2001 USA Fluvoxamine Parallel ITT 10 DSM-III-R 57 13.4 50.9 24.20 4.40 18.20 8.60 -6.00 NR 
   Placebo - pill     63 12.7 56.6 24.20 4.80 20.90 8.50 -3.30 NR 
Geller  2001 USA Fluoxetine Parallel ITT 13 DSM-IV 71 11.4 48.0 24.50 5.10 15.00 9.60 -9.50 9.2 
   Placebo - pill     32 11.4 47.0 26.30 4.60 21.10 8.40 -5.20 7.4 
March  1998 USA Sertraline Parallel ITT 12 DSM-III-R 92 12.6 c NR 23.36 4.56 16.56 8.30  -6.80 8.3 
   Placebo - pill     95 12.6 c NR 22.25 6.15 18.85 8.00  -3.40 8.0 
DeVeaugh- 1992 USA Clomipramine Parallel ITT 8 DSM-III 31 14.5 74.2 27.10 5.90 17.10 8.30 -10.00 7.9 
  Geiss   Placebo - pill     29 14.0 55.2 28.40 4.40 26.10 6.80 -2.30 5.8 
Riddle 1992 USA Fluoxetine Crossover COM 8 DSM-III-R 7 12.0 28.6 24.30 4.20 13.60 5.70 -10.70 NR 
   Placebo - pill     6 11.2 50.0 20.20 7.70 14.80 7.00 -5.40 NR 
Flament  1985 USA Clomipramine Crossover COM 10 DSM-III 19 14.5 c 73.7 c 20.90 8.60 10.30 6.20 -10.60 NR 
   Placebo - pill     19 14.5 c 73.7 c  20.90 8.60 14.90 9.90 -6.00 NR 
Note. POTS = Pediatric OCD Treatment Study Team, COM = Completers analysis, ITT = Intention-to-treat analysis, NR = not reported.  
a Treatment was intensive (up to 10 sessions, once to three times weekly) b Based on full sample, data not available for completers c Pooled data given for treatment 
and control condition. 
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Children’s Yale-Brown Obsessive Compulsive Scale (Goodman et al., 1986) as the 
primary OCD measure, except for Flament and colleagues (1985) who used the 
Leyton Obsessional Inventory - Child Version (Berg & Whitaker et al., 1988). A 
study by March and colleagues (1990) was excluded because it was part of a larger 
study by DeVeaugh-Geiss and others (1992), and a study by Scahill and colleagues 
(1997) was excluded because results had been published previously (Riddle et al., 
1992). Two pharmacotherapy studies (Leonard, Swedo, Lenane et al., 1991; Leonard 
et al., 1989) were excluded because the comparison group was an active comparator 
and not a control comparator. A study on a PANDAS OCD subgroup was excluded 
(Perlmutter et al., 1999). Remaining studies were excluded as they were not RCTs. 
 
Standardised Mean Difference and Pooled Effect Sizes 
 
A forest plot of bias-corrected effect sizes is presented in Figure 1. Table 4 
shows the pooled weighted effect sizes for each subset of studies that was compared. 
No significant heterogeneity was observed in the pharmacotherapy versus control 
comparison (I2 = 0%, p = .59), whereas significant heterogeneity was observed in the 
CBT versus control comparison (I2 = 91.9%, p = .0006).  
 
Table 4  
Pooled Effect Sizes of OCD Symptom Severity for Treatment Approach Compared to 
Control 
 
Treatment  Average  
effect size
95% CI 
(lower, upper)
I2 (%) Test for overall 
effect (z, p) 
n 
CBT 1.45 0.68, 2.22 76.0 3.69, p =.0002 5 
Pharmacotherapy .48 0.36, 0.61 0 7.50, p < .00001 10 
  Clomipramine .85 0.32, 1.38 37.2 3.21, p = .0018 2 
  Fluoxetine .51 0.18, 0.84 0 3.02, p = .0026 3 
  Fluvoxaminea .31 -0.05, 0.67 NA 1.71, p = .09 1 
  Paroxetine .44 0.24, 0.64 0 4.36, p < .0001 2 
  Sertraline .47 0.21, 0.73 0 3.61, p = .0003 2 
Note. n = number of studies. NA = not applicable 
a Results were not pooled due to lack of multiple studies 
 91
Chapter 3: Study 1 
 
 
 
Weight 
(%) 
Effect  
Size 
95% CI  
Lower   Upper
CBT      
Bolton (in press)   20.62 .80 -.12 1.71 
Barretta (2004)   19.55 2.50 1.56 3.45 
Barrettb (2004)   20.62 2.35 1.49 3.20 
POTS (2004)   24.24 .96 .40 1.51 
Himle (2003)  15.72 .55 -.73 1.83 
 
 
 
 
Pharmacotherapy      
POTS (2004)   5.47 .66 .12 1.20 
Geller (2004)   20.29 .51 .23 .79 
Geller (2003b)   19.59 .38 .09 .66 
Liebowitz (2002)   4.19 .66 .04 1.27 
Riddle (2001)   12.22 .31 -.05 .67 
Geller (2001)   8.88 .49 .07 .91 
March (1998)   18.91 .42 .13 .71 
DeVeaugh-Geiss (1992)   5.35 1.09 .55 1.64 
Riddle (1992)   1.33 .18 -.92 1.27 
Flament (1985)   3.77 .55 -.10 1.19 
          
        
-1 0 1 2 3 4
                    Favours control         Favours treatment 
 
aIndividual CBT condition  bGroup CBT condition  
- 0 1 2 3 41 
  
     Figure 2. Weighted effect sizes and 95% confidence intervals of RCTs included in the CBT and pharmacotherapy meta-analyses.  
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The 95% confidence interval for the pooled effect size of the CBT versus 
control comparison did not contain zero, indicating that the effect of CBT on OCD 
symptom severity was significantly greater than zero. This significant random effect 
is generalisable to the population. Using Cohen’s conventions, the magnitude of the 
treatment effect is large. The large standard error of the pooled effect indicates low 
precision. Pharmacotherapy versus control generated a significant treatment effect, 
with a medium magnitude. The narrow conference interval indicates precision in 
measurement.   
 
Publication Bias 
 
Publication bias was tested graphically and statistically. Funnel plots of effect 
size plotted against the reciprocal of the standard error were constructed. The small 
number of studies included in the meta-analyses presented difficulty verifying the 
presence or absence of asymmetry. Egger’s (1997) unweighted regression test 
showed no evidence of publication bias. (CBT, p = .72; pharmacotherapy, p = .28). 
The fail-safe N statistic indicated that 66 CBT RCTs and 132 pharmacotherapy 
RCTs with null results would have to exist to reduce the effect sizes to a non-
significant level. Rosenthal’s (1983) guideline suggests that the results are robust to 
publication bias.  
 
Heterogeneity, Sensitivity, and Moderators 
 
Significant heterogeneity existed in the CBT versus control comparison. 
Separate forest plots of CBT subgroup outcomes (wait-list versus placebo) are 
presented in Figure 2. The chi-square test revealed statistically significant between-
subgroup heterogeneity [Qint (1) = 7.67, p = .006]. The placebo subgroup had a lower 
pooled effect size than the wait-list subgroup, though both pooled effect sizes 
remained large and statistically significant.  
Figure 1 illustrated that the effects attained in Barrett and colleagues study 
were larger than other CBT studies. Sensitivity analysis excluding this study’s 
results revealed that CBT still had a large and significant pooled effect of 0.87 (95% 
CI = 0.42 to 1.32) and significant heterogeneity between subgroupings, Qint(1) = 
15.25, p < .001. 
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-1 0 1 2 3 4 -1 0 1 2 3 4
CBT Wait-List Controlled CBT Placebo-Controlled Trials 
 
 
 
 
 
 
 
 
 
Pooled effect size = .89, 95% CI = .38 to 1.40 
Test for heterogeneity: χ2 (1) = 1.45, p = .23, I2 = 31.1% 
Test for overall effect: z = 3.56, p < .0004 
  
Pooled effect size = 1.88, 95% CI = .83 to 2.94 
Test for heterogeneity: χ2 (2) = 4.36, p =.11, I2 = 54.1% 
Test for overall effect: z = 12.15, p < .00001 
 
 
 
 
Figure 3. Subgroup analysis of CBT RCT studies differentiated by method of control. 
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Sensitivity analysis comparing pharmacotherapy trials by intention-to-treat to 
completer analyses yielded medium effects for these subgroupings, yet the 
completers pooled effect was no longer significant. Heterogeneity among subgroups 
was non-significant, Qint(1) = 0.01, p = .92. Among the CBT trials, the completers 
subgrouping yielded a higher effect size. There was significant heterogeneity 
between the completers and intention-to-treat subgroups [Qint(1) = 15.25, p < .001], 
but both effect sizes were large. 
 
Table 5 
Characteristics and Reporting of Moderator Variables in CBT and 
Pharmacotherapy RCTs for Paediatric OCD 
 
Moderator variables CBT Pharmacotherapy 
 n Percent 
missing
Meana n Percent 
missing 
Meana
Methodological        
Method of control       
   Placebo 2  0 - 10 0 - 
   Wait-list 2 0 - 0 0 - 
Prior course of treatment       
    Excluded 2 0 - 6 0 - 
    Did not exclude 2 0 - 4 0 - 
Tic disorder and/or Tourette’s       
    Excluded 1 0 - 3 0 - 
    Did not exclude 3 0 - 7 0 - 
Patient        
Age, years 4 0 12.06 10 0 12.19 
Sex, % male 4 0 51.60 10 0 55.12 
Baseline OCD severity (CYBOCS) 4 0 23.55 10 0 21.12 
Age at onset, years 2 50% 11.25 5 50% 8.48 
Duration of symptoms, years 2 50% 2.36 5 50% 4.18 
Comorbidity       
   Any Axis I 3 25% 76.84 6 40% 44.84 
   Internalising 2 50% 69.31 2 80% 59.71 
   Externalising 1 75% 26.95 2 80% 24.89 
   Tourette’s/tic disorder 3 25% 9.89 8 20% 7.08 
   ADHD 1 75% 20.00 7 30% 8.16 
Baseline depression severity 2 50% -b 4 60% -b 
Treatment        
Length of treatment       
   Weeks 4 0 11.74 10 0 11.91 
   Hours of therapy  4 0 16.37 NA NA NA 
Attrition, % 3 25% 11.89 10 0 22.17 
Note. a Weighted by study sample size b Not computed as difference measures were employed. 
CYBOCS = Children’s Yale-Brown Obsessive Compulsive Scale (Goodman et al., 1986). 
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The small number of studies negated meta-regression examination of 
moderator variables or further heterogeneity analysis. Several potential moderator 
variables were coded in the studies, and the nature of these variables and reporting 
rates are presented in Table 5.  
 
Discussion 
 
Despite a variety of treatments discussed in the literature, a comprehensive 
literature search revealed that CBT and pharmacotherapy were the only treatment 
modalities examined using RCT methodology. The effect size of CBT was large at 
1.45 (95% CI = 0.68 to 2.22). The pharmacotherapy effect was medium at 0.48 (95% 
CI = 0.36 to 0.61). The pharmacotherapy response varied somewhat according to 
type of medication used. Both treatments were significantly superior to control, with 
CBT yielding a larger treatment effect. These findings are consistent with treatment 
outcomes in the adult OCD population (Kobak et al., 1998) and support the 
recommendations of the Expert Consensus guidelines. CBT should comprise the first 
line treatment for paediatric OCD, followed by pharmacotherapy. Although 
clomipramine had the largest effect size of the pharmacological interventions, it is 
known to have a more adverse side effect profile than the selective serotonin 
reuptake inhibitors (Rapoport & Inoff-Germain, 2000). Clomipramine is generally 
regarded as a second-line pharmacological agent compared to these medications 
(Geller et al., 2003a).  
The theories underlying CBT and pharmacotherapy have different bases. 
Whereas pharmacotherapy emphasises a biological mechanism of change involving 
correction of dysfunction to neurochemistry, CBT modifies unhelpful thinking styles 
and promotes habituation to anxiety-provoking stimuli. The efficacy of these 
interventions supports current discourse highlighting not one, but both models, as 
implicated in the maintenance of OCD in children. These results are consistent with 
literature reporting that treatment using a combination of pharmacotherapy and CBT 
is superior to one treatment modality only (POTS, 2004). Although the models differ 
in proposed change pathways, an alternative way of conceptualising these models is 
via a shared commonality. Both treatments are anxiolytic, therefore, it may be that a 
reduction in anxiety precedes a reduction in OCD symptoms. Although this 
conceptualisation is plausible it cannot explain the finding that relaxation training 
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among adults with OCD is an inert treatment. Nonetheless, this study should serve to 
focus research and clinical attention on the theoretical models above, as opposed to 
theoretical models that fail to predict treatment change.  
This study substantiated findings from previous meta-analyses of RCTs and 
non-RCTs, showing that CBT and pharmacotherapy are efficacious, but contributed 
unique insight into the composition of this effect. Pooled effect sizes can be 
significantly inflated in meta-analyses employing non-RCTs. Lipsey and Wilson 
(1993) examined 45 treatment meta-analyses, and found that effect sizes were an 
average 62% larger in studies not including a control group (e.g., one group pre-post 
designs) and a meta-analysis of adult OCD treatments found that effect size was 52% 
larger for uncontrolled studies compared to controlled studies (Kobak et al., 1998). 
Uncontrolled studies do not rule out the influence of non-specific factors, which may 
bias effect size upwards. Nonspecific factors are contextual or incidental aspects of 
treatment, such as therapeutic alliance, expectations for improvement, and attention 
(Grencavege, Bootzin, & Shoham, 1993). Placebo control groups are the only 
effective means of controlling for non-specific factors. All of the medication trials 
used a placebo control. As expected, the exclusion of uncontrolled trials in the 
pharmacotherapy meta-analysis resulted in an attenuated pooled estimate of effect 
compared to previous meta-analyses. The pooled effect size for pharmacotherapy 
was 49% to 57% lower than in meta-analyses including non-RCTs. In the CBT 
meta-analysis, 40% used placebo-controls and 60% used wait-list controls. The 
pooled effect size was 6% to 27% lower than in previous meta-analyses with 
controlled and uncontrolled trials (Abramowitz et al., 2005; Freeman et al., 2007; 
Phillips, 2003). It cannot be conclusively inferred whether the attenuated CBT effect 
is due to a placebo effect, as waitlist controls do not control for many nonspecific 
factors. Subgroup analysis provided evidence that placebo factors may influence 
treatment outcome. However, this may have been confounded by differences in 
between-study characteristics, such as hours of treatment and use of completer 
versus intention-to-treat analyses.  
The precision of treatment effect varied between CBT and pharmacotherapy. 
The narrow confidence interval of the medication effect shows that improvement can 
be predicted with good reliability. Conversely, the confidence interval surrounding 
the pooled CBT effect size were large. Poor reliability can result from heterogeneity 
in study outcomes, attributable to small subject numbers or moderator variables. 
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Moderator variables include patient (e.g., age, comorbidity), methodological (e.g., 
control method used, rater blinding) and treatment characteristics (e.g., intensity, 
duration, delivery method). Heterogeneity in the CBT meta-analysis was diminished 
when the outlying high effect size study by Barrett was excluded. Without moderator 
analysis, it is unclear what source produced heterogeneity and greater improvement 
in this trial. The higher effect size could have been due to the use of a wait-list 
control, completer analysis (as opposed to intention-to-treat), or increased treatment 
hours (21 hours of treatment versus an average 14 hours in the other trials). 
Moderator analysis is required to identify variables that produce differences in 
treatment outcome.  
Moderator analysis is an important application of meta-analytic procedures. 
Individual trials often have insufficient statistical power to detect moderators. Many 
putative treatment moderators have been documented in the extant paediatric OCD 
literature (March & Curry, 1998). Moderator investigation methods, such as meta-
regression, require a minimum sufficient number of studies and variable statistics 
(e.g., means, SDs) must be available for extraction in published trials. This meta-
analysis found that putative moderator variables are not adequately described in 
RCTs. RCTs forthwith are urged to include this information. 
 
Study Limitations  
 
There were only a small number of RCTs available and subject exclusion 
criteria within RCTs means that results may not be generalisable to the entire 
paediatric OCD population. The method of effect size calculation for a meta-analysis 
can vary. The effect size methodology chosen in this study was prespecified and 
contemporary, yet alternative procedures would have produced somewhat varying 
estimates. In this meta-analysis, CBT studies were pooled based on theoretical 
grounds, despite heterogeneity. This may not have been appropriate.  
 
Research Implications 
 
The large treatment effect generated by CBT is encouraging to researchers. 
The therapeutic promise inherent in this treatment, and the inchoate nature of 
research in this area, necessitates further investigations. Barrett and colleagues 
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(2003b) initiated the examination of cognitive developmental factors implicated in 
the maintenance of paediatric OCD. The extension of this line of research could have 
important application to cognitive treatment strategies, which may increase treatment 
effect. Component studies could be conducted to tease apart the relative efficacy of 
cognitive and behavioural elements. Focus on the impact of developmental factors 
on treatment response is overdue. Investigations are required to understand how well 
individuals of different age groups respond to the cognitive therapy component of 
CBT. Young people with OCD are more likely than adults to have comorbid 
diagnoses of Tourette’s Syndrome and tic disorders, or may be part of the Paediatric 
Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections 
(PANDAS) subgroup. It is not clear whether CBT or pharmacotherapy treatment 
response varies as a function of paediatric patient characteristics. A further avenue 
for exploration is CBT delivered in different treatment formats. Other formats may 
comprise useful alternatives to traditional individual CBT. Delivery in an intensive 
format may increase uptake and retention in treatment, as therapy time would 
conflict less with external family commitments. As children with OCD experience 
shame and embarrassment regarding their symptoms, group therapy may comprise a 
powerful means for normalising experiences, and obtaining support and motivation. 
Only one pilot study has investigated this treatment modality in comparison to a 
placebo, but the sample size was only ten (Himle, 2003). The contribution of family 
involvement in treatment to CBT efficacy is also unknown, as is the efficacy of 
treatments following discontinuation. In the adult literature CBT outperforms 
pharmacotherapy at follow-up, yet follow-ups periods are short or non-existent in the 
paediatric literature. Studies need to be controlled and incorporate longer follow-up 
periods in order to be meaningful. Further understanding of the long-term effects of 
CBT and medication is warranted. More randomised CBT research incorporating 
standard methodology and placebo control groups is required, as is more research 
that investigates the long term physical, social, and behavioural sequelae of SRI and 
SSRI use among children.  
 
Clinical Implications 
 
The findings from this meta-analysis clearly show that CBT and 
pharmacotherapy are the only treatment methods for paediatric OCD supported by 
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evidence. There is often a time-lag between research studies and knowledge uptake 
by clinicians (Weisz, Donenberg, & Han, 1995). The preferred treatment method of 
psychiatrists and psychologists in clinical practice often differs from those 
recommended in research publications (Valderhaug, Gotestam, & Larsson, 2004). A 
recent survey of clinicians involved in the treatment of paediatric OCD found that 
only one third regularly used exposure techniques, one third “sometimes” used them, 
and the remaining third reported “rarely or never using” them (Valderhaug et al., 
2004). This is concerning because exposure (and response prevention) is the core 
treatment strategy in CBT. Efficacious treatments need to be made available to the 
individuals they can assist. A reason treatment may not be accessible is because few 
therapists are adequately trained in the use of cognitive-behavioural techniques for 
OCD, especially those proficient in working with children (March, Frances, 
Carpenter, & Kahn, 1997).  To date, only one treatment manual has been published 
(March & Mulle, 1998). Accessibility to CBT could be enhanced via inclusion in 
relevant graduate training programs, peer supervision from practitioners proficient in 
CBT treatment for paediatric OCD, workshops by skilled practitioners, and literature 
illuminating the process of treatment. 
 
Conclusion 
 
Even though the pooled effect size for CBT is larger than pharmacotherapy, 
meta-analysis cannot outrightly determine which treatment is superior. Differences 
in design, methodology, and patient characteristics (i.e. moderator variables) could 
account for the difference in observed effect sizes rather than differences in the 
efficacy of the interventions. Only head-to-head RCTs can determine the relative 
efficacy of different interventions. Nonetheless, this study presents findings 
consistent with the POTS study, which determined a large CBT treatment effect and 
medium pharmacotherapy effect, and that both treatments alone and in combination 
were significantly superior to placebo.  
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Chapter Summary 
 
This study is the first known meta-analysis of randomised, controlled 
treatment trials for paediatric OCD. Despite the availability of multiple treatment 
modalities for paediatric OCD, only CBT and pharmacotherapy have been evaluated 
using randomised, controlled methodology. This study makes an important 
contribution by highlighting the most likely magnitude of the effect of these 
treatments, as the use of RCTs eliminates bias in effect size calculation arising from 
confounding variables. Study results supported the efficacy of CBT and 
pharmacotherapy relative to placebo. CBT demonstrated the largest effect size of all 
the treatments. The medications (sertraline, fluoxetine, paroxetine, and fluvoxamine) 
had moderate effect sizes, except for clomipramine which had a large effect size. 
The results of this meta-analysis support the recommendations of the Expert 
Consensus Guidelines. Literature suggests that although clomipramine is more 
effective at treating paediatric OCD, it has a more adverse side effect profile than the 
SSRIs. It should be used as a second line pharmacological agent. CBT appears to be 
the most effective treatment available for paediatric OCD. Many opportunities to 
expand the knowledge related to this clinical approach are possible. One such avenue 
of inquiry is the evaluation of innovative treatment delivery formats. 
Chapter 4 
 
Chapter 4 
Group Therapy: An Alternative Model of Treatment Delivery 
for Paediatric Obsessive-Compulsive Disorder 
 
 
 
CBT administered in an individual format has proven to be an effective 
treatment for paediatric OCD. Despite the recent advances in the treatment research 
literature, relatively few studies have examined the delivery of CBT in a group 
format. There is a strong rationale for investigating this treatment modality. There 
are; (1) practical and therapeutic advantages to this treatment modality, (2) firm 
theoretical grounds for CBT, and (3) adult OCD studies have supported the efficacy 
of group CBT.  
 
Practical and Therapeutic Advantages of Group CBT 
 
The practical rationale for evaluating therapy in a group format is 
compelling. Group therapy is more time and cost efficient than individual treatment 
(Fals-Stewart, Marks, & Schafer, 1993; Himle et al., 2001; Himle, Van Etten, & 
Fischer, 2003). Fals-Stewart and colleagues reported that the number of hours 
required to treat approximately 30 adult clients with OCD over a 12-week period 
was 720 for individual therapists compared to 48 for group therapists. This 
corresponds to a 93% reduction in therapist time. A 12-week course of CBT with an 
estimated cost of $120 per individual session and $70 per group session would save 
the client approximately $600 if they opted for group therapy (Himle, Van Etten et 
al., 2003). Group therapy provides a means of utilising specialist skills in a 
resourceful manner. Few therapists are adequately trained in the use of cognitive-
behavioural techniques for OCD (Marks, 1997), especially those proficient in 
working with children (March et al., 1997). Delivery of the treatment in a group 
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format is a useful means of deriving the most benefit from limited resources (Himle 
et al., 2001; Whittal & McLean, 2002).  
Unique group therapeutic benefits add further incentive to explore this 
treatment modality. Group therapy may be associated with a lower participant 
attrition rate than individual therapy (Cordioli et al., 2003). Clinical observations 
suggest that treatment compliance is superior during adolescent group therapy than 
individual therapy (Fischer et al., 1998). Peer reinforcement promotes engagement in 
ERP tasks during sessions and homework completion between sessions (McLean et 
al., 2001). Attendance at sessions may be positively reinforced by the pleasure group 
members receive in helping others gain success over OCD-related behaviours. This 
can enhance perceptions of mastery, competence, and a positive self-concept, and 
decrease feelings of isolation and loneliness (Himle, Van Etten et al., 2003; Van 
Noppen et al., 1997). High levels of group cohesiveness and likeability have been 
reported among individuals receiving group treatment (Himle, Van Etten et al., 
2003). The pattern of OCD symptoms varies over time. In group treatment, children 
are exposed to a broader array of OCD symptoms and ERP applications (Himle, Van 
Etten et al., 2003). This can promote the generalisation of treatment gains should 
children develop subsequent alternative symptomatology. In the context of 
individual therapy, the therapist models ERP tasks and functional behaviours. In 
group therapy the child’s peers model CBT exercises. Social learning theory predicts 
that individuals will be more likely to adopt a modelled behaviour if they perceive 
the model to be similar to themselves and the model is rewarded (Bandura, 1977). 
Seeing other children perform ERP exercises and experience gains can promote 
therapeutic imitative behaviour. Children have the opportunity to teach other 
children how to initiate ERP tasks. Pedagogical action in the form of teaching 
enhances the retainment of procedural and declarative knowledge relative to other 
forms of learning, such as teacher-directed instruction. Group contexts allow group 
members to identify the cognitive distortions of others, which may potentially 
facilitate the recognition and disputation of their own unhelpful distortions 
(Morrison, 2001). 
Additional therapeutic benefits may be afforded by the group process. These 
include the normalisation and destigmatisation of symptoms (Fischer, Himle, & 
Hanna, 1998; Himle, Van Etten, & Fischer, 2003; Whittal & McLean, 2002). 
Children often keep their symptoms secret as they fear that they are going “mad” or 
 103
Chapter 4 
 104
worry about the consequences of disclosure (Chowdhury, Caulfield, & Heyman, 
2003). Group treatment can afford children and parents the opportunity to develop 
informal and durable support networks (Himle, Van Etten et al., 2003). These 
networks can comprise invaluable sources of information about OCD and relevant 
community resources. Theories of group therapy support the utility of group 
approaches. Yalom (1995) proposed a number of therapeutic factors that may 
operate in the group treatment mode, including altruism, interpersonal learning, 
social learning, group cohesiveness, and universality. Universality refers to the 
learning that one is not alone in the types of thoughts, feelings, and experiences one 
has.  
 
Theoretical Rationale 
 
Treatment interventions utilised in group CBT are derived explicitly from 
cognitive-behavioural theory. The cognitive-behavioural model proposes that OCD 
symptoms are maintained by unhelpful cognitions that lead to anxiety when an 
individual is confronted with relevant internal or external situational stimuli. 
Compulsions maintain OCD symptoms by precluding opportunities for habituation 
to anxiety and disconfirmation of unhelpful cognitions. Compulsions negatively 
reinforce rituals, due to an anxiety-alleviating effect, thereby increasing the 
likelihood that they will be repeated. Theoretical mechanisms of OCD symptom 
maintenance are targeted in group CBT interventions. The reader is referred to 
Chapter 1 and 2 for a more comprehensive account of this model and related 
intervention techniques. The application of this model to adult and child OCD has 
been supported in an extensive clinical and research literature (Clark, 2004). The 
intervention strategies in group CBT for OCD are derived directly from this theory, 
hence, group CBT is likely to be an effective treatment for paediatric OCD.  
 
Group CBT for Adult OCD 
 
A third rationale for the hypothesis that group CBT is likely to be effective 
for paediatric OCD is derived from its demonstrated efficacy in treating adult OCD. 
Eight known studies have examined group CBT in adults, with four including a 
control comparison. Table 6 displays the properties of these studies, including the 
Chapter 4 
Table 6  
Studies on Group CBT for Adult OCD 
 
First author N Control 
group 
Total 
treatment 
(hours) 
Exclusion 
criteria 
Follow-up 
(months) 
Reduction in 
symptoms (%) 
Effect sizea 
    Pre-post Pre-follow-up Pre-post Pre-follow-up
Krone (1991)   36 No 14 Yes 3 24 45 .79 1.49 
Fals-Stewart (1993)  93 Yes 24 Yes 6 46 37 - - 
Van Noppen (1997) 17 No 20 No 12 31 39 1.01 1.31 
Van Noppen (1998) 90 No 15 Yes 25 24 NA .93 3.89 
Himle (2001) 113 No 14 No 3 30 32 1.03 1.38 
  No 19 No 3 32 30 1.02 .94 
McLean (2001) 76 Yes 30 Yes 3 27 21 1.00 .79 
  Yes 30 Yes 3 39 41 1.87 1.95 
Cordioli (2003) 47 Yes 24 Yes 3 43 55 2.37 2.98 
Anderson (2007) 63 Yes 20 Yes 1 29 33 1.00 1.14 
aEffect size (Cohen’s d) was calculated as the difference between the mean posttreatment and pretreatment score, divided by the pretreatment SD. Effect sizes could 
only be computed if pretreatment SDs were available. 
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average reduction in symptom severity and treatment effect sizes. Group CBT 
resulted in mean reductions in symptom severity ranging between 24% and 43% at 
posttreatment and between 21% and 55% from pretreatment to follow-up. The effect 
size for each treatment arm across time was large. The four RCTs supported the 
efficacy of group CBT. Anderson and Rees (2007) randomly allocated subjects to 
group CBT, individual CBT, and wait-list control. The treatment conditions had 
significantly lower symptom severity compared to the control condition at 
posttreatment. Group CBT had equivalent effectiveness to individual CBT. McLean 
(2001) compared group CBT and group ERP to wait-list control. Each treatment was 
significantly more effective than the control group at alleviating OCD symptoms. The 
control condition used in Cordioli’s (2003) study was a wait-list condition. Group 
CBT was significantly effective at reducing the severity of OCD symptoms over time. 
Fals-Stewart (1993) used individual relaxation as a comparison to group and 
individual CBT, and found that group and individual CBT were significantly more 
effective than control at reducing symptomatology. Neither treatment arm was 
significantly superior to the other. This result suggests that group CBT for adults is 
effective beyond a placebo effect or nonspecific treatment effect.  
Results from adult group CBT are likely to be applicable to children. The 
clinical presentation of OCD is very consistent between children and adults (Grados, 
Labuda, Riddle, & Walkup, 1997). Children appear to have a similar response to 
treatments used with adults and similar pathophysiology has been implicated, 
including neurochemical, cognitive, behavioural, and genetic factors. Although the 
disorder is not perfectly congruent in childhood and adulthood, there seems to be 
sufficient overlap to warrant the prediction that group CBT will be efficacious among 
children with OCD. 
 
Existing Studies on Group CBT for Paediatric OCD 
 
Despite the numerous practical and therapeutic advantages potentially 
afforded by group CBT and the compelling rationale for its validation and use, group 
CBT is an understudied mode of treatment delivery. Six studies have examined the 
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efficacy of this treatment approach. These studies utilised a treatment protocol based 
upon the work of March and Mulle (1998). March and Mulle developed an individual 
CBT treatment manual including elements of psychoeducation, cognitive therapy, and 
ERP which has been adapted to group delivery by research teams. The existing child 
group CBT treatment studies will now be reviewed.  
Fischer, Himle and Hanna (1998) reported results from an open trial of group 
CBT with 15 adolescents (aged 12 to 17). Participants were administered a 7-week 
treatment program that provided a) education about OCD and its treatment b) a 
framework for externalising OCD c) behavioural techniques to ‘fight’ OCD, and d) 
therapist-guided ERP. The program was based on March and Mulle’s  (1998) 
program. Children met once weekly for 1.5 hour sessions. OCD was diagnosed using 
unstructured clinical interviews based on DSM-III-R or DSM-IV criteria. Symptom 
severity decreased an average 32% at posttreatment. Follow-up data at six months 
indicated significant treatment gains. Symptom severity had decreased by a further 
23%. This reflected a change in symptom severity from moderate (distress and 
functional impairment) to mild (distress but not necessarily functional impairment). 
Methodological shortcomings limit the validity of the findings. The lack of a control 
group poses problems for the attribution of causality. Although the results could have 
been due to a specific treatment effect it is just as plausible that they were the product 
of nonspecific factors, such as regression to the mean or a natural reduction in 
symptom severity over time. Treatment was not restricted between posttreatment and 
follow-up, hence, it is unclear whether the treatment gain during this phase was the 
result of group CBT or additional treatments. The lack of a standardised approach to 
diagnostic assessment limits conclusive interpretations. Unstructured diagnostic 
procedures reduce the reliability and validity of the diagnosis. The researchers 
employed a narrow assessment procedure. Greater confidence in findings is enhanced 
when multiple measures are employed. Strengths of the study included the 
stabilisation of medication and discontinuation of other psychotherapies prior to the 
commencement of group treatment. The researchers employed the use of a protocol-
driven treatment, which increases the likelihood that different therapy groups received 
similar treatment content. This strengthens the generalisability and internal validity of 
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the findings, and makes transportability to alternative research and clinical settings 
more feasible. Exclusion criteria employed included mental retardation and autistic 
disorder, as examples. This strategy is commonly utilised in efficacy studies to 
examine the effects of the treatment upon ‘pure’ symptomatology. Despite the 
shortcomings of this study, it set a valuable benchmark in that it supplied preliminary 
information regarding the effectiveness of group CBT for children with OCD. 
Thienemann and colleagues (2001) conducted an open trial of group CBT for 
adolescent OCD. Eighteen adolescents aged 13 to 17 years received a 14-week 
program of CBT adapted from March and Mulle’s (1998) program. Weekly two-hour 
sessions were held, and parents attended the final 15 minutes of each session, and all 
of session six. Session nine comprised an individual session, and was used to check in 
with individual patients and their parents to address individual issues. DSM-IV 
diagnoses were assigned during a clinical interview, although no standardised 
interview schedule was employed. No exclusion criteria were utilised. Results showed 
that symptom severity declined from severe at pretreatment to moderate at 14 weeks, 
representing a 25% mean reduction. Several potential confounds were inherent within 
the design of the study. Firstly, no control group was employed. Secondly, a number 
of participants received concomitant treatment. Fifteen of the participants reported 
concurrent use of medication, and eight received concurrent individual or family 
psychotherapy. Four adolescents underwent a change in medication dosage during the 
study. It is not possible to attribute the improvement to CBT alone. Nonspecific 
factors including placebo effects may have led to an inflation in improvement ratings. 
No follow-up data were collected to determine the durability of the results.  
Himle (2003) compared group CBT to a credible placebo intervention using a 
block randomised, controlled design. Five adolescents received a 12-week course of 
group CBT and five adolescents received a 12-week course of group AMT. Sessions 
lasted 90 minutes, and parents attended sessions one, six, and twelve. The CBT 
programme was adapted from March and Mulle’s manual (1998). Structured, clinical 
interviews based upon DSM-IV diagnostic criteria were used to assign a diagnosis of 
OCD. The Schedule for Affective Disorders and Schizophrenia for School-Age 
Children – Epidemiological Version – 5 (Orvaschel, 1995) was used. Exclusion 
 108
Chapter 4 
criteria included co-occurring diagnoses (current substance use disorder, mental 
retardation, autistic disorder, chronic neurological disorder other than chronic tics, 
schizophrenia and other psychotic disorders, bipolar I disorder, anorexia nervosa), a 
prior course of CBT for OCD, and prominent suicidal/homicidal ideation with 
imminent risk. At posttreatment, children in the group CBT condition showed a 
significantly greater reduction in symptom severity (average 40% versus 22%) 
compared to children receiving placebo. This outcome was established using blind 
raters. At follow-up, children in the group CBT condition maintained gains, while 
children in the AMT programme returned to baseline. A strength of the study was that 
none of the children received concurrent pharmacotherapy or psychotherapy for 
OCD. The results provide preliminary support for the efficacy of group CBT in 
treating childhood OCD beyond non-specific treatment factors, such as normalisation 
of symptoms, increased social support, and the therapeutic relationship. The small 
sample size attenuates the validity of the findings. It is unclear whether the results 
would generalise to children with OCD as only adolescents were included in the 
study. The authors stated that the placebo was credible, yet did not appear to assess 
credibility from patients. No follow-up data were collected making it impossible to 
determine whether the improvement in symptomatology was sustained beyond 
treatment completion.  
Barrett and colleagues (2004) compared group and individual CBT to a wait-
list control condition. The program consisted of 14 weekly sessions and two booster 
sessions that lasted approximately 1.5 hours each. Eighty-two children aged 7 to 17 
years were randomly assigned to conditions. Children were diagnosed using the DSM-
IV based ADIS-P (Silverman & Albano, 1996). Exclusion criteria were primary major 
depression, primary externalising disorder, Tourette’s syndrome, autistic spectrum 
disorder, schizophrenia, organic mental disorder, concurrent psychotherapy, and non-
stabilisation of OCD medication in the three months prior to treatment. The study 
utilised a group adaptation of the March protocol with an extensive family 
component. The programme targeted intervention at the child, parents, and siblings. 
At posttreatment participants in the individual and group CBT conditions had a 
significant mean reduction in the severity of OCD symptomatology (65% and 61%, 
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respectively), contrary to the control group (5% increase). At 6-month follow-up 87% 
of the group CBT participants were OCD diagnosis-free, compared to 65% of the 
individual CBT participants. No data were available on the control condition at 
follow-up, as these participants had since completed a CBT program. Gains were 
maintained at 3-year follow-up (Barrett et al., 2005). Relative strengths of the study 
included assessment raters that were blind to pre- versus post-group status, a 
standardised diagnostic procedure, standardised treatment delivery, randomisation to 
conditions, and stabilisation of medication prior to CBT. Some methodological 
limitations were inherent within the methodological design. The primary limitation 
was the lack of equivalence of the control condition. The wait-list condition received 
endpoint assessments 4 to 6 weeks after pretest assessments, while participants in the 
individual and group CBT conditions were reassessed 14 weeks after pretesting. This 
design issue and the use of a wait-list as a control condition do not allow a researcher 
to discriminate between specific or nonspecific treatment effects. As well as differing 
in the level of exposure to active treatment components, participants in these 
conditions also differed in the amount of attention they received, the quality of the 
therapist-client relationship, cognitive expectations for change, and the opportunity 
for normalisation of symptoms. These nonspecific factors may be important in 
promoting treatment outcome. Overall, this was a high-quality research study with 
promising findings.  
Martin and Thienemann (2005) conducted an open trial of group CBT among 
14 children aged 8 to 14 years. Treatment lasted 14 weeks, and included weekly 90-
minute sessions comprising a one-hour session for parents with one therapist; a one-
hour session for children with a separate therapist, and a 30-minute combination 
session with parents and children. The program was based on March and Mulle’s 
(1998) manual. OCD was diagnosed using a DSM-IV based clinical interview, though 
it was not reported if a standardised, diagnostic interview schedule was employed. No 
exclusion criteria were utilised. At posttreatment children showed an average 25% 
reduction in symptoms. Limitations of the study were that four of nine children 
utilising concurrent medication for OCD had medication dosage adjusted during 
treatment, children receiving concurrent psychotherapy were not excluded, and a 
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controlled design was not employed. It is unclear whether the treatment or extraneous 
variables were the causal agent of improvement.  
Asbahr and colleagues (2005) randomly allocated 40 children with OCD to 
group CBT or sertraline for 12 weeks. Children in the group CBT condition met for 
weekly 90-minute sessions. Families attended sessions one, seven, and 12. The 
program was based on March and Mulle’s (1998) program. OCD was diagnosed 
using DSM-IV clinical interviews, though the particular interview schedule used was 
not reported. Exclusion criteria were bipolar disorder, ADHD with psychostimulants, 
neurological disorders except for Tourette’s syndrome, pervasive developmental 
disorders, posttraumatic stress disorder, borderline personality disorder, psychosis, or 
an organic brain disorder. Both treatment conditions demonstrated significant 
improvement in OCD symptomatology. Children in the CBT condition showed an 
average 79% reduction in symptoms at posttreatment. The study included one, three, 
six, and nine-month follow-ups. One of 19 children in the group CBT condition and 
10 of 18 children in the sertraline condition relapsed during the follow-up period, and 
did not complete the follow-up due to reintroduction of treatment. Data from those 
completing follow-up indicated that improvement in the CBT condition was 
maintained over the follow-up period. The average reduction in symptoms from 
pretreatment was 87% at 9-month follow-up. Group CBT demonstrated equivalent 
efficacy to sertraline, with promise of greater treatment durability.  
 
Direction for Future Paediatric OCD Treatment Research 
 
A consistent finding among the studies summarised above is that group CBT 
is a promising treatment for children with OCD, with symptom severity decreasing up 
to 87% following treatment. A deficit in studies of group CBT for paediatric OCD is 
the lack of use of a credible placebo control condition. The efficacy of a treatment 
must be evaluated relative to control because factors extraneous to the treatment can 
produce a treatment response. In child OCD medication trials, placebo response has 
ranged between 0% to 37%, and between 6% and 51% in trials of CBT for paediatric 
anxiety disorders (Thienemann et al., 2001). Only two trials of paediatric group CBT 
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included a control group. Barrett (2004) employed a wait-list control, yet it did not 
have equivalent pre-post duration to the experimental condition, and Himle (2003) 
included a placebo control comparison but had a sample size of only 10 and did not 
evaluate whether participants viewed the treatments as equally credible. Clearly there 
is a need for controlled trials to evaluate the group CBT treatment modality. A well-
designed placebo control condition can rule out non-specific factors as an explanation 
for treatment improvement. A brief overview of specific and nonspecific factors and 
their relevance to efficacy trials follows.  
Specific treatment factors are well-defined, intentional actions or intervention 
strategies derived from a particular theoretical orientation (Grencavege et al., 1993; 
Jones, Cumming, & Horowitz, 1988). They are referred to as the ‘active’ components 
of a treatment. For instance, cognitive therapy is used to alter dysfunctional thinking. 
Active treatment techniques are theorised to result in specific treatment effects. 
Nonspecific factors are the contextual or incidental aspects of the treatment process 
(Grencavege et al., 1993). Examples of non-specific factors include the personality of 
the therapist, the therapeutic alliance, the passage of time, expectations for 
improvement, attention, regression to the mean, societal conditions or events, and 
effort justification. Non-specific factors are contingent on contextual aspects of the 
broader treatment milieu. Non-specific factors that may affect treatment outcome in 
group CBT for paediatric OCD include the above examples and incidental aspects of 
the group approach, such as peer modeling, incidental reinforcement, and the 
development of informal support networks. Non-specific factors exert indirect and 
non-specific treatment effects.  
Much debate exists on the dimensionality and independence of specific and 
non-specific treatment factors. The most common view asserts that specific and non-
specific factors represent parallel dimensions. Grencavage and colleagues (1990) 
proposed that the specific-nonspecific dimension might be orthogonal to the unique-
common dimension of therapy. This idea is outlined in Table 7. Common specific 
interventions are outcome-oriented therapist actions that are shared by a number of 
therapeutic approaches and intervention programs. For instance, cognitive 
restructuring is utilised in the treatment of many psychological problems, including 
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panic disorder, major depressive disorder, adjustment difficulties, OCD, and 
relationship and work difficulties. A unique specific intervention is a therapeutic 
action or strategy that is applied in only one (or a few types of) therapy. Examples 
include systematic desensitisation, interoceptive conditioning, and ERP. These 
techniques are used to treat phobias, panic disorder, and OCD, respectively.  
 
Table 7  
Examples of Specificity and Uniqueness of Treatments: Two Interacting Dimensions 
 
 Common Unique 
Specific Offer alternative view 
(reframing, cognitive 
restructuring) 
A particular intervention (ERP, 
systematic desensitisation) 
Nonspecific Rapport, expectations for 
improvement, passage of time 
Therapeutic setting (e.g., context, 
particular group therapy members, 
etc.) 
 
 
Grencavage and colleagues defined common non-specific interventions as 
process-oriented therapist actions that are incidental to the treatment context. They occur 
irrespective of the therapist’s theoretical orientation or preferred treatment strategy. 
Examples are rapport building, the therapeutic relationship, attention, and modeling. I 
would also argue that this includes other factors such as time and statistical regression to 
the mean. Unique non-specific interventions are contextual factors of the treatment 
setting, such as the influence of other clients in a group therapy session, the personality 
of the therapist, and the perceived credibility of the professional and/or organisation. It 
may also include the sociocultural context and circumstances that locate the individual.  
Specific and non-specific factors are often presented as juxtaposed in the 
literature, yet they are not independent. Shoham-Solomon (1990) argued that each serve 
as each other’s context and acquire meaning only though association with the other. It is 
not possible to exclude non-specific treatment factors during the application of a specific 
treatment intervention, nor in order to evaluate the “specific effect” of a treatment. 
Instead, the researcher must utilise a placebo comparison group, which holds the non-
specific treatment factors constant between the treatment and placebo groups. The 
placebo condition should be equivalent to the intervention condition in all respects 
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except that it should not contain the active treatment ingredients. In psychological 
research, such as OCD efficacy studies, the placebo condition comprises an inert therapy 
modality. A randomised, placebo-controlled design enables researchers to evaluate 
whether the effect of intervention strategies exceeds the effect of non-specific treatment 
factors. A randomised, placebo-controlled evaluation of group CBT for paediatric OCD 
will contribute important insight into the efficacy and specific effectiveness of this 
treatment approach.  
 
Chapter Summary 
 
Group CBT represents a potentially valuable means of treating paediatric OCD. 
It has practical and therapeutic advantages, a sound theoretical rationale supporting its 
use, and demonstrates efficacy in treating adult OCD. Currently, six studies have 
evaluated group CBT among children with OCD. OCD symptomatology appears to 
decrease between 25% and 79% at the conclusion of a 7 to 14 week treatment 
programme. Methodological shortcomings limit the validity of results and provide 
difficulty assessing the true magnitude of the treatment effect and clinical relevance of 
the changes. Four of the studies did not include a control condition, and one included a 
non-equivalent wait-list control condition. The one study that used a placebo control 
only had a sample size of ten, and did not include children younger than 13, and did not 
verify how the placebo control condition was deemed credible. Undeniably, the 
rationale outlined in this chapter and the results of these studies indicate that group CBT 
is likely to be a promising and specific treatment for paediatric OCD. Assessing the 
effect of this treatment beyond nonspecific factors is an important direction for future 
research. Credible placebo controls in treatment trials represent the only adequate means 
of determining treatment efficacy beyond nonspecific effects. 
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Chapter 5 
Study 2: A Randomised, Placebo-Controlled Trial of 
Cognitive-Behavioural Group Therapy  
for Paediatric Obsessive-Compulsive Disorder 
                                                                                        
 
 
Previous studies have highlighted the utility of CBT for childhood OCD 
delivered in an individual format, yet group CBT for children with OCD remains 
understudied. Chapter 4 discussed the practical and therapeutic advantages inherent in 
the group approach and outlined a rationale for hypothesised efficacy and specific 
treatment effectiveness.   
The aim of this study was to determine if group CBT for paediatric OCD is 
effective beyond non-specific treatment effects. Group CBT was compared to a credible 
placebo control condition that received group AMT. Children in the group CBT 
condition were hypothesised to demonstrate a lower average level of symptom severity 
at posttreatment and follow-up compared to children in the placebo control condition.  
 
Method 
 
Participants 
 
Twenty-two children aged 6 to 16 years with a DSM-IV primary diagnosis of 
OCD comprised the intention-to-treat sample (11 in CBT; 11 in AMT). Exclusion 
criteria included schizophrenia, mental retardation, Tourette’s syndrome, an autistic 
spectrum disorder, a substance-related disorder, suicidal ideation, or concurrent 
psychotherapy for OCD. Children receiving pharmacological treatment were included 
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provided medication dosage had been stabilised for at least three months. Four children 
were on concurrent SSRI treatment. Medication was stabilised prior to study entry and 
dosage remained unchanged throughout the treatment and follow-up phase. 
Figure 3 shows patient flow over the course of the study. This sample size was 
lower than intended, due to difficulties recruiting and retaining eligible families. Of the 
ITT population, 36% were adolescents (aged 13 and older) and 64% were children (aged 
12 and younger). The mean age of the sample was 11.82 years (SD = 2.66, range 6 to 
16). Five groups were assembled, of which three were CBT groups (n1 = 3, n2 = 3, n3 = 
5) and two were AMT groups (n4 = 5, n5 = 6).  Demographic characteristics are 
presented in Table 8.  
 
Screened 
n = 83 
Did not meet inclusion criteria n = 46
Decided not to participate n = 15 
Randomly allocated 
to a condition 
n = 22 
AMT intention-to-treat population n = 11 
   10 completed treatment 
   1 withdrew (child decided wanted to    
   manage difficulties on own) 
CBT intention-to-treat population n = 11 
  10 completed treatment  
   1 withdrew (scheduling difficulties) 
 
 
Figure 4. Flow diagram of participant recruitment and allocation. 
 
Twenty participants (91%) had both obsessions and compulsions, while two 
(9%) reported compulsions only. Types of obsessions included contamination (50%), 
aggressive (41%), magical/superstitious (9%), somatic (5%), and miscellaneous (14%). 
Compulsions included washing/cleaning (45%), repeating (36%), ordering/arranging 
(27%), checking (23%), counting (18.2%), and miscellaneous (27%). Most children 
(73%) reported one obsessions type only, 23% reported two types, and 5% reported 
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three types. Nearly half the children (45%) reported one type of compulsion, 32% 
reported two types, 14% reported three types, and 9% reported four types.     
 
Table 8 
Demographic and Baseline Characteristics of Study 2 Sample by Condition (Intention-
to-Treat) 
 
Demographic characteristics Group CBT 
(n = 11) 
Group AMT 
(n = 11) 
Sex, n (%)   
  Male 6 (54.55) 7 (63.64) 
  Female 5 (45.45) 4 (36.36) 
Age (yr), mean (SD) 11.81 (2.63) 11.83 (2.81) 
OCD characteristics   
  Age at onset (yr), mean (SD) 9.46 (2.74) 8.39 (1.87) 
  Illness duration (yr), mean (SD) 2.18 (2.62) 3.20 (2.68) 
Psychiatric comorbid disorders, n (%)   
  Internalising 5 (45.45) 8 (72.73) 
  Externalising 3 (27.27) 3 (27.27) 
Concurrent medication, n (%) 1 (9.09) 3 (27.27) 
Note. No significant differences between subjects in conditions on demographic characteristics (as tested 
by the independent group t test for continuous variables and Fisher’s exact test for categorical variables).  
 
 
Design and Statistical Analysis 
 
This study utilised a randomised, placebo-controlled design, with measurements 
taken at pretreatment, posttreatment, and one-month follow-up. To expediate treatment 
entry, a block randomisation procedure (stratified by timing and age < 13 or ≥ 13 years) 
was employed. This protected against attrition and was ethically beneficial as it reduced 
wait times). 
One-way analyses of covariance (ANCOVAs) were used to test for differences 
between treatment conditions on outcome measures. ANCOVA was considered more 
appropriate to alternative applicable analyses because it statistically equates groups on 
pretreatment variables and increases statistical power by removing the variance 
associated with the covariate from the F test error term. ANCOVAs were conducted on 
posttreatment and follow-up scores using pretreatment scores as covariates. Because a 
priori hypotheses had been determined for each study variable, each ANCOVA was 
evaluated at a one-tailed alpha level of .05 without adjustment for multiple comparisons 
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(Tabachnick & Fidell, 2007). ANCOVAs test for differences between groups, but do not 
provide information about the nature of the treatment effect or the change within 
conditions over time. Significant ANCOVAs were followed by mixed 2 x 2 analyses of 
variance (ANOVAs) to explore main and interaction effects. Treatment condition (group 
CBT/group placebo) comprised the between-subjects factor and time 
(pretreatment/posttreatment) comprised the within-subjects factor.  
An a priori power analysis was conducted to determine the sample size required 
to detect a large treatment effect (f = .40) at 80% power on a one-tailed between-groups 
F test (alpha level = .05). G*Power 2 (Erdfelder, Faul, & Buchner, 1996) computed a 
sample size of 42. This number was determined based on individual randomisation to 
conditions and not cluster randomisation (randomisation of individuals to therapy 
groups nested within conditions). Calculations pertaining to cluster randomisation 
require estimates of variances that were unavailable in the published literature. When 
small numbers in clusters (i.e., therapy groups) are required there is only a marginal 
inflation to sample size requirements (Kerry & Bland, 1998). Hence, a required sample 
size of 42 was deemed appropriate, or 21 per treatment and placebo condition.  
Statistical hypothesis testing was supplemented by calculation of effect size and 
clinically significant change. The effect size of group CBT at posttreatment and follow-
up on outcome measures was determined using Cohen’s d, with Hedge’s small sample 
correction (Hedges & Olkin, 1985). Hedge’s correction provides a more conservative 
estimate of effect size when the sample size is small. Effect size was calculated using 
change scores, as these increase reliability by controlling for pretreatment differences 
between groups. The mean control change score was subtracted from the mean 
treatment change score, and divided by the mean pooled SD of change. This method is 
outlined in more detail in Chapter 3. The effect size sign was standardised so that a 
positive score meant that the group CBT condition performed better than the placebo 
control condition.  
The clinical significance of individual change in outcomes was assessed using 
Jacobson and colleagues methodology. Clinically significant change occurs when the 
status of a patient’s measured functioning falls in the non-functional range at the 
beginning of treatment and in the functional range after treatment, providing that the 
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change is statistically reliable (Jacobson & Truax, 1991). There are two steps to 
determining clinically significant change; (1) the establishment of cut-offs for assessing 
clinically significant change; and (2) determining the reliability of that change. 
Jacobson’s methodology (1986) and subsequent revision (Jacobson & Truax, 1991) 
proposed three cut-off criterions. Cutoff a refers to the point at which values fall outside 
the range of the dysfunctional population, operationalised as two SDs from the 
pretreatment mean in the direction of functionality. Cutoff b is the point at which values 
fall within the range of the functional or normal population, operationalised as within 
two SDs from the mean of the functional population. Cutoff b can only be calculated if 
non-patient data are available. Cutoff c is the midpoint between the mean of the 
functional population and the mean of the dysfunctional population. Scores falling 
closer to the functional population mean are deemed clinically significant. When 
normative data exists for both functional and non-functional populations, c is the 
method of choice. Cutoff a is applied when normative data are unavailable for the 
functional population, and Cutoff b when normative data are not available for the 
dysfunctional population. For change to be clinically significant it must be reliable 
beyond measurement error. Reliability is determined by calculating the Reliable Change 
Index (Jacobson et al., 1986). If the value of RCI occurs outside the range ±1.96 it is 
unlikely that the change is due to random measurement error, therefore the change is 
considered reliable (p < .05). Jacobson and Truax (1991) suggested a classification 
system based on RCI and outcome scores. If the client’s posttreatment score falls in the 
functional range, and the RCI is larger than 1.96, the client is classified as recovered. If 
the RCI is above 1.96, but the client’s posttreatment score does not fall in the functional 
range, the client is classified as improved. If neither criterion is met, the client is 
classified as unchanged. If the RCI is greater than 1.96, and the client’s posttreatment 
score has moved in the direction of dysfunction, the client is classified as deteriorated.  
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Measures 
 
Anxiety Disorders Interview Schedule for DSM-IV – Parent Version (ADIS-P) 
The ADIS-P (Silverman & Albano, 1996) was used to establish a diagnosis of 
primary OCD. The ADIS-P is a semistructured interview that diagnoses anxiety, 
affective, and externalising disorders in children aged 6 to 18. It has good test-retest 
reliability (Silverman et al., 2001) and concurrent validity (Wood et al., 2002). 
Silverman et al. reported that this interview and the earlier version (Anxiety Disorders 
Interview Schedule for Children; Silverman & Nelles, 1988) have been used in all 
published childhood anxiety clinical trials (Scahill, Riddle, McSwiggin-Hardin et al., 
1997).  
 
Children’s Yale-Brown Obsessive-Compulsive Scale (CYBOCS) 
The CYBOCS (Goodman et al., 1989a, 1989b; Scahill, Riddle, McSwiggin-
Hardin et al., 1997) assessed severity of OCD symptomatology. The CYBOCS is a 
widely used, clinician-rated, semi-structured interview, comprising 10 core items that 
yield a total score ranging from 0 to 40. Higher scores indicate greater severity of OCD 
symptomatology. Clinical descriptions for clusters of scores on the scale are mild (10-
18; distress but not necessarily functional impairment), moderate (19-29; distress and 
functional impairment) and severe (30 or above; severe distress and functional 
impairment requiring significant help from others). The CYBOCS has good reliability 
and validity. Internal consistency is high (α = .90) and interrater reliability is excellent 
(McKay et al., 2003; Scahill, Riddle, McSwiggin-Hardin et al., 1997; Storch et al., 
2004). Convergent validity has been established with the Leyton Survey (r = .62), and 
discriminant validity with the Revised Children’s Manifest Anxiety Scale (r = .37) and 
Children’s Depression Inventory (r = .34; Scahill et al., 1997). The measure is sensitive 
to treatment effects. 
 
NIMH Global Obsessive-Compulsive Scale (NIMH-GOCS) 
The NIMH-GOCS (Insel et al., 1983) is a single item measure of global 
diagnostic severity ranging from 1 (minimal symptoms or within normal range) to 15 
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(very severe). A score of 7 or higher indicates clinical OCD severity. The NIMH-GOCS 
has good test-retest reliability (Kim et al., 1992; Kim et al., 1993). Convergent validity 
has been demonstrated with the Symptom Checklist-90, the Yale-Brown Obsessive-
Compulsive Scale, a physician global rating scale, and a patient global rating scale (Kim 
et al., 1992; Taylor, 1998). It has sensitivity to treatment effects (Barrett et al., 2004; 
Piacentini et al., 2002; Piacentini et al., 1994). 
NIMH Clinical Global Impression of Severity of Illness Scale (CGIS) 
The CGIS (Guy, 1976) is a single-item, clinician-rated device that provides a 
psychological impairment rating ranging from 1 (not at all ill) to 7 (extremely ill). This 
scale is sensitive to treatment effects and has been used in many previous OCD 
treatment trials (Barrett et al., 2004; Piacentini et al., 2002; Piacentini et al., 1994; 
Waters et al., 2001).  
 
Children’s Depression Inventory (CDI) 
The CDI (Kovacs, 1985) is a 27-item self report measure of children’s 
depressive symptomatology in the previous 2-week period. It measures a range of 
cognitive, behavioural, and affective symptoms of depression. Psychometric studies 
have shown that the scale has good internal consistency (Chronbach’s α = .71 to .89), 
test-retest reliability (r = .74 to .83), and convergent and divergent validity. Scores range 
from 0 to 54, with higher scores indicating greater symptom severity.  
 
Child Obsessive Compulsive Impact Scale – Parent Version (COIS-P) 
The COIS-P (Piacentini & Bergman, 1999) is a 52-item parent report of the 
impact of OCD upon child psychosocial functioning. It assesses impairment across 
school, family, and social settings on a scale ranging from 0 (not at all) to 3 (very 
much). The total score ranges from 0 to 156 and is derived by summing item scores. 
Higher scores suggest greater functional impairment. Preliminary data suggest that the 
COIS-P displays sound internal consistency and construct validity (Piacentini, 1999).  
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Credibility/Expectancy Questionnaire (CEQ) 
The CEQ (Devilly & Borkovec, 2000) measures beliefs about treatment 
credibility (how logical and suitable a particular treatment seems) and expectancy (how 
much improvement an individual expects). It contains six items, three comprising the 
credibility scale and three comprising the expectancy scale. The CEQ utilises two Likert 
rating scales, one from 1 (not at all) to 9 (very much) and one from 0% (not at all) to 
100% (very much). Scale scores are derived by applying a linear transformation with a 
minimum value of one and a maximum value of nine, and a composite score is created 
by summing individual items. Scale scores range from 3 to 27, with higher scores 
indicating greater credibility or expectancy. Factor analysis has shown that the scale 
produces two reliable factors, credibility and expectancy. Standardised alpha is between 
.79 and .86 for the credibility scale (Devilly & Borkovec). Cronbach’s alpha ranges 
between .81 to .90 for the expectancy factor (Devilly & Borkovec). The test has good 
test-retest reliability (Devilly & Borkovec). The CEQ was administered to children and 
parents. Parents received an adapted version, with the wording changed to reflect beliefs 
about child treatment. The adapted version is presented in Appendix A.  
 
Treatment Protocol 
 
Group Cognitive-Behavioural Therapy Programme 
Individuals in the group CBT condition met for 1.5 hour sessions once weekly  
for 12 weeks. The treatment programme was adapted from March and Mulle’s 
individual CBT protocol (March & Mulle, 1998). Appendix B contains a session-by-
session outline of the programme. The core components of the treatment programme 
included graded ERP, cognitive therapy, family skills training, and relapse prevention. 
Parents were present for the full duration of sessions 1, 7, and 12.  
Session 1 consisted of psychoeducation, dissemination of the treatment rationale, 
and a general introduction to the therapeutic strategies. In weeks two, three, and four, 
children were introduced to the fear thermometer, learnt cognitive techniques to 
externalise OCD, and constructed exposure hierarchies. Weeks 5 and 6 comprised in-
session exposure combined with practice of cognitive therapy techniques. Session 7 
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included reiteration of the therapeutic rationale, discussion of family accommodation of 
symptoms, and parents had relevant concepts and procedures explained to them. In 
session ERP was were continued in Sessions 8 through 11, whereby children moved 
progressively to more difficult items on the exposure hierarchy. Session 12 consisted of 
relapse prevention, programme review, presentation of achievement certificates, and a 
celebration party. Homework was administered weekly. In the first four sessions, 
homework involved “playing a detective” and writing down the ways that OCD 
“bullied” or “bossed” the child and his/her family around. From Session 5 onwards, 
daily out-of-session exposures were planned. Homework worksheets were administered 
which encouraged children to record completed exposure exercises, subjective units of 
distress ratings during exposure exercises, the self-talk the child used to boss back OCD, 
or tallies of the number of times the child “won” compared to OCD.  
 
Group Anxiety Management Training Programme 
The control condition received weekly, 1.5 hour sessions of a 12-week 
programme of group AMT (session-by-session outline in Appendix B). AMT was 
selected as a placebo control because of perceived credibility and lack of specific 
efficacy among adults with OCD (Fals-Stewart et al., 1993; Lindsay, Crino, & Andrews, 
1997). The program was adapted from child relaxation texts (e.g., Rickard, 1994) and 
included education in stress management, controlled breathing, progressive muscle 
relaxation, visualisation, problem-solving, and goal-setting. Parents were present during 
sessions 1, 7, and 12.  
The first session introduced the therapeutic rationale - that stress can exacerbate 
OCD symptoms and that stress management techniques reduce OCD symptoms by 
decreasing stress and general anxiety. This session included psychoeducation about 
OCD. Session 2 and 3 comprised an introduction to relaxation, such as the identification 
of anxious body clues, progressive muscle relaxation, and deep breathing. Session 4 to 6 
involved identification and exploration of feelings, brainstorming of pleasant events one 
can engage in during stressful periods, and advanced practice in breathing and 
progressive muscle relaxation. Session 7 reviewed the treatment rationale and 
techniques learnt in previous sessions. Scenarios of anxious children were presented and 
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family units brainstormed strategies to decrease stress and anxiety. Sessions 8 through 
11 introduced problem-solving, visualisation, and goal-setting. Problem-solving was 
aimed at addressing stressful psychosocial situations. Children were taught to 
brainstorm as many strategies as possible, to evaluate the advantages and disadvantages 
of each strategy for themselves and others, to choose and plan the implementation of a 
strategy, and to evaluate the outcome of implementation. Breathing and progressive 
muscle relaxation exercises were continued. Session 12 comprised relapse prevention, 
review of the programme, presentation of achievement certificates, and a celebration 
party. Daily homework was administered in the form of relaxation exercises (e.g., deep 
breathing, progressive muscle relaxation, visualisation) or completion of worksheets 
related to session content.  
  
Procedure 
 
The Curtin University Human Research Ethics Committee granted ethical 
approval to conduct this research. Participants were recruited via the Curtin University 
Psychology Clinic and were self-referred, referred from community health agencies, or 
were respondents to media advertisements.  
Screening was conducted to determine if children met study inclusion criteria. 
Screening comprised a semi-structured telephone interview with a parent of the child 
(see Appendix C). This form was adapted from a telephone screening interview used in 
a previous CBT trial for youth with obsessive-compulsive disorder (Farrell, 2003). The 
parents of children meeting screening criteria were invited to attend a diagnostic 
interview at the Curtin University Psychology Clinic. If the child met the criteria for a 
primary diagnosis of OCD, an appointment session for the child was scheduled. Only 
the child and a clinician were present in the child session. The child session involved 
establishment of rapport, general information about group therapy and attendance, and 
pretreatment assessments. The interview to inform ratings on the CY-BOCS was 
conducted with children at this point.  An exception to this was if the child did not have 
the cognitive developmental abilities required to provide reliable answers. This was 
gauged at the time of administration by the clinician according to factors such as child 
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difficulty answering questions, limited attentiveness, and child age. This occurred for 
three children (< 8 years old; 1 female in CBT; 1 female in AMT; 1 male in AMT) at 
pretreatment and at repeated time points and one parent was interviewed in addition to 
the child. This was deemed a non-ideal, but preferable, adequate approach. Young 
children that present to treatment are likely to exhibit primarily behavioural symptoms 
that are observable to parents and that originally inspired parental treatment-seeking. 
The protocol and consent documentation was approved by the Curtin University Human 
Research Ethics Committee. At their respective appointments, parents and children were 
provided with a participant information sheet that described the nature of the study and 
the rights of participants. This was discussed verbally at the parent and child 
appointments. Participant information sheets and consent forms are shown in Appendix 
D. Written consent was obtained from a parent or legal guardian, and participating 
adolescents.  
Children were randomly assigned to group CBT or placebo using a randomised 
list generated by an online randomiser. Individuals in each condition attended 12 weekly 
1.5 hour sessions. Groups were cofaciliated by two therapists. All therapists that 
facilitated groups were clinical psychology doctoral candidates and there were six in 
total. These clinicians also administered the assessment measures. Credibility of the 
treatment programs was assessed at the end of the first session, after the therapeutic 
rationale had been given. Posttreatment data were collected in the week of the final 
session and follow-up data by telephone at one month. Longer follow-ups were not 
feasible given the resources and time constraints of the study.  
 
Results 
 
Preliminary Analyses 
 
Treatment Credibility 
Conditions were assessed for differences in perceptions of treatment credibility 
and expectations for treatment improvement on the CEQ. Mean child-rated credibility 
for the CBT condition was 20.89 (SD = 5.11) compared to 18.72 (SD = 4.73) for the 
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AMT condition. Parents of CBT participants gave a mean credibility rating of 21.22 (SD 
= 3.46) compared to 22.95 (SD = 3.26) for AMT. Children in the CBT condition rated 
average expectations for improvement as 19.24 (SD = 6.50) compared to an average 
15.37 (SD = 5.41) in the AMT condition. Mean parent-rated expectation for 
improvement was 17.25 (SD = 3.62) for children in the CBT condition and 18.27 (SD = 
4.13) for children in the AMT condition. Four independent groups t-tests were 
conducted with parent and child credibility and expectation ratings serving as the four 
dependent variables and treatment condition as the independent variable. A Bonferroni 
correction was applied for multiple testing, resulting in a per test alpha level of .012. 
Parent and child treatment credibility and expectation ratings were equivalent across 
conditions. 
 
Data Screening 
Univariate descriptive statistics were generated to assess the accuracy of data 
input (Tabachnick & Fidell, 2007). Data were screened for missing values using SPSS 
Missing Values Analysis. Of 440 possible observations, four (.91%) were missing. 
Little’s MCAR test was used to determine whether data were missing randomly or non-
randomly. The test was non-significant, χ2 (56) = 46.310, p = .819, suggesting that data 
were missing completely at random. If less than 5% of data are missing in a large data 
set in a random pattern, the seriousness of the problem is reduced and almost any 
method for remedying the problem yields similar outcomes (Tabachnick & Fidell, 
2007). Data were imputed by substituting the mean DV score of the relevant treatment 
condition.   
 
Assumption Testing  
Assumptions underlying analyses were tested prior to data analysis. ANCOVA 
assumptions include normality, homogeneity of regression slopes, homogeneity of 
variance, and linearity (Coakes & Steed, 1999). Assumptions underlying the mixed 
model ANOVA are normality, homogeneity of variance, sphericity, and homogeneity of 
intercorrelations (Coakes & Steed, 1999).  
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Normality, homogeneity of regression slopes, and homogeneity of variance. 
Normality of variables and standardised residuals was tested at each treatment level 
through examination of box-plots and normality statistics such as skewness, kurtosis and 
the Shapiro-Wilks test. Shapiro-Wilks test indicated non-normal distributions for some 
variables and standardised residuals (p < .05). Values of univariate skew greater than ±3 
and univariate kurtosis greater than ±10 are considered problematic (Keppel, 1991). 
There were no values outside these parameters. Cases with standardised z scores greater 
than 3.29 SDs from the mean for that variable (p < .001, two-tailed test) are considered 
univariate outliers. No univariate outliers were detected. In an ANCOVA, DVs and 
covariates are screened for outliers at each level of the IV. Standardised residuals with 
absolute values greater than 3 are considered problematic. This assumption was met. 
Cooks distance (values greater than 1), Mahalanobis distance (values with p < .001) and 
leverage (values greater than .5) were used to detect multivariate outliers. No suspect 
cases were observed.  
Homogeneity of regression slopes was investigated via a multivariate analysis of 
variance (MANOVA) procedure (Tabachnick & Fidell, 2007). The assumption was 
satisfied for all variables except for the pretreatment NIMH-GOCS and the pretreatment 
CDI (p < .05). Homogeneity of variance of the DVs and the covariates was tested. 
Violation of the assumption was observed on the posttreatment NIMH-GOCS and the 
posttreatment CDI.  
Although in some instances data departed slightly from normality, homogeneity 
of regression slopes, and homogeneity of variance, the F test is robust to these 
departures when group sizes are equal (Hamilton 1977; Levy, 1980; Olejnik & James, 
1984; Shields, 1978). Hence, the decision was made to leave data intact and avoid 
applying a corrective strategy as this would have compromised power and 
interpretability. 
Linearity. Linearity between DVs and covariates was inspected via scatterplots. 
This assumption was violated for some variables. Violation produces a loss of power to 
the ANCOVA test, and can lead to the biasing of results in a conservative direction. No 
corrections, such as transformation, were undertaken, as it was considered more 
important to preserve the constructs and to be able to compare the results to previous 
 127
Chapter 5: Study 2 
OCD paediatric studies. This decision was also based on the consideration that violation 
does not inflate the Type I error rate, a potentially serious circumstance, but instead 
produces more conservative results.  
Sphericity. The sphericity assumption assumes that the covariances and 
variances are equal in the population. This assumption was automatically satisfied as 
mixed ANOVAs contained only two levels of the within-subjects factor.  
Homogeneity of intercorrelations. The pattern of intercorrelations among the 
levels of the within-subjects factor should be equivalent across levels of the between-
subjects factor in mixed ANOVAs. This assumption was tested using Box’s M statistic. 
Heterogeneity is indicated when the statistic is significant at an alpha level of .001. This 
assumption was satisfied.  
Intragroup dependency. Treatments delivered in group formats jeopardize the 
independence of observation assumption, which assumes that observations on a variable 
are independent. When data are collected in groups, the common environment and the 
interactions shared by group members may bias the treatment response. Response within 
groups may become more homogenous than response between groups, as group 
members can affect each other’s behaviour. For instance, high group cohesion may 
enhance compliance with treatment, whereas observing members skip sessions could 
lead to greater absences (Baldwin, Murray, & Shadish, 2005). The intracluster 
correlation (ICC) measures the degree of dependency among observations taken from 
members of the same group. The maximal value of the ICC is 1, indicating dependency, 
or low within-group variability relative to between-group variability. An ICC of zero 
denotes independence. In instances where the ICC is negative, by convention it is 
deemed equivalent to zero. The ICC was calculated for each outcome measure at 
posttreatment and follow-up using the equation (Fleiss, 1981): 
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where MS values are the mean squares from a nested ANCOVA table when group is a 
random factor and n is the average size of the group. As the size of groups varied, n was 
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substituted for n0, the harmonic mean, denoted by the equation (Armitage & Berry, 
1994): 
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where k is the number of groups and n is the of the number of children in the ‘ith’ group, 
with i ranging from 1 to k. The harmonic mean was 4.054. The following ICCs were 
determined: CYBOCS at posttreatment (ICC = -.01, p = .44) and follow-up (ICC = .02, 
p = .38); the NIMH-GOCS at posttreatment (ICC = .-.08, p = .62) and follow-up (ICC = 
.01, p = .39), the CGIS at posttreatment (ICC = -.04, p = .51) and follow-up (ICC = .13, 
p = .19); the CDI at posttreatment (ICC = -.17, p = .85) and follow-up (ICC = .17, p = 
.15); and the COIS-P at posttreatment (ICC = .32, p = .04) and follow-up (ICC = -.07, p 
= .58). ICCs greater than .1 are considered problematic (2001). As some intragroup 
dependency was present, ANCOVAs on variables with high ICCs were evaluated using 
adjusted F values that accounted for inflation due to dependence (Baldwin et al., 2005).  
 
Hypothesis Testing 
 
Descriptive statistics for outcome measures are displayed in Table 9. Statistically 
significant differences were obtained on the posttreatment CYBOCS [F (1, 19) = 5.26, p 
= .02, η2 = .22], posttreatment NIMH-GOCS [F (1, 19) = 9.21, p = .0003, η2 = .33], 
posttreatment CGIS [F (1, 19) = 4.98, p = .02, η2 = .21], follow-up CYBOCS [F (1, 19) 
= 5.71 , p = .01, η2 = .23], follow-up NIMH-GOCS [F (1, 19) = 4.16, p = .03, η2 = .18], 
follow-up CDI [F (1, 19) =  3.16, p = .04, η2 = .20], and follow-up COIS-P [F (1, 19) = 
6.07, p = .02, η2 = .24]. Non-significant differences were obtained on the follow-up 
CGIS [F (1, 19) = 2.76, p = .06, η2 = .17], posttreatment CDI [F (1, 19) = 2.16, p = .08, 
η2 = .10], and posttreatment COIS-P [F (1, 19) = .45, p = .26, η2 = .05].  
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Table 9 
Descriptive Statistics for Outcome Measures at Pretreatment, Posttreatment and One-
Month Follow-Up  
 
Outcome measure Time CBT (n = 11) AMT (n = 11) 
  M SD     M SD 
CYBOCS Pre 23.27 7.51 19.36 5.08 
  Post 9.00 7.25 15.27 10.50 
 Follow-Up 7.18 5.23 13.55 8.03 
 NIMH-GOCS Pre 8.00 1.95 6.91 1.51 
 Post 4.18 3.09 6.18 2.89 
 Follow-Up 4.09 2.66 5.91 3.18 
CGIS Pre 4.36 1.21 3.82 1.08 
 Post 2.27 1.42 3.27 1.68 
 Follow-Up 2.18 1.17 3.09 1.51 
COIS-P Pre 39.89 23.72 35.27 27.05 
 Post 30.55 31.28 19.80 15.04 
 Follow-Up 10.61 9.79 26.91 29.42 
CDI Pre 10.55 7.31 8.55 6.61 
 Post 6.82 3.52 8.64 5.73 
   Follow-Up 4.00 2.32 6.55 5.41 
 
 
Significant ANCOVAs were followed by 2 (pre; post/follow-up) x 2 (CBT; 
AMT) mixed model ANOVAs. Significant time x condition interaction effects were 
obtained in the pre-post ANOVAs on the CYBOCS [F (1, 20) = 7.76, p = .01, η2 = .28], 
NIMH-GOCS [F (1, 20) = 9.93, p = .01, η2 = .33], and CGIS [F (1, 20) = 6.63, p = .02, 
η2 = .25], demonstrating an intervention effect. Significant time x condition interactions 
between pretreatment and follow-up were apparent on the CYBOCS [F (1, 20) = 8.51, p 
= .000, η2 = .30], NIMH-GOCS [F (1, 20) = 6.09, p = .02, η2 = .23], and COIS-P [F (1, 
20) = 5.43, p = .03, η2 = .21]. No interaction was present on the pre-follow-up analysis 
of the CDI [F (1, 20) = 3.60, p = .07, η2 = .153].  
Significant effects from pretreatment to posttreatment were further analysed 
using simple main effects analyses for scores within each level of the treatment 
condition. The simple main effects analysis for the CBT condition yielded a significant 
effect of pre-post on the CYBOCS [F (1, 10) = 3.60, p = .00, η2 = .73], NIMH-GOCS [F 
(1, 10) = 32.87, p = .00, η2 = .77], and CGIS [F (1, 10) = 16.02, p = .00, η2 = .62], 
suggesting that OCD symptoms decreased significantly from the beginning to end of 
treatment. No significant pre-post change was revealed in the AMT condition on the 
 130
Chapter 5: Study 2 
CYBOCS [F (1, 10) = 2.83, p = .12, η2 = .22] or CGIS [F (1, 10) = 2.29, p = .16, η2 = 
.19], although a significant change was observed on the NIMH-GOCS [F (1, 10) = 
186.18, p = .02, η2 = .42]. OCD symptom severity did not seem to decrease significantly 
across this time period. There was a significant time effect on the CDI from the 
beginning to end of treatment for children that received CBT, F (1, 10) = 5.34, p = .04, 
η2 = .35, but not for those that received AMT, F (1, 10) = .002, p = .96, η2 = .00. No 
significant differences across time were found on the COIS-P in the CBT [F (1, 10) = 
.80, p = .39, η2 = .07] and AMT [F (1, 10) = 2.84, p = .12, η2 = .22] conditions.  
Simple main effects analyses were conducted to investigate the effect of pre-to-
follow-up on symptomatology within each condition. A significant reduction on the 
CYBOCS was observed across time for both conditions [CBT, F (1, 10) = 33.87, p = 
.00, η2 = .77; AMT, F (1, 10) = 7.11, p = .02, η2 = .42]. Reduction in OCD 
symptomatology on additional OCD severity measures was observed for the CBT 
condition [NIMH-GOCS, F (1, 10) = 16.02, p = .00, η2 = .62; CGIS, F (1, 10) = 18.95, p 
= .00, η2 = .66], but not the AMT condition [NIMH-GOCS, F (1, 10) = 2.29, p = .16, η2 
= .19; CGIS, F (1, 10) = 2.91, p = .07, η2 = .29]. The CBT condition showed a 
significant reduction on the CDI, F (1, 10) = 9.64, p = .01, η2 = .49. No such effect was 
found in the AMT condition, F (1, 10) = 3.10, p = .11, η2 = .24. Lower interference in 
psychosocial functioning due to OCD was reported across the pre-to-follow-up period 
by parents of children that participated in CBT [F (1, 10) = 15.11, p = .00, η2 = .60], but 
not AMT [F (1, 10) = 2.93, p = .12, η2 = .23].  
 
Subsidiary Analyses 
 
Effect Size 
Effect sizes for each measure are displayed in Table 10. According to Cohen’s 
conventions, large and significant treatment effects at posttreatment were observed on 
the CYBOCS, NIMH-GOCS, and CGIS. The poisttreatment COIS-P and CDI effect 
sizes were not significant. CBT had a large and significant effect on all OCD outcome 
measures at follow-up, and a non-significant effect on the CDI.  
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Table 10 
Effect Size of Group CBT at Posttreatment and Follow-Up on Outcome Measures 
 
Measure Change in score Effect 95% CI p 
 M SD size (lower, upper)  
 CBT AMT CBT AMT    
CYBOCS        
   Posttreatment -14.27 -4.09 9.05 8.07 1.14 .23, 2.06 <.05
   Follow-Up -16.09 -5.82 9.17 7.24 1.20 .27, 2.12 <.05
NIMH-GOCS        
   Posttreatment -3.82 -.73 2.82 1.62 1.29 .36, 2.23 <.05
   Follow-Up -3.91 -1.00 3.24 2.19 1.01 .11, 1.91 <.05
CGIS        
   Posttreatment -2.09 -.55 1.58 1.21 1.05 .15, 1.96 <.05
   Follow-Up -2.18 -.73 1.66 1.19 .97 .07, 1.86 <.05
COIS-P        
   Posttreatment -9.34 -15.47 34.69 30.43 -.18 -1.02, .66 >.05
   Follow-Up -29.28 -8.36 24.99 16.21 .96 .06, 1.85 <.05
CDI        
   Posttreatment -3.73 .09 5.35 6.35 .63 -.23, 1.49 >.05
   Follow-Up -6.55 -2.00 6.99 3.77 .78 -.09, 1.65 >.05
 
Clinically Significant Change 
The CYBOCS was chosen to assess clinically significant change as it is the gold 
standard measure of OCD symptomatology in children and has good reliability and 
construct validity. Data used to calculate statistics are contained in Table 11 and 
formulae are displayed in Table 12. No normative data for a functional population 
exists, hence Cutoff a was used. The value of Cutoff a was 8.19. 
 
 
Table 11 
Data Used to Compute Cutoff a and the Reliable Change Index 
 
Symbol Definition Value
M1 Pretreatment mean of the study sample 21.33 
S1 Standard deviation of the pretreatment mean of the study sample  6.57 
X1 Pretreatment CYBOCS score of an individual  
X2 Posttreatment CYBOCS score of an individual  
X3 Follow-up CYBOCS score of an individual  
rxx Reliability of the CYBOCSa .79 
SE Standard error of measurement of the CYBOCS 3.01 
SDIFF Standard error of difference between the two test scores 4.26 
aTest-retest reliability over a mean of 40.76 days (Christiana et al., 2000). 
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Table 12 
Formulae Used to Compute Reliable and Clinically Significant Change 
 
 Cut-off a RCI SDIFF SE 
Formula 11 2SM −  
diffS
XX 12 − ( )22 ES xxrS −11
 
 
Participants were classified on degree of improvement according to Jacobson’s 
classification system (see Table 13). Children in the CBT condition showed a higher 
recovery rate than children in the AMT condition at posttreatment and follow-up. At 
follow-up, children who received CBT were four times more likely to have a recovered 
status than children who received AMT. At follow-up, less than 10% of children that 
received CBT showed no reliable improvement, compared to 73% of children that 
received AMT.  
 
Table 13 
Rates of Clinical Improvement from Pretreatment to Posttreatment and Follow-Up (%) 
 
Clinical status CBT (n = 11) AMT (n = 11) 
 Pre-post  Pre-follow-up Pre-post Pre-follow-up 
Recovered, % 54.5 72.7 27.3 18.2 
Improved, % 18.2 18.2 0 9.1 
Unchanged, % 27.3 9.1 63.6 72.7 
Deteriorated, % 0 0 9.1 0 
 
 
Discussion 
 
This was, to my knowledge, the largest placebo-controlled trial of group CBT 
conducted to date. Consistent with previous adult and child studies of group CBT 
(Barrett et al., 2004; Cordioli et al., 2003; McLean et al., 2001), the treatment 
programme was effective in reducing OCD symptomatology with clinically meaningful 
outcomes. Children that received CBT had significantly larger reductions in symptoms 
compared to children that received a psychological placebo. The low response rate of 
children to AMT is congruent with adult studies of AMT for OCD (Fals-Stewart et al., 
1993; Lindsay et al., 1997). Gains made by children in the CBT condition were 
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maintained at follow-up. The group CBT programme demonstrated a large treatment 
effect, which was comparable to effects observed in adult studies and existing child 
studies of individual and group CBT.  
This study is the first non-pilot study to demonstrate that group CBT for 
paediatric OCD accounts for improvement beyond a placebo effect. This indicates that 
specific factors, which correspond to the intervention strategies derived from the 
cognitive-behavioural model of OCD, are effective for treating paediatric OCD. In 
addition to a specific treatment effect, there appeared to be a small nonspecific 
component to treatment outcome. Although the reduction in symptoms evidenced by 
children with AMT was not statistically significant over time, one-quarter of AMT-
treated children showed clinically significant gains. The AMT condition included all of 
the nonspecific aspects of treatment, such as time, treatment credibility, and therapist 
attention, minus the specific treatment ingredients. This research shows that nonspecific 
factors can lead to some improvement in symptomatology. It is unclear whether the 
families that agreed to participate in this research study differ in substantive ways from 
treatment refusers or the population of families of children with OCD. It is possible that 
sampling bias or confounding factors may have impacted on the results.    
Treatment credibility and expectations for change can predict treatment outcome 
(c.f. Weaver, 1998). In the NIMH Treatment of Depression Collaborative Research 
Project (Elkin, 1994) participants’ expectations for improvement significantly predicted 
treatment outcome across four treatment conditions (Sotsky et al., 1991). Higher client 
ratings of treatment credibility generate higher expectancy for improvement, which can 
influence treatment outcome (Bowers & Clum, 1988). Safren, Heimberg, and Juster 
(1997) found that initial credibility rating of a CBT programme for social phobia 
predicted treatment outcome. Lower expectancies for positive outcome were associated 
with a greater severity of social phobia and depressive symptoms. The passage of time is 
a non-specific factor that can lead to improvements, because patients often seek help at a 
time when symptoms are the most severe. It may be that children in the AMT condition 
showed a degree of placebo response because of some of these factors, even though the 
improvement was ultimately non-significant. Other non-specific factors deemed 
important in the literature include the therapeutic relationship, hope, and the opportunity 
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to discover the “universality of problems” (Yalom, 1995). The notion that children with 
OCD respond to nonspecific treatment factors is support by the medication literature. 
The meta-analysis presented in Chapter 3 and a previous medication meta-analysis 
found a small to moderate placebo response for children with OCD (Abramowitz et al., 
2005).  
Treatment outcome in health and wellbeing research is often defined as the 
absence of symptomatology or pathology, yet this definition is narrow. Clinicians’ 
interested in the full scope of the effects of a health care intervention have broadened the 
definition of clinical outcome to include psychological and social well-being (Gladis, 
Gosch, Dishuk, & Crits-Christoph, 1999). Clinical trials for paediatric OCD typically 
focus on the measurement of OCD symptomatology to the exclusion of other important 
outcomes, like quality of life and psychosocial functioning. Impairment in psychosocial 
functioning accompanies up to 90% of children with OCD in school, social, and home 
settings (Piacentini et al., 2003). OCD is associated with school absence, concentration 
difficulties, social withdrawal, impunctuality to lessons, excusing from class to perform 
rituals, and homework difficulties (Allsopp & Verduyn, 1990; Piacentini et al., 2003). 
Children with OCD have greater difficulties maintaining friendships and can experience 
impairment in engaging in normal peer activities such as sleepovers and play (Allsopp 
& Verduyn, 1990). Difficulties in home and family functioning are common. This study 
was the first known controlled CBT trial to assess psychosocial functioning over the 
duration of paediatric OCD treatment. A recently developed measure by Piacentini and 
Jaffer (1999) was employed to assess OCD-related impairment in psychosocial 
functioning across the school, social, and home domains. Children that received CBT 
showed less impairment in overall psychosocial functioning from pretreatment to 
follow-up, and significantly lower impairment at follow-up than children treated with 
placebo. This improvement was not present among children in the comparative 
condition, suggesting that a significant reduction in OCD symptoms accompanies gains 
in psychosocial functioning. CBT treatment for paediatric OCD appears to affect 
broader domains of well-being than just OCD symptomatology. These improvements 
are noteworthy considering the developmental importance of this age period. 
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Group CBT showed a positive effect upon level of depressive symptomatology. 
Depression is frequently comorbid with OCD, and has been reported to affect up to 73% 
of children with OCD in clinical samples (Barrett et al. 2004; Gellar et al. 1996; Hanna, 
1995). The time-consuming nature of OCD symptomatology and the associated 
impairment in functioning may produce depressive symptoms, even if full clinical 
criteria are not met. There was a significant decrease in depressive symptomatology 
among CBT-treated children, but not AMT-treated children. This reduction covaried 
with the reduction in OCD symptomatology and gain in functioning. Even though the 
group CBT programme was targeted specifically to OCD symptoms, it may have 
benefits for secondary clinical symptoms. Future research is needed to understand 
whether this is because OCD is a causal factor for these symptoms, or whether a third 
factor such as the serotonergic system comprises a common mechanism of change.   
Although there are many benefits that can be derived from group CBT, there 
may be factors that challenge the organisation and administration of this modality in 
service settings. Firstly, a significant volume of referrals is necessary to facilitate the 
formation of developmentally homogenous groups, to reduce wait-list attrition, and to 
allow a higher intake than desired group size. This is necessary to mitigate the loss of 
participants immediately prior to group commencement. Second, a fairly large 
population base that lives within a relatively short distance from the treatment site 
appears necessary. Third, although group therapy was envisaged to be a treatment 
modality that could facilitate accessibility to treatment, during the course of recruitment 
39% of screened, eligible families declined participation, despite treatment being offered 
at no cost. A lower number of participants than originally planned were recruited. These 
difficulties and the high non-participation rate suggest that families may experience 
barriers that impede access to treatment. Fourth, the effort that therapists have to expend 
to assemble groups may not make the delivery of this treatment practical in a 
community setting. Participants and families have many competing school, social, and 
sporting commitments which makes scheduling a group treatment difficult. Practitioners 
may have a preference to work with rolling admission, open-ended groups, making the 
current group therapy model undesirable. The closed-ended, finite timeline may also be 
a contributing factor in parental reluctance to participate in the treatment modality. A 
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problem that has manifested for years may be perceived as a problem that cannot be 
clinically significantly changed in a matter of months.   
  
Limitations 
 
Future studies could improve upon this research by employing larger sample 
sizes. Although this study was underpowered, significant treatment differences emerged 
on many outcomes, particularly at follow-up. There may be further differences in 
outcome that failed to be detected due to low power. This is certainly supported by an 
inspection of effect size estimates. Despite fewer participants than recommended, it is 
encouraging that differences between and within groups were detected across study 
phases. The large confidence intervals surrounding effect sizes suggest that future 
research with larger samples is needed to increase the reliability of the estimated 
treatment effect. Due to limited resources, it was not possible to ensure enhanced control 
with techniques such as blinded raters, independent checks on treatment fidelity, or 
diagnostic interrater reliability. Efforts were made to mitigate the effects of deviation 
from control by using standardised instrument delivery, manualised treatment protocols, 
and the parent version of the most widely accepted diagnostic instrument for child 
anxiety disorders. Future studies could improve the diagnostic procedure of this study 
by including the child version of the diagnostic interview. In this study the parent 
interview was chosen to homogenise methodology and facilitate comparability with the 
largest published group CBT controlled trial at the commencement of this project 
(Barrett et al., 2004). This may have produced underidentification of cases as parents 
may not know the child’s obsessional content or the full extent of rituals due to 
children’s embarrassment, lack of disclosure, or lack of insight. Adherence to homework 
by participants was not measured. If this sample was particularly conscientious about 
homework completion this could have biased results by inflating the trial outcomes. 
High completion rates are not likely to be representative of the general treatment-
participating OCD population. Alternatively, low adherence to homework could 
underepresent the effectiveness of treatment, as homework is an integral part of CBT 
treatment. Future studies should incorporate measures of treatment fidelity.  
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Future Research 
 
A replication of this study is required to establish generalisability of findings. 
Future research is needed to investigate treatment efficacy among more complex 
samples. This would include children with Tourette’s syndrome, other tic disorders, an 
autistic spectrum disorder, and complex comorbidity. Group CBT efficacy evaluations 
would benefit from transition to effectiveness studies. Lengthier follow-ups in treatment 
studies are required. A shortcoming of paediatric OCD treatment studies in general, is 
that with the exception of a few studies, follow-ups are generally absent or very brief. 
The inclusion of longer follow-ups would allow a much clearer picture of the true 
efficacy of treatments to emerge. Studies with greater sample sizes and clinical 
complexity could facilitate the identification of factors that moderate or mediate 
treatment response. Variables that may benefit from examination include age, sex, 
duration of OCD, severity of OCD, comorbidity (particularly oppositional and tic 
disorders), presence or absence of secondary depression, degree of insight, length of 
treatment, presence of overt rituals, treatment compliance, parental psychopathology, 
family functioning, cognitive functioning, and psychophysiologic indicators. Future 
treatment studies should include broader measures of health and well-being in addition 
to symptomatology measures. The ultimate success of a treatment is contingent not only 
on efficacy, but upon accessibility. Despite the availability of evidence-based treatments 
for OCD, there is a significant delay in help-seeking among individuals with OCD and 
many fail to access care (Pollard, Henderson, Frank, & Margolis, 1989). An 
understanding of the barriers that contribute to non-participation in paediatric group 
CBT is critical to developing strategies that encourage children and families to access 
help. Only a short-follow up could be conducted, future studies should incorporate 
longer follow-ups.  
 
Clinical Implications 
 
The efficacy of group CBT was investigated for its predicted effectiveness and 
unique practical and therapeutic advantages. Benefits include savings to therapist time, 
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increased treatment affordability, and increased treatment accessibility. Few therapists 
are adequately trained to administer CBT for paediatric OCD, hence group therapy 
represents an ideal means of maximising accessibility (March et al., 1997). Unique 
therapeutic advantages accompany the group treatment modality. Children can observe 
ERP being applied to a spectrum of OCD symptoms, thereby potentially promoting the 
generalisation of treatment gains. Peer modeling of in-session ERP and homework 
exercises may enhance treatment compliance. Observing other children perform ERP 
exercises successfully may alter dysfunctional catastrophic cognitions that impede 
motivation. The commonality afforded by the group experience may reduce the sense of 
isolation, embarrassment, and stigmatisation that frequently accompanies anxiety 
problems (Segee et al., 1999). Although group CBT appears to be a promising treatment 
modality with many practical and therapeutic benefits, there are serious organizational 
factors that may undermine practicality of application in community clinical settings. 
These would need to be given serious consideration prior to any treatment service 
planning.   
 
Chapter Summary 
 
This chapter presented the results of the largest to-date randomised, placebo-
controlled trial of group CBT for paediatric OCD. The most important contribution 
made by this research is the confirmation of a specific treatment effect for CBT. 
Children that received CBT improved beyond nonspecific or placebo factors. They 
experienced a significantly greater reduction in OCD symptomatology compared to 
children that received placebo, and the improvement was clinically meaningful. 
Approximately three-quarters of children were recovered at follow-up.  Group CBT had 
a large treatment effect, making results comparable to trials of individual CBT for 
paediatric OCD and group CBT for adults with OCD. CBT-treated children 
demonstrated greater improvement in psychosocial functioning and depressive 
symptoms relative to control at follow-up. A high number of families deemed eligible at 
screening declined participation in the trial. Individuals with OCD are known to delay-
treatment seeking and more understanding of treatment barriers is required. Evidence-
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based treatments are only valuable to the extent that they are received and used by the 
targeted clinical population. 
 
Chapter 6: Study 3 
 
 
Chapter 6 
Study 3: Group Cognitive-Behavioural Therapy for Paediatric 
Obsessive-Compulsive Disorder: Perceptions and Perceived 
Barriers to Treatment 
                                                            
 
 
Once considered a ‘treatment refractory’ condition, multiple treatments for OCD 
have been identified. CBT and the SSRIs are evidence-based treatments for OCD in 
youth. Despite the high level of burden associated with OCD, and the availability of 
efficacious treatments, the level of unmet need for treatment is high. Research among 
adolescent and adult community samples suggest that only a small minority of 
individuals with OCD access treatment (Kennedy & Schwab, 1997; Shapiro et al., 1984; 
Whitaker et al., 1990). Individuals with OCD delay seeking professional help by an 
average 11 years after onset (Simonds & Elliot, 2001). Sufferers are more likely to seek 
help in the first year of onset, with the rate declining over subsequent years (Thompson, 
Hunt, & Issakidis, 2004). In an Australian sample, only 28% of adults receiving 
treatment at a specialist anxiety and mood disorder clinic had sought help within one 
year of disorder onset (Thompson et al., 2004). Community-based surveys in Canada 
and USA have found that only 34% to 37% of adults with OCD had disclosed their 
symptoms to a doctor (Robins, Locke, & Regier, 1991), and only 20% had sought help 
from a mental health professional (Leon, Portera, & Weissman, 1995). Data from a 
community-based sample showed that 28% of individuals with OCD had sought 
professional help, and that less than half of this proportion had seen a mental health 
professional (Swinson, Anthony, Rachman, & Richter, 1998).  
The Senate Select Committee on Mental Health was established by the 
Australian government to investigate the provision of mental health services in 
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Australia. The report published by the committee found that among young people “the 
first and foremost issue is the extent of unmet need” (2006, p. 411). The report stated 
that only 25% of children who need access to mental health services will receive help. 
The level of unmet mental health need in children is higher in other countries, such as 
the United States where it has been estimated as 70% (U.S. Congress Office of 
Technology Assessment, 1986, 1991).  
Many parents are reluctant to initiate treatment for their child. There is a 15% to 
35% no show rate to first appointments following parental telephone request for services 
(Morrissey-Kane & Prinz, 1999). The most common reasons for failing to attend a first 
appointment are scheduling conflicts, cost of treatment, and a change of attitude to 
viewing the problem as improved or that help is no longer necessary (Kourany, Garber, 
& Tornusciolo, 1990). Children with OCD are likely to be particularly vulnerable to 
failing to access services, due to the shame and embarrassment associated with 
symptoms. To maximize treatment access, barriers that preclude families of children 
with OCD from accessing treatment need to be understood.  
 
Overview of Barriers to Treatment 
 
Kazdin and colleagues (2000) proposed the ‘barriers-to-treatment’ model to 
account for treatment utilisation. The assumption underlying the ‘barriers-to-treatment 
model’ is that for many families seeking help, initiating and attending treatment is a 
burden. Non-utilisation of mental health services results from practical and attitudinal 
barriers (Aupperle, Lifchus, & Coyne, 1998; Nada-Raja, Morrison, & Skegg, 2003; 
Simon, Fleck, Lucas, & Bushnell, 2004; Smith, Highstein, Jaffe, Fisher, & Strunk, 
2002). Practical barriers include treatment cost, distance to services, long waiting lists, 
lack of time, inadequate insurance coverage, and inconvenient operating hours of clinics 
and practitioners. Practical barriers may be systemic, meaning endemic to and located 
within the structure of mental health service provision, or patient-based. Owens and 
colleagues (2002) surveyed 116 parents whose children required, or had recently 
utilised, mental health services. Approximately 21% of families cited practical barriers 
as impeding access to services. The most common barriers were lack of knowledge 
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about where to access help, cost of services, and inconvenience of services. Cornelius 
and colleagues (2001) found that the number of siblings predicted unmet treatment need 
in adolescents. Larger family size could present significant dilemmas in terms of cost, 
time, and scheduling. Flisher and colleagues (1997) examined data from an 
epidemiological study of the prevalence of psychological disorders among children and 
adolescents. Approximately 17% of the youth had unmet need and this was significantly 
associated with financial factors, such as lack of insurance and parental receipt of public 
benefits. Practical treatment barriers reported by parents in another study were distance 
from service providers, scheduling difficulties, cost, transportation, child care 
arrangements, and lack of child care (Kruzich, Jivanjee, Robinson, & Friesen, 2003).  
Attitudinal barriers are cognitive impediments to treatment utilisation, such as 
negative perceptions of a treatment, excessive shame regarding difficulties, and fear of 
stigmatisation or labeling. Parent and child attitudinal barriers may be responsible for 
preventing children with OCD from accessing help. In one study, less than 40% of 
parents reported that they would take a family member, including children, to see a 
mental health professional in the event of a psychiatric diagnosis. Reasons included 
stigmatisation related to use of services, skepticism about the utility of services, and 
reluctance to acknowledge the presence of a serious problem (Eapen & Ghubash, 2004). 
As many as 80% of parents and children believe that a mental health problem will “get 
better by itself’ (Pavuluri, Luk, & McGee, 1996). OCD is a highly persistent condition, 
with 40% and 19% of children meeting criteria for clinical and subclinical OCD, 
respectively, after an average follow-up period of six years (Stewart et al., 2004). 
Parents’ beliefs about the utility of a treatment may affect treatment participation. Nock 
and colleagues (2007) measured parents’ beliefs about treatment credibility and 
expectancies for child improvement prior to participation in a programme for 
externalising disorders. Beliefs predicted adherence to treatment and contributed unique 
variance beyond demographic factors. A study conducted among a community-based 
sample of adults identified as meeting criteria for OCD, found that approximately 28% 
did not seek help for OCD because they believed that they could ‘handle it on their own’ 
(Goodwin, Koenen, Hellman, Guardino, & Struening, 2002). This attitude may prevail 
among children and adolescents. One-fifth of the adult sample reported that they did not 
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seek help because they were afraid of what others might think, 6% reported that they did 
not think the treatment ‘would work’, and 5% believed that they did not have an anxiety 
disorder. Parents and children may not trust mental health professionals, believe that 
treatment will not be successful due to previous unsuccessful experiences with services, 
or fear stigmatisation resulting from publicly disclosing symptoms (Flisher et al., 1997; 
Thompson et al., 2004). One study reported a statistically significant relationship 
between fear of stigmatisation and longer delays in obtaining treatment (Christiana et 
al., 2000). It is common for individuals with anxiety problems to experience 
embarrassment and shame regarding symptoms, and clinical experience suggests that 
this is characteristics of young people with OCD (Segee et al., 1999). Children with 
OCD frequently hide their symptoms from others, and relatives often serve as 
accomplices (Stengler-Wenzke, Trosbach, Dietrich, & Angermeyer, 2004). Jorm (2000) 
used the term ‘poor mental health literacy’ to describe a priori attitudes held by some 
individuals that mental health problems will improve with time and that psychological 
and medical treatments were ineffective.    
 
Barriers to Participation in Group CBT for Paediatric OCD 
 
Group CBT has demonstrated favorable outcomes in a number of studies. 
(Asbahr et al., 2005; Barrett et al., 2004; Fischer et al., 1998; Himle, 2003; Thienemann 
et al., 2001). Individual therapy is the gold standard for CBT delivery, however group 
therapy offers unique advantages. Group CBT is time- and cost-efficient and has many 
potential therapeutic benefits. Benefits include the normalisation of symptoms, peer 
reinforcement of compliance with treatment techniques, development of informative 
support networks, and reduction in isolation for children and families. Although it is an 
efficacious treatment, it is unknown whether attitudinal factors negatively affect 
treatment participation and the types of perceptions families hold about group therapy. 
A limited amount of research has examined child and parent perceptions of group 
therapy in general. Some reports have suggested that children may experience 
discomfort participating in group treatment. Mishna and Muskat (2004) reported the 
case of a 15-year old boy who stated that he felt nervous and “weird” about attending 
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group therapy. Children may be fearful that if they enter group therapy it means that 
they are crazy. Gunther and colleagues (1998) reported that children, and particularly 
adolescents, may worry about encountering someone that they know and the resultant 
stigmatisation. A proportion of adolescents receiving individual and group therapy for 
clinical issues reported preferring individual therapy because it allowed them to more 
openly discuss issues, however other adolescents preferred group therapy because they 
did not have to be the sole focus of attention and it was less personally intrusive (White, 
Godley, & Passetti, 2004). Some children may deny the seriousness of their difficulties. 
This perception could lead them to refuse participation in the group. Adolescents are 
often suspicious of anything recommended by their parents or other adults, which may 
comprise an additional source of resistance.  
Parents may hold attitudes that contribute to nonutilisation of services. Despite 
receiving a diagnosis of a mental health difficulty in their child, many parents deny or 
minimise the severity of a problem (Pavuluri et al., 1996). Parents may think that the 
problem will attenuate over time, or attribute the difficulties to pubertal changes. It is 
commonly believed that group therapy is a “watered-down” version of individual 
therapy, and hence, less effective (Pollock & Kymissis, 2001). Parents may have 
catastrophic cognitions that their child will be placed in a group with children with 
severe mental health problems, and that this may trigger similar difficulties in their own 
child.  
No studies have examined barriers to group CBT treatment among children with 
OCD, nor investigated perceptions about group therapy. The aim of this study was to 
explore the treatment-related barriers and perceptions (positive and negative) evidenced 
by families with an OCD-affected child. This knowledge could inform the viability of 
disseminating group CBT to community settings. Knowledge of barriers to and 
perceptions of group CBT for childhood OCD can contribute to the development of 
strategies to enhance service utilisation.   
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Method 
 
Participants 
 
Families that met study criteria but declined participation in a RCT of group 
CBT for paediatric OCD were identified from a screening database (see Figure 4). Ten 
parents and one child consented to participate in the study. To enhance validity, only 
parent data was included as views held by the child were unlikely to be generalisable. 
The low participation rate of children was due to lack of parental permission (e.g., due 
to the young age of child, parental anxiety about causing the child undue stress) or child 
refusal.  
 
 
Lost to contact
N = 4 
Eligible families 
identified from RCT
N = 15 
Agreed to 
participate 
N = 9 
Did not agree 
to participate 
N = 2  
 
Figure 5. Flowchart diagram of recruitment from families that met study criteria, but 
declined participation in a RCT of group CBT for paediatric OCD.  
 
 
Descriptive information for participants is provided in Table 14. The average 
length of time between programme contact and participation in this study was 1 year and 
4 months (SD = 3 months; range = 10 months to 1 year and 8 months). The mean age of 
children was 14.95 (SD = 2.67). The mean age of onset of OCD symptomatology was 
10.64 (SD = 3.41).  
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Table 14  
Descriptive Characteristics of Study 3 Sample  
 
Participant Parent Child 
sex 
Child 
age 
(yrs) 
Age at 
onset 
(yrs) 
Symptoms 
1 father male 12.92 - contamination, arranging 
2 mother male 16.75 7 Contamination 
3 mother male 16.67 14.5 Contamination 
4 mother female 14.08 11 checking, arranging, repeating 
5 mother male 14.42 14 arranging, symmetry 
6 mother male 15.50 12.5 contamination, aggressive 
7 mother male 13.67 10 Contamination 
8 mother female 8.67 5.5 contamination, repeating, touching 
9 mother male 8.83 - Arranging 
 
 
Procedure  
 
This research was approved by the Curtin University Human Research Ethics 
Committee. Parents of families identified as eligible for participation were phoned and 
asked if they would participate in a study about factors influencing the decision not to 
participate in group therapy for childhood OCD. Participants gave informed consent to 
participate (participant information sheets and consent forms are contained in Appendix 
E). Families agreeing to participate were visited and interviewed using a semi-structured 
format. The interview schedule examined the reasons families did not participate in 
treatment (e.g., “Could you tell me about some of the reasons for not participating?”, 
“Who decided that your child would not join the therapy group?”). Issues explored 
included parent’s expectations of treatment, thoughts and feelings about having one’s 
child participate (e.g., “What were your thoughts about having your child start the 
therapy?”, “What would be some of the most negative things about your child starting 
group therapy?”, “What would be some of the most positive things about your child 
joining the group?), and perceptions of the relative advantages and disadvantages 
compared to individual therapy (e.g., ‘Are there any benefits of group therapy compared 
to individual therapy?”). It was deemed important to elucidate perceptions of group 
therapy in relation to individual therapy, as the latter comprises the gold standard for 
CBT delivery. A full copy of the interview schedule is contained in Appendix F. 
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Duration of interviews was approximately 30 to 60 minutes. Interviews were audiotaped 
and transcribed. 
 
Data Analysis 
 
The methodological framework adopted was a qualitative, phenomenological 
approach known as thematic analysis. Qualitative methodology is appropriate when the 
subject of research is previously unexplored. Qualitative research designs are inductive, 
allowing for the development of theory, and for description and exploration of meaning. 
Quantitative designs are deductive, and are generally used to test theories or to establish 
relationship or causation. As there is minimal research on family barriers implicated in 
the treatment of paediatric OCD, qualitative methodology is the most appropriate 
research strategy.  
A phenomenological approach is suited to addressing the study’s aim. 
Phenomenological analysis seeks to capture as closely as possible how a phenomenon is 
experienced within the context in which the experience takes place (Giorgi & Giorgi, 
2003). Thematic analysis is a type of phenomenological analysis that focuses on 
identifying recurrent themes within a data set. It is highly inductive, as themes emerge 
from the data and are always located within the context of the data. The thematic 
analysis procedure specified by Smith and Osborn (2003) was employed. Analysis 
begins with a single transcript, which is analysed to identify emergent themes. An initial 
list of themes is generated and inspected to determine connections between themes, then 
themes are clustered together. As the clustering of themes occurs, it is checked against 
the transcript to verify that the connections are representative of the primary source 
material. These procedures are iterative and involve a close association between reader 
and text. Once analysis of the first transcript is complete, analysis extends to other cases. 
Data are scanned and analysed for documented themes and new themes. Once all 
transcripts have been analysed, a list of superordinate themes (and supporting quotations 
from primary source material) is constructed. 
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Results 
 
Barriers to Accessing Treatment 
 
Practical and attitudinal barriers precluded access to treatment. Attitudinal 
barriers more frequently impeded access than practical barriers. Approximately 67% of 
parents reported the presence of an attitudinal barrier, 56% reported a practical barrier, 
and 22% reported both types of barriers. The types of barriers reported are summarised 
in Table 15. The most common practical barrier was a lack of time, and the most 
common attitudinal barriers were the child’s belief that therapy would not work and 
embarrassment associated with symptoms. In one case, a child’s OCD symptoms and 
anxiety levels were so severe that he was house-bound. One parent reported that the 
structure of the group was a barrier, referring to the finite time-frame, lack of 
opportunity for follow-up by the therapists, and the interaction of therapy course with 
her child’s separation anxiety symptoms.  
 
Table 15 
Types of Practical and Attitudinal/Psychological Barriers Precluding Access to Therapy 
 
Barriers N 
Practical  
  Lack of time/scheduling difficulties 4 (44%)
  Distance 1 (11%)
  OCD was too severe  1 (11%)
  Financial (cost of travel) 1 (11%)
  Child physical health 1 (11%)
Attitudinal   
  Embarrassment associated with symptoms 3 (33%)
  Child did not think the therapy was going to work 3 (33%)
  Fear of social aspect of group 2 (22%)
  Lack of previous success with psychology 2 (22%)
  Lack of trust in strangers 2 (22%)
  Parent concern about structure of the group 1 (11%)
  Child and family ‘not ready for it’ 1 (11%)
  Child did not view difficulties as a serious problem 1 (11%)
Note. Percentages do not equal 100 as parents were not limited in the number of barriers they identified.  
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Six parents reported that it was the child’s decision not to participate in therapy, 
one parent reported that the decision was made by parents, and two parents reported that 
it was a joint decision. To exclude the possibility that parents did not participate in 
therapy because the therapy was part of a research project, attitudes on this topic were 
elucidated. All parents reported being supportive of the research project, and no parent 
identified the issue of participating in a research study as a barrier.  
 
Negative Perceptions of Group Therapy for Paediatric OCD 
 
Parents identified several possible disadvantages of group therapy. These were 
categorised into four themes; (1) greater child discomfort compared to individual 
therapy; (2) reduced effectiveness compared to individual therapy; (3) problems related 
to the structure of group therapy; and (4) greater likelihood of risk to the child compared 
to individual therapy. 
 
Greater Child Discomfort in Group Therapy Compared to Individual Therapy 
Parents identified the group context as providing a higher level of discomfort for 
their child, in terms of heightened social anxiety, fear, and embarrassment. Some parents 
appeared resistant to group therapy because of the guilt associated with the perception of 
potentially causing their child anxiety that could have been avoided. Individual therapy 
was viewed as less-anxiety provoking and more agreeable to the child.  
 
Reduced Effectiveness of Group Therapy Compared to Individual Therapy 
Parents voiced concerns that group therapy would be less effective than 
individual therapy, and proposed reasons to account for this. A recurring theme was the 
possible heterogeneity in symptom profiles among children, due to the diverse 
presentation of OCD. Many parents felt that the techniques delivered would be too 
generic for their child, and would not specifically address their child’s symptoms. Some 
parents thought that group therapy may alienate some group members, whose symptoms 
were not adequately represented in the group: 
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“I think you probably learn a lot more strategies [in individual 
therapy], because it’s actually, with OCD, as you know, there is 
many, many things that these children have and for someone like my 
son his would be totally different to another person's so at least 
they’d deal with his particular issues” (Participant 3) 
“I mean like, some of the strategies would be perhaps applicable to 
the whole group, they’d be more generic in the group, whereas if 
you’re dealing with just one person he would then tailor them 
perhaps just for you, and maybe perhaps target the problem better. 
Whereas, in a group they’d be more generic” (Participant 5) 
 
 
Parents thought that the heterogeneity of symptoms would lead to the application 
of more generic techniques, which would reduce the helpfulness of the intervention. 
Many parents thought that therapy was simply the product of children sharing 
management strategies with one another or the catharsis associated with emotional 
disclosure. They expressed concern that their child would receive fewer techniques 
compared to individual therapy:   
 
“[In individual therapy] You might get more professional feedback, 
you know, like from someone who’s a doctor, you actually get some 
feedback, whereas in a group I don’t know how the feedback 
situation operates, whether it was just from the group experience or 
whether there is someone going to be overseeing the group and 
actually saying, “You can do this yourself”, you know, that it would 
be more individual” (Participant 5) 
 
 
Parents thought that group therapy may be less effective because the degree of 
openness is constrained. Parents believed that it would be harder to speak about 
difficulties in the group situation, due to the personal nature of some difficulties and the 
greater risk of embarrassment. One parent spoke about her daughter’s participation in 
individual therapy: 
 
“Because for her, it was a big secret, and she didn’t want anyone to 
know. And being able to talk to someone outside of the family that 
kind of knew what she was going through, made her realise, “Oh, I 
can talk about it to other people”. And so she was then more 
comfortable talking to like, my husband and the family as well. 
Yeah, it allowed her to open up and I think that if she was put into a 
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group situation first of all she wouldn’t have opened up” (Participant 
8) 
 
“There's lots of things that I mean, I still don't know all of them, but 
I know there's lots that he's got that he still manages to hide, but I 
think he talks to them, the psychiatrist, and he may not talk in the 
group situation about some of the things, because they're probably a 
bit more personal “ (Participant 3) 
 
“I would think that it [group therapy] doesn’t quite get to the nitty-
gritty as much as individual therapy can” (Participant 5) 
 
 
Individual therapy was seen as a superior method of facilitating disclosure, because trust 
was being invested in a single person and there was minimal risk that information would 
be distributed to external, ‘unsafe’ parties. It was also suggested that it may be easier for 
a child to ask questions in individual therapy.  
There was a view that children would not participate actively in the group due to 
excessive social anxiety. Parents thought that the group may not be as beneficial as 
individual therapy because the child could not form as close a relationship with the 
therapist, and they perceived it as less time-efficient. They demonstrated concern that 
because the child was not the sole focus of attention, the child could take on an observer 
role in therapy rather than an active agent of change. Receiving the sole attention of the 
therapist was seen as an important strength of individual therapy. Symptoms could be 
treated faster, the child’s problem could be targeted with greater specificity, and there 
was greater opportunity to learn more management strategies. Individual therapy was 
also seen as a superior means of becoming familiar with the child’s character and 
problems.  
 
Group Therapy Has More Risk Involved - It Could Make My Child Worse 
A salient theme was that group therapy was more unpredictable, had more risks 
involved and could worsen problems for the child. One parent remarked, “I think the 
risks are spread out more in a group situation” (Participant 5). There was a concern that 
children may adopt more OCD symptoms by being exposed to a greater range of 
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symptoms and subtypes of OCD. While discussing their anxieties about having their 
child start group therapy, parents commented: 
 
“Just perhaps really coming away with having more worries in his 
head, listening to some of the other problems” (Participant 6) 
 
“[Will group therapy] make the OCD worse for him, or will it make 
him worry more because some of them are going to have different 
problems to what he had. Some of them are going to have order 
problems or, and his particular problem was germs, and I suppose I 
was a little bit concerned that maybe he’d hear about the order 
problems and that might become another issue for him” (Participant 
3) 
 
 
There was a view that group therapy was more likely to burden the child with an “OCD 
identity”, by making the problem more concrete and real, thereby, negatively impacting 
the child’s self-concept.  
 
“I didn’t want him to sort of start befriending other kids with the 
same thing, particularly. I’d rather he, you know, I didn’t want him 
labeled” (Participant 3) 
 
“But I think she would maybe see herself as being different. 
Because at the moment, she knows that it’s different to other kids, 
but she doesn’t see herself as different” (Participant 8) 
 
 
In group therapy it was thought that children may be confronted more often with “OCD 
the label”. There was the idea that in individual therapy, the ‘label’ would reside more in 
the background and not foreground: 
 
“If you sort of walk in and say well, you know, you have got 
obsessive compulsive and this is how we going to deal with it and 
you say it every time they're going to start to believe it, you know. 
Once he was told he was dumb and now he thinks he's dumb, and I 
have spent my whole life trying to convince him he's not dumb…. 
One-on-one, with OCD, I suppose, you would slowly bring it round 
to working all the tools in and making him realise that you know, 
that's how he is” (Participant 9) 
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Individual therapy was seen as a gentler means of addressing the negative link that can 
form between OCD and identity, thereby minimising any deleterious impact on the 
child’s self-esteem.  
Parents perceived a child could be negatively impacted if the child had the most 
severe case of OCD in the group: 
  
“That possibly his case was an extreme case. That he would feel, 
that he would see it along a continuum where perhaps he was at one 
end of it. And although I didn’t perhaps think so, that was perhaps a 
risk that he took that he would think, “I’m really bad here, I’m 
worse than anybody”, and maybe that would have some impact on 
his self esteem” (Participant 5) 
 
 
There was a perceived risk that interaction with other children with OCD could 
result in more problems than gains. Not only could it result in greater labeling, 
but there may be negative corollaries from peer interaction. Children may 
befriend children from family backgrounds or family circumstances that parents 
did not wish their child to be exposed to.  
 
The Group Structure is Problematic  
The finite course of group therapy was viewed as a limitation of group 
therapy. There was concern that a child may need more help at the end of the 
therapy course, but that it would not be available. Greater possibility of 
extension of therapy or scheduling of follow-up sessions was perceived for 
individual therapy. Group therapy was perceived as problematic for children 
with comorbid separation anxiety issues. Termination of therapy may be 
difficult in terms of having to part with multiple therapists and peers, whom 
bonds had been formed with. The collection of different age groups within the 
therapy group was viewed as problematic. Groups comprised children aged 7 to 
12 years or 13 to 17 years. Parents thought that the differences in maturity, self-
expression, and emotional development may be too great within these age 
brackets. A recurring theme was the possibility of younger children being 
exposed to developmentally inappropriate information.  
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“I still see her as a young 8-year old that hasn’t reached that 
preadolescent age yet and so for a 12 year old who might be dealing 
with a lot of different issues, to be talking about that in a group with 
my 8-year old who hasn’t come to that point in her life yet, it may 
be information that she gets that I’m not happy for her to receive 
yet” (Participant 8)  
 
 
There was the view that older children may have obsessions or compulsions 
that could be shocking to younger children, and resultant parental reluctance to 
expose children to group therapy. 
 
Positive Perceptions of Group Therapy for Paediatric OCD 
 
Four themes describing advantages of group CBT were salient; (1) unique group 
therapeutic benefits; (2) enhanced peer and parental support; (3) non-OCD therapeutic 
benefits; and (4) contextual factors that may increase the agreeableness of therapy to the 
child.  
 
Group Therapy May Help My Child Deal With OCD 
Children with OCD often think that they are strange or abnormal. They may see 
themselves as being different from other children, and are often ashamed and 
embarrassed by their OCD-related thoughts and behaviours. All parents identified group 
therapy as a powerful means of normalising and destigmatising OCD. They saw it as 
reducing the psychological burden on the child, and alleviating the sense of being alone:  
 
“I hoped that he would understand, again, that he wasn’t some sort 
of freak” (Participant 3) 
 
“…meet other people that have the same and he can see other people 
that are the same as him that he is not, you know, a freak as he gets 
told by his peers and his brother” (Participant 9) 
 
 “But I just hoped that he would be with people of his own age that 
he wouldn’t feel that he was unusual, or completely unusual 
anyway, that there were a lot of other people out there having 
similar problems. That it wasn’t something he had to be ashamed of 
and that he could get help for” (Participant 5) 
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“To actually learn that he wasn't alone because he puts himself 
down as being weird, different, odd. So to actually meet other 
people who have the same issues and had a normal conversation that 
didn’t contain OCD as well, somebody else's hobby, for instance, 
you know, just chatting about that, would maybe take that off of him 
a bit. It is a label OCD, but he's a person as well and to learn that 
because he just felt for a long time that OCD is him. And that's it 
locked, and that there is no personality other than that” (Participant 
6) 
 
 
Another therapeutic benefit of group therapy identified by parents was the knowledge 
and strategies that children may be able to share with each other.  
 
“You also benefit from hearing other people’s experiences. 
Sometimes they’ve picked up strategies which, you know, they can 
share and you can adopt” (Participant 7) 
 
 
Parents saw children participating with each other as a means of instilling hope, and of 
improving compliance with treatment. They saw enhanced compliance as resulting from 
instilled hope, peer modeling of techniques, and normalisation of the use of management 
techniques: 
 
“Because he sees that it’s worked for them and their anxiety levels 
might have been a 10 like his are a majority of the time and yet they 
were able to do it. Okay, they're still breathing, and they're actually 
maybe smiling about it. So he is seeing that and I think he'd benefit 
from that” (Participant 6) 
 
 
One parent discussed how her child did not practice the strategies she had learnt in 
individual therapy outside the therapy room. The mother said that no one else in the 
family used the techniques, so her child was not compelled to use them: 
 
“I think it would make her do them more because it would be part of 
the norm, not just a thing that no one else in the family did” 
(Participant 4) 
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An advantage of group therapy perceived by parents was that knowledge could be 
obtained from peers, and peers may offer greater credibility than therapists. Parents 
reported that children may not have faith that health professionals can help them, 
because the professional has not personally experienced OCD. They may have “read a 
couple of books” on OCD, as one parent commented, but they are not credible 
“helpers”. Group therapy could facilitate the adoption of beneficial strategies. Group 
therapy may motivate children to utilise techniques. It was suggested that children may 
see someone with more severe symptoms, realise how the condition could escalate, and 
be more motivated to engage in treatment. Alternatively, they may see someone at a 
greater stage of recovery, which may instill hope and greater compliance: 
 
“Everybody has different issues that has OCD, and each person's 
overcome it in various ways, and learnt management skills and that kind 
of thing and they're all at different levels of recovery if you like. So for 
him to see the whole group of people at different levels, that there’s hope 
for him” (Participant 6) 
  
 
It was suggested by one parent that group therapy may offer a more time-efficient 
treatment method than individual therapy, because of the sharing of techniques.  
 
Children and Parents Can Gain Support 
A strong theme of enhanced support emerged in the context of discussions of 
group therapy. Parents perceived the group as important for their children. It could 
enable their child to meet other children with OCD, make friends, receive support 
during therapy and following therapy completion, and to have the repository of support 
from people facing similar issues. Parents could also obtain a source of support for 
themselves: 
 
“Making connections with other families and people that are in the 
same boat. Yeah, because like I’ve said, there’s no one that we can 
ring up and say, “Oh, I’m having a bad day”. So that would be a 
really good thing to come out of it” (Participant 8) 
 
Participant 6: I was hopeful he would go and actually just give it a 
try. So for me, as well, to get some support, because I was very 
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isolated at the same time, you know. I'd maybe speak to one person 
every second week, you know, or see one person every second 
week. 
Interviewer: Because you were home so much? 
Participant 6: Yes, home-based - couldn't go out the door. He 
wouldn't allow it because there could be a crash or all sorts of 
things. 
 
 
Group Therapy May Feel Less Like “Therapy” 
Some parents reported that contextual aspects of the group therapy environment 
may make therapy more agreeable to the child compared to individual therapy. 
Attention would be divided among members of the group, making it less confronting for 
the child. Children would be interacting with people their own age, and it may feel more 
like a classroom environment; “They might just think it’s more like school rather than 
going to a psychiatrist or something” (Participant 5).  
 
Group Therapy May Benefit My Child in Non-OCD Areas 
Parents reported that the group may be beneficial in reducing other difficulties 
experienced by their child or by providing the child with adaptive skills. Parents 
reported that it could help to reduce social anxiety in group situations and separation 
anxiety. It could also teach a child how to effectively work in a group.   
 
Preference for Type of Therapy 
 
Parents were asked whether they would have preferred their child to undergo 
individual or group therapy. Two parents indicated a preference for individual therapy, 
two indicated a preference for group therapy, four reported that they would have liked 
their child to undergo both types, and one parent responded “either”.  
 
Receipt of Treatment Following Contact with the Group CBT Programme 
 
Following non-participation in the group CBT programme, five children had not 
received any treatment (56%), one had received individual therapy with a psychologist 
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(11%), one had received SSRI treatment (11%), and two (22%) had received a 
combination of individual therapy with a psychologist and SSRI medication.  
 
Discussion 
 
Practical and attitudinal barriers precluded access to treatment, and attitudinal 
were more common. This finding is consistent with previous studies of parent-identified 
mental health barriers (Thompson et al., 2004). The most frequent practical barrier 
reported was a lack of time or scheduling constraints. This barrier is likely to be more 
pronounced for group CBT compared to individual therapy. Establishing a group 
requires considerable energy expenditure and negotiation of logistical difficulties on the 
part of therapists (Pollock & Kymissis, 2001). Therapists need to be available during 
out-of-school hours and external commitments of children, parents, and other siblings 
means that families may be unable to attend the allocated therapy time-slot. In 
individual therapy, there is greater flexibility in appointment scheduling and therapy can 
be tailored around family holidays or sickness. Other practical barriers discussed by 
parents included severity of OCD and child physical health. These difficulties accounted 
for non-participation in 22% of families, and may indicate the need for availability of 
home-based CBT therapy services or medication treatment. Treatment for paediatric 
OCD must be flexible, and investigation of multiple treatment modalities (e.g., 
medication, CBT) and delivery formats (e.g., individual, group, weekly, intensive, 
home-based, bibliotherapy) is necessary to increase accessibility.  
Common attitudinal barriers were child embarrassment associated with 
symptoms, children believing that therapy would not work, anxiety associated with the 
social aspects of the group, a lack of previous success with psychological treatments, 
and a lack of trust in strangers. Embarrassment regarding mental health issues is largely 
an artifact of stigmatisation and prevailing community attitudes towards mental health. 
Stigma is a leading barrier to mental health treatment-seeking. Recent research efforts 
have begun to examine the construct of stigma and the malleability of stigmatic 
attitudes. Strategies for reducing stigma include community awareness campaigns, 
school education programmes, education of targeted groups (e.g., police officers, 
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government workers, journalists), protest against stigmatic public content, and media-
watch organisations (Pinfold et al., 2003; Rüsch, Angermeyer, & Corrigan, 2005; 
Warner, 2005). More research is needed to investigate the effectiveness of stigma-
reduction programs and to understand the active mechanisms of these programs. 
Subsequent dissemination of strategies to increase acceptance of mental health 
difficulties among youth is necessary. These campaigns could also be used to increase 
‘mental health literacy’ and the perceived value of mental health services. Altering 
public attitudes toward mental illness and associated services may reduce barriers to 
care for youth.  
Perceptions of group CBT held by families that declined participation in a group 
CBT programme were investigated. Parents held many anxieties and concerns about the 
potential experience their child could have in the group. A recurrent theme was the 
discomfort children may experience in the group. Parents were worried that group 
therapy would exacerbate anxiety, discomfort, and embarrassment for their child, 
relative to individual therapy. Parents perceived group therapy as a less helpful form of 
treatment than individual therapy. They believed that the heterogeneity of symptoms 
would lead to the application of more generic techniques, which would reduce the 
helpfulness of the intervention. This is contrary to actual practice in CBT programs for 
childhood OCD, where treatment is tailored to children individually according to the 
exposure hierarchy constructed by the therapists and child. Parents thought that it may 
take longer to treat a child in group therapy compared to individual therapy, and that 
children may be less likely to participate in treatment because there was less pressure to. 
Many parents thought that effectiveness would be decreased because the child’s ability 
to be open would be constrained in the group, due to the perceived social risks. Contrary 
to parents’ beliefs, group CBT has demonstrated equivalent effectiveness to individual 
therapy, and children who receive group therapy have shown higher rates of symptom 
remission at treatment termination and three-year follow-up than children that receive 
individual therapy (Barrett, Farrell, Dadds, & Boulter, submitted). These gains have 
been achieved using identical treatment hours and duration. It is likely that children will 
be less inclined to disclose the full picture of their OCD difficulties in a group 
environment, due to the shame and embarrassment involved. This is especially 
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conceivable in an adolescent group, where there is a developmental motivation to 
project a peer-accepted identity and status. Although studies show that individual and 
group therapy have equivalent efficacy, it may be useful to examine the relationship 
between OCD subtype and symptom improvement. A young person who experiences 
sexual, harm-related, or socially unusual obsessions may experience more benefit from 
individual therapy than group therapy.  
The perception that children may not actively participate in group CBT was a 
concern held by parents. Children may choose not to engage in any treatment offered to 
them. Within a group CBT programme, each child participates in treatment via 
construction of an exposure hierarchy and in-session exposures. It is acceptable if 
children are not verbally active during group sessions, as children have different levels 
of extraversion and respond to group contexts differently. The important issues are that 
children have an understanding of treatment principles and engage in the core 
components of treatment. Introversion and social anxiety are unlikely to predict poor 
group treatment outcome, as outcome is based on completion of exposure exercises and 
utilisation of cognitive techniques. Children who lack general engagement and 
motivation in group therapy would most likely lack that engagement in individual 
therapy. The concern that group therapy would unilaterally promote non-engagement in 
treatment is unsubstantiated by clinical observation.  
   Parents perceived group therapy as being associated with more risks than 
individual therapy. There was concern that children would “pick up” other children’s 
worries, within the same OCD subtype or across different subtypes. It would be highly 
unlikely for children to adopt a new subtype of OCD as a result of interacting with OCD 
peers, although it is conceivable that two children with contamination concerns may 
provide each other with new material to ponder. Whether this is an adverse happening, 
however, is debatable. Exposure to further anxiety-provoking information in a CBT 
context may actually be beneficial, promoting habituation to a greater range of trigger 
stimuli. 
The structure of group therapy was perceived as a problem among some parents. 
The finite duration of therapy could potentially restrict a child’s treatment trajectory. 
There would not be the same opportunity for extension or follow-up as with individual 
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therapy. This is a limitation of group therapy. Although children who receive a standard 
14-week course of group therapy show equivalent improvement levels to children 
receiving individual therapy, it is not unusual for these children to evidence mild or even 
moderate symptoms at treatment completion. Many avenues are available for addressing 
this issue. Research to address gaps in knowledge of paediatric OCD and treatment (e.g., 
cognitive mechanisms of treatment, variables that moderate treatment response) could 
be used to enhance the effect size of treatment. The addition of optional periodic booster 
sessions for clients may also be beneficial, or perhaps more severe cases might benefit 
from initial individual CBT so that duration of treatment has greater flexibility. 
A strong theme that emerged was the difference in developmental maturity 
among group members. It was suggested that group therapy would be more beneficial if 
children were matched on age and gender. This may not be possible in clinical settings 
due to insufficient referrals and the need to disseminate help to treatment-seeking 
families as soon as possible. If groups comprise children or adolescents of a 
heterogeneity of ages, then therapists supervising the group should be sensitive to the 
content of the material discussed, and the parameters for discussion. If adequate 
structure is provided, it is not difficult to manage the potential manifestation of age 
differences in conversation. A behavioural management programme can be implemented 
to reward positive behaviour, such as speaking politely and being “on-task”. This is 
useful for promoting compliance with session tasks. The risk of younger children being 
exposed to developmentally inappropriate information can be minimised to approximate 
the risk in everyday life. This is a parental concern that can be addressed, so need not be 
viewed by parents as an influential factor in the decision to participate in treatment. 
Interestingly, this concern by parents may be suggestive of the presence of an over-
protective parenting style, which has been hypothesised to be implicated in child OCD 
development (Turgeon, O'Connor, Marchand, & Freeston, 2002).  
 Parents identified positive factors unique to group CBT. They suggested that it 
can be an important means of normalising and destigmatising OCD in children. It could 
enhance the support network of children and families. Children may experience 
enhanced hope for improvement, by seeing other children improve in therapy, children 
with similar difficulties functioning well externally, and children successfully applying 
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ERP strategies, despite the anxiety-provoking nature of the strategies. Participating in 
treatment with other children was seen as a means of enhancing compliance with 
treatment through the establishment of norms for the use of management techniques. 
Parents reported no differences in preference for individual or group therapy, suggesting 
that group CBT is a potentially viable treatment for dissemination in community mental 
health settings. The reluctance of some families to participate in group CBT may not 
represent a specific bias against this type of therapy, but may be indicative of broader 
barriers to treatment participation in this population.  
 
Study Limitations and Future Research  
 
Future research could improve this study by recruiting a larger sample size and 
sufficient numbers of child and adolescent helpseekers. The small sample size in this 
study means that it is unlikely that saturation of themes took place. Further barriers to 
treatment and attitudes about group therapy are likely to exist. The sample 
underrepresented parents of children relative to parents of adolescents. Future research 
could examine whether attitudes are homogenous across these age groups. Lack of 
resources meant that interrater agreement of themes could not be ascertained, and 
caution is warranted when interpreting the findings of this study. Further research is 
needed to assess the validity and generalisability of the observed themes. The 
assessment of OCD was performed using a screening instrument, rather than a 
structured diagnostic interview. To enhance the validity of the screening procedure the 
telephone interview was DSM-IV-structured. Further investigations should include a 
standardised diagnostic procedure to replicate these findings. The interview required 
parents to recall perceptions in retrospect, between three months and nearly two years 
after initial contact with the treatment study. This would have biased the reliability and 
validity of the study findings downwards (Schwarz & Sudman, 1993). It may be 
important to investigate whether there is a relationship between symptomatology (e.g., 
sexual obsessions, bizarre compulsions) and reluctance to obtain help. This would assist 
in the development of strategies used to target the at-risk groups. Lastly, it was noted 
that parents and youth were reluctant for youth to participate in interviews, hence only 
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parent-identified barriers and perceptions were obtained. Generalisations about child-
identified barriers and perceptions cannot be made from this research. Future studies 
should aim to incorporate youths’ views. A less invasive method that would likely 
facilitate data obtainment from children and adolescents might be to devise open or 
closed-response questionnaires for children to complete.   
 
Clinical Implications 
 
Some barriers that preclude treatment participation are difficult to negotiate, and 
can indicate that alternative treatment modes are preferable. For example, medication or 
home-based therapy may be preferable when OCD is extremely severe or regular 
attendance at therapy is compromised. These findings highlight the importance of 
flexibility in mental health treatment options.  
When attitudinal barriers are present in presenting families, they must be 
explored and addressed. Attitudinal barriers are best addressed at the point of contact 
with a service. When parents are seeking information about group therapy, it is 
important to elucidate concerns held by parents or children. These concerns may be the 
difference between accepting or declining treatment. Concerns parents hold may not be 
supported by fact, so it is important to provide corrective information. Parents’ 
perceptions about group CBT can be addressed prior to treatment participation. The 
view that group therapy might not be effective or that children may acquire other 
children’s symptoms can be corrected. Parents concern about their child’s discomfort in 
therapy can be attenuated by informing them that it is normal for children to be anxious 
about attending the group. The anxiety can be likened to the anxiety children feel when 
they start a new year at school and are adjusting to a new teacher and peer formation. 
Although more discomfort and embarrassment may be felt in a group CBT situation, the 
anxiety is not harmful to children, dissipates over time, and the benefits of the group far 
outweigh the negatives. Children frequently come to enjoy the group environment for 
the peer interaction and light-hearted moments that group members provide for one 
another. Parent and child myths about group therapy can be dispelled and potential 
positive aspects could be emphasised. Positive parent attitudes towards a treatment 
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approach can significantly enhance child treatment participation and retention (Ewalt, 
Cohen, & Harmatz, 1972; Pekarik & Stephenson, 1988; Singh, Janes, & Schechtman, 
1982; Viale-Val, Rosenthal, Curtiss, & Marohn, 1984). Preparation for treatment 
positively affects parental cognitions. Day and Reznikoff (1980) used a videotape 
preparation procedure to educate parents and children attending a child psychiatric 
clinic. The videotape increased correct expectations for treatment, which was related to 
fewer appointment cancellations and retention in treatment. Interventions used to 
promote treatment participation or engagement have included an orientation letter, 
family orientation meeting, telephone contact, brochure, and preparation video (Holmes 
& Urie, 1975; Kourany et al., 1990; Lown & Britton, 1991; McKay, McCadam, & 
Gonzales, 1996; Shuman & Shapiro, 2002; Wenning & King, 1995) 
According to parents’ reports, it was primarily the children who decided not to 
participate in treatment. It is important to elucidate children’s concerns from parents, 
and to provide corrective information that parents can communicate to children. In 
circumstances where children are ambivalent about attending therapy, children and 
parents should be informed that it is acceptable to attend one or two sessions to develop 
a sense of the experience, and that withdrawing is acceptable. This may provide children 
that catastrophise the group CBT experience with the opportunity to have maladaptive 
assumptions disconfirmed, and thus promote participation and retention. 
Alarmingly, 56% of the children in this study did not receive any treatment for 
OCD symptomatology following initial parental telephone interest in the group CBT 
programme. Families that decline participation in treatment are at risk of not pursuing 
further help for their child. Attitudinal and practical barriers frequently prevent children 
from accessing necessary treatment, and unmet mental health need is a major issue in 
mental health (Senate Select Committee on Mental Health, 2006; U. S. Congress Office 
of Technology Assessment, 1986, 1991). It is important to encourage help-seeking and 
to provide adequate referral advice and information if families do not choose to utilise a 
particular mode of treatment offered by a service. OCD can be a persistent and disabling 
condition when left untreated (Wewertzer et al. 2001). The study indicates that further 
research exploring barriers to alternative treatment modalities, such as medication and 
individual CBT, may also benefit from exploration.         
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Chapter Summary 
 
This is the first study to examine barriers to help-seeking for children with OCD. 
Thematic analysis methodology was used to examine parental responses to reasons for 
non-participation in a group CBT programme. Non-participation was predicted by 
attitudinal and practical barriers. The most common attitudinal barriers comprised child 
embarrassment about symptoms and child belief that the therapy would not be effective 
in alleviating symptoms. Scheduling difficulties or a lack of time comprised the most 
common practical barrier encountered by families. Perceptions of group CBT revealed 
that parents viewed it as a treatment modality that offered both benefits and 
disadvantages compared to individual therapy. Some of the disadvantages cited by 
parents are not supported by evidence – such as the suggested decreased effectiveness 
and increased risk relative to individual therapy. Knowledge of barriers and perceptions 
of treatment can inform initiatives to promote participation. Reinforcing positive 
perceptions, addressing practical barriers, and providing information that accurately 
addresses attitudinal barriers and negative perceptions is an important future step to 
encouraging treatment participation.  
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Chapter 7 
Conclusions 
 
 
 
             OCD in childhood can be a difficult and debilitating condition. The research 
reviewed in this thesis discussed the significant interference in functioning across the 
school, social, and family domains that often accompanies the disorder. It is a 
distressing and time-consuming problem, and is associated with significant adult 
morbidity if untreated.  
The programme of research described in this thesis used a mixed-methodological 
approach to explore issues pertinent to paediatric OCD treatment. Contributions were 
made to knowledge of evidence-based treatments and the barriers that impede treatment 
participation in group CBT. Key results, fundamental issues, and areas for future 
research, are highlighted in this chapter.  
 
Restatement of Results 
 
Study 1 
Meta-Analysis of Randomised, Controlled Treatment Trials for Paediatric 
Obsessive-Compulsive Disorder 
 
This research contributed to the understanding of efficacious treatments for 
paediatric OCD. It was found that of the numerous treatments available for paediatric 
OCD, only CBT and pharmacotherapy (fluvoxamine, fluoxetine, paroxetine, sertraline, 
clomipramine) have been examined using randomised, controlled methodology. RCTs 
are the gold standard of scientific evidence, because they control for all factors that 
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affect treatment response. Given appropriate statistical power and overall quality in 
methodology, these trials can illuminate the clinical efficacy of a treatment.  
Although individual studies provide important information about treatment 
effect, the reliability of findings is enhanced when consistent findings are obtained 
across treatment trials. One method to examine the magnitude and reliability of a 
treatment effect is to pool results from multiple trials in a procedure called meta-
analysis. Meta-analysis derives the “average” effect of a treatment across multiple 
studies. The results have greater generalisability than results from individual trials, 
because numerous samples with variability in patient, therapist, treatment site, and 
geographical characteristics are included. Meta-analysis standardises treatment effect, 
allowing a common metric with which to compare effectiveness among treatments.  
Including only RCTs in a meta-analysis offers several advantages. 
Methodological quality of the included studies is higher, leading to less bias in 
outcomes. Greater control has been exerted over confounding factors, so there is more 
confidence that the ‘treatment effect’ is due to the actual treatment. This reduced bias 
raises the validity of indirect comparisons made among treatments based on effect sizes. 
Effect sizes are spuriously inflated in non-controlled trials, as the variance in outcome 
attributable to non-specific treatment factors (e.g., regression to the mean, attention from 
a therapist, expectations for change) is not partialled out in the computation of effect 
size. Pooling of these effect sizes reproduces this anomaly. Limiting inclusion of studies 
to RCTs in a meta-analysis results in more accurate and valid estimations of the effect of 
a treatment on a particular outcome.  
Several key findings emerged in the meta-analytic study. Synonymous with 
practice guidelines, pharmacotherapy (clomipramine, sertraline, paroxetine, fluoxetine, 
fluvoxamine) and CBT were the only two treatments supported by empirical evidence. 
The overall effect of CBT on OCD symptoms was large (d = 1.45, 95% CI = 0.68 to 
2.22) and pharmacotherapy had a medium treatment effect (d = 0.48, 95% CI = 0.36 to 
0.61). Consistent with the POTS (2004) comparison of CBT and pharmacotherapy, CBT 
showed a higher effect size. There was some heterogeneity in the CBT meta-analysis, 
most likely related to methodological differences between studies. Some studies used 
wait-list controls whereas others used placebo controls. When subgroup analyses were 
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performed on the wait-list and placebo-controlled trials, both analyses replicated the 
earlier significant and large treatment effect, though the effect was attenuated among 
placebo-controlled trials. CBT still showed a larger effect than medication. The 
confidence interval surrounding the pooled effect was large for CBT and narrow for 
pharmacotherapy, suggested that pharmacotherapy predicts treatment outcome with 
greater precision and reliability than CBT. There appeared to be more heterogeneity in 
CBT trials and sources need to be explored in future research. Moderator variable 
reporting rates in the extant literature were described, and a recommendation for future 
RCTs to include descriptive statistics that facilitate extraction and statistical analysis of 
moderator variables was made. The findings provided important insight into the 
composition of the pharmacotherapy effect, suggesting it comprises specific and non-
specific treatment effects.  
The meta-analytic study has advanced knowledge of paediatric OCD in 
psychiatry and psychology. Findings provide a clear contribution to knowledge of 
evidence-based treatments, composition of treatment effect, and moderator variable 
identification. Current treatment practice guidelines for paediatric OCD are based on 
extrapolations from the adult OCD treatment literature. These treatment guidelines are 
currently being revised and republication is expected in the near future. The programme 
of research described in this thesis capitalises on the acute interest and demand for 
evidence-based treatments for these children. No equivalent meta-analysis has 
previously been conducted. 
 
Study 2 
A Randomised, Placebo-Controlled Trial of Cognitive-Behavioural Group 
Therapy for Paediatric Obsessive-Compulsive Disorder 
 
The meta-analysis in Study 1 demonstrated that CBT is an evidence-based 
treatment for paediatric OCD which has the capacity to deliver strong treatment results. 
Although CBT in the paediatric population is well-researched, studies have primarily 
comprised open, uncontrolled trials of the standard CBT package. This standard package 
involves weekly, one-hour, individual sessions delivered across 8 to 14 weeks. 
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Innovations in treatment delivery have been appearing in the treatment literature, with 
bibliotherapy, intensive therapy, and group treatment comprising ready examples. The 
potential benefits of these approaches have been extolled and each has the common goal 
of increasing treatment accessibility. Child clientele with OCD can be a challenging 
population to treat. Family schedules, school hours, and extracurricular commitments 
such as sports practice, restrict available time for therapy attendance. Moreover, the 
amount of clinicians adequately trained in the use of CBT for paediatric OCD is less 
than sufficient. The value of having other treatment delivery formats available besides 
the standard package is significant.  
Group treatment for adults with OCD is a successful and evidence-based 
treatment with many conferrable benefits. Benefits include savings in time for therapists 
and costs for clients, and numerous non-specific treatment factors unique to the group 
milieu. Only two controlled studies of group CBT exist in the paediatric literature. One, 
comparing group CBT to a wait-list and individual therapy, and another, that randomly 
assigned 10 subjects to group CBT or a placebo control condition. The most superior 
method for establishing treatment efficacy of a non-validated treatment is to compare 
the treatment to a credible placebo control. Although wait-list control conditions control 
for many threats to validity and non-specific factors, there are some non-specific factors 
that they do not rule out. These include expectations for treatment change, hope, and 
cognitive justification of effort exerted, as examples. These are all part of the placebo 
response which is separate to the treatment response. There was a clear deficit in the 
literature of randomised, placebo-controlled trials for group CBT. This methodology is a 
prerequisite for establishing treatment efficacy.  
Study 2 of this thesis was the largest placebo-controlled trial of group CBT for 
paediatric OCD that has been conducted to date. Twenty-two children were randomly 
assigned to group CBT and a credible group placebo control. The placebo condition was 
employed to ensure that nonspecific treatment factors, such as time, contact with a 
therapist, attention, expectations for improvement, regression to the mean, peer group 
interaction, symptom normalisation, destigmatisation, and other nonspecific and 
confounding variables, were kept constant between conditions. Any differences in 
improvement between the groups would therefore be attributable to specific treatment 
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factors. Results showed that children that received group CBT demonstrated 
significantly greater improvement in OCD severity at the end of therapy and 1-month 
follow-up compared to children that received group AMT. Group CBT demonstrated a 
large treatment effect of 1.14 at posttreatment and 1.20 at 1-month follow-up on the 
primary OCD outcome measure. Clinical significance analysis demonstrated meaningful 
clinical outcomes. Using Jacobson and Truax’s criteria, 73% of the CBT-treated sample 
were recovered or improved at posttreatment. This increased to 91% at follow-up. The 
majority of children that received AMT were classified as “unchanged” at posttreatment 
and follow-up. The results of the study support the efficacy of group CBT beyond 
placebo or non-specific treatment factors. Results showed that child psychosocial 
functioning improved with the CBT treatment, but not the placebo treatment. This study 
has made a valuable and original contribution to the paediatric OCD field. 
 
Study 3 
Group Cognitive-Behavioural Therapy for Paediatric Obsessive-Compulsive 
Disorder: Perceptions and Perceived Barriers to Treatment 
 
The third study was borne from observations made while conducting Study 2. A 
high rate of families deemed eligible at screening (approximately 39%) declined 
participation in the clinical trial. This was concerning because; (1) OCD can lead to 
significant impairment in a child’s life; (2) untreated OCD increases risk for 
psychological and social problems in adulthood; (3) parents were contacting the trial in 
order to receive help for their child. If families declined participation, why did they 
decline? And did they receive help elsewhere? And; (4) group CBT is envisaged as a 
potential means of promoting treatment accessibility due to decreased wait-list times 
and treatment of multiple individuals simultaneously. For it to perform this function in 
community clinics, it needs to be an acceptable treatment to families.  
The final study of this thesis explored families’ reasons for non-participation in 
the treatment program. Examination of the literature revealed that no previous study 
known to myself had investigated barriers to treatment among children with OCD. A 
qualitative methodological approach was adopted due to the exploratory nature of the 
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research. Families were interviewed regarding reasons for non-participation, and 
thoughts about the relative merits and disadvantages of group and individual therapy 
were elicited. Data were analysed using thematic analysis. The study addressed several 
important questions, such as: Was non-participation a result of practical barriers? Was 
non-participation due to attitudinal barriers? How is group CBT perceived? What do 
parents view as the positive aspects of group CBT? What disadvantages or concerns do 
parents hold? Would they prefer individual or group therapy for their child? Was non-
participation attributable to the treatment being part of a research trial? Following non-
participation, did these children receive help? The findings were numerous and 
informative.  
Nine parents consented to be interviewed. The mean age of parents’ children was 
15, ranging between 8 and 18 years. The interviews took place an average 16 months 
after non-participation (range = 10 to 20 months). Attitudinal barriers impeded access to 
treatment in 67% of cases. Most commonly, children thought that therapy would not 
work, or they were too embarrassed about their difficulties to attend. Practical barriers 
impeded access for 56% of families. Lack of time or scheduling difficulties was the 
most common practical barrier cited. Parents had many positive perceptions of group 
therapy. Emergent themes included its unique capacity to destigmatise symptoms and 
reduce alienation, to provide peer support for children and parents, to help children deal 
with comorbid social and separation anxiety, and increased acceptability to children as it 
may feel “less like therapy”. Parents raised concerns about the treatment, which were 
categorised into four emergent themes. They worried that group CBT could make their 
children worse, through acquiring other children’s worries and compulsions or by 
negatively influencing the child’s self-concept. They saw disadvantages in the structure 
of group therapy, in terms of being able to devote time to each child’s symptoms and the 
time-limited nature of the programme. They tended to believe that it would be less 
effective than individual therapy, as it might not adequately address children’s 
symptoms, children could possibly ‘get away’ with not participating adequately, and 
group CBT might not be able to deal adequately with the heterogeneity in symptom 
presentation. They perceived that children would experience more discomfort in the 
group in the form of anxiety, embarrassment, and fear. Parents had mixed preferences 
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when asked to nominate whether they would prefer individual or group therapy for their 
child, and no one modality was favored. A concerning finding was that 56% of these 
children had not received help for their difficulties. The remaining children had received 
individual therapy with a psychologist, an SSRI medication, or their combination.  
The findings of this exploratory study have important implications for addressing 
the barriers that lead to non-participation. Previous clinical literature has articulated that 
children with OCD may be more reluctant to seek help than children with other 
difficulties, due to heightened shame, stigma, and embarrassment. Despite the 
availability of evidence-based treatments, it may be that a significant proportion of 
children with clinical OCD do not access them.  
 
Key Issues 
 
From Evidence-Based Treatment to Evidence-Based Practice 
 
 The health and medical fields strongly advocate evidence-based practice. 
Evidence-based practice is the integration of best research evidence with clinical 
practice in order to raise outcomes for patients (APA Task Force on Evidence Based 
Practice, 2006). The discipline of psychology actively adheres to this approach, training 
clinicians in the ‘scientist-practitioner model’ and encouraging constituents to adopt a 
dual clinician-researcher role. Evidence-based treatments are a core feature within the 
domain of evidence-based practice.  
 Evidence-based treatments are developed and evaluated to inform practice, yet 
identification does not necessarily lead to automatic integration into practice. Rebate 
systems may only allow a fixed number of sessions, usually fewer than the number in 
standardised treatment trials. Clinics and practitioners may have preferred methods for 
treating problems, lack sufficient knowledge regarding treatment implementation, or 
may not adhere to the treatment program, thereby reduce the integrity of the treatment.  
When laxness in implementation is present, the specific components of a 
treatment may be “diluted”. In the context of group CBT, it is unclear what effect this 
might have on patient outcomes, except to speculate that outcome is likely to be 
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attenuated. An important line of research involves establishing the size of the treatment 
effect when the program is implemented in community settings. This would allow 
appropriate treatment benchmarking. Incorporation of measures of treatment adherence 
in studies would provide information on the relationship between treatment integrity and 
outcome. 
 Future treatment literature could enhance treatment integrity by illuminating the 
treatment process. Efficacy publications are written to present scientific evidence of 
treatment efficacy or non-efficacy. They rarely provide sufficient information to 
elucidate the process and programme of treatment. Deficient information about a 
treatment is problematic if a high level of technical skill and clinician confidence is 
required to disseminate treatment, and when the modality of the treatment is more 
challenging than competing modalities. Clinicians are often hesitant to run group 
therapy, and perhaps even more reluctant to run a group with young children or 
adolescents (Leader, 1991). Reluctance to implement a therapy can arise from an 
informed decision based on a clinician’s self-perceived knowledge of and skill in a 
treatment (Markus & Abernethy, 2001). Process and content literature may remedy 
these deficiencies. To date, there is no published treatment manual available for group 
CBT, and only one individual CBT treatment manual, despite present evidence that 
these are efficacious and specific treatments. This is likely to impede the integration of 
evidence-based treatments into clinical practice. More media to illuminate the process of 
treatment, such as reports with clinical vignettes, treatment manuals, treatment 
workshops, and guides that troubleshoot challenging group therapy scenarios, is 
recommended. Greater accessibility to this information could increase uptake of the 
treatment in community clinical settings, to confer benefit to the intended population. 
The above recommendations are consistent with the evidence-based practice model.  
 
Treatment Accessibility 
 
Developments in psychiatry and clinical psychology, and increased societal 
demands for accountability, have raised emphasis on identifying specific treatments for 
specific disorders. This is primarily achieved through efficacy studies, which determine 
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whether a treatment has a specific effect upon a particular outcome. This thesis has 
provided evidence that group CBT is more effective than placebo in treating paediatric 
OCD. The ultimate reason for evidence-based treatment research is to inform the quality 
and outcomes of evidence-based practice. However, what if an efficacious treatment has 
been identified, is integrated in clinical settings, but the targeted population fails to 
access it or clinicians do not implement it? The inherent value of a treatment is in its 
real-world success.   
 The group therapy model for paediatric OCD is associated with organizational 
challenges that may impede clinicians’ use of this model. A large population base is 
required to assemble groups in a timely manner, prevent waitlist attrition, and arrange 
developmentally homogenous groups. Group leaders may need to exert considerable 
effort organizing and assembling groups, which may not be possible in a busy practice. 
The high rate of non-participation despite willingness of some families to consider the 
treatment modality and undertake screening may ultimately lead to time inefficiency and 
administrative penalities. Some practitioners may decide that the closed-ended model of 
treatment does not suit their clinical practice. These are important and significant 
barriers to implementation that would need to be considered prior to application of the 
treatment in community clinical settings.  
Lack of uptake of a treatment by the intended population is an important 
treatment accessibility issue. Many children in the community with diagnosable clinical 
problems do not receive help (U.S. Congress Office of Technology Assessment, 1986, 
1991). Families are likely to encounter more problems accessing services due to 
scheduling conflicts, financial impediments, competing activities, and child care 
arrangements. Clinical reports suggest that children with OCD may be more vulnerable 
to failing to access care due to the stigma, secrecy, shame, and embarrassment that 
accompanies OCD. Despite many parents initiating contact about the group therapy 
program and meeting preliminary eligibility criteria, a significant proportion declined 
participation. When followed up an average year or so later many of these children had 
not received professional help. 
 It is necessary to explore the reasons for non-service utilisation and to generate 
strategies that counter this phenomenon. No research currently exists on the barriers that 
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inhibit utilisation of pharmacological treatment for OCD, or parents’ decision-making 
processes when seeking help for their children. An understanding of treatment barriers is 
essential to promoting accessibility to treatment. Identification of evidence-based 
treatments must be supplemented by dissemination to service settings and strategies to 
improve treatment accessibility, in order to confer benefit to as many children as 
possible.  
 
Recommendations for Future Research  
 
Placebo-Controlled CBT Trials 
 
More placebo-controlled trials of CBT are required to determine the composition 
of the CBT treatment effect. Non-specific factors such as expectations for change and 
placebo effects are not controlled for in wait-list controlled trials, which can inflate the 
apparent effectiveness of a treatment. For discourse to claim that a treatment truly has a 
specific treatment effect, evidence via placebo-controlled trials is required.  
 
Effectiveness Trials 
 
 This research provided evidence of a specific treatment effect of group CBT for 
paediatric OCD. Group CBT appears to be more effective than placebo. This finding is 
consistent with previous trials of group CBT among children and research with adults. 
Applicability of this treatment to more heterogeneous samples is required to evaluate the 
generalisability of this finding. As the group CBT trial was an efficacy study, exclusion 
criteria were employed. It is unclear whether the results would generalise to individuals 
outside those included in the study. Most individual CBT trials have likewise included 
strict inclusion criteria. Effectiveness trials of these treatment modalities are required.  
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Longer Follow-Ups 
 
Follow-ups in the paediatric OCD treatment literature are scarce. Although they 
can be challenging to conduct, they are essential in order to examine the durability of 
treatment effects. Longer follow-ups are required for pharmacotherapy and CBT studies.  
 
Moderator Variables 
 
Two controlled group CBT studies, and one pilot controlled study, have 
supported the efficacy of group CBT. Future research should explore the factors that 
positively and negatively affect treatment response. For instance, it has been suggested 
that children with obsessions only, without overt compulsions, or who have particularly 
bizarre or sexually referent symptoms, may not benefit as much from group therapy 
compared to other children with OCD. Comorbidity, such as ADHD or oppositional 
defiant disorder, could conceivably affect treatment outcome by impairing information 
processing and treatment compliance. Depression may affect concentration and 
motivation, and social anxiety may impair the ability to discuss symptoms, process 
information, and seek advice from therapists and peers. Patient characteristics, such as 
duration of symptomatology and age could affect treatment outcome in CBT. Factors 
that moderate treatment response need to be more clearly understood.  
 
Treatment Barriers 
 
Barriers to treatment can significantly impede access to treatment. Some of the 
barriers to group CBT use identified in Study 3 were attitudinal, and represent views 
which may be modifiable. For example, parents and children had doubts about the 
efficacy of group CBT, with some parents believing that it may even make their child 
worse. Group CBT is an effective treatment modality, as demonstrated in Study 2, and 
there is evidence to indicate that treatment effects are durable up to three years (Barrett 
et al., 2005). It is unclear what barriers affect participation in pharmacotherapy 
treatment, and what strategies are effective in ameliorating barriers for families. More 
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research investigating treatment barriers in paediatric OCD treatment is required and 
strategies that seek to ameliorate barriers require evaluation and dissemination.  
 
Combination Studies 
 
There are two-evidence based treatments for paediatric OCD – CBT and 
pharmacotherapy. Each modality postulates a different theoretical model of maintenance 
and mechanism of change. CBT using ERP assumes that improvement results from 
physiological habituation to anxiety-provoking stimuli, correction of unhelpful thinking 
styles, removal of negative reinforcement associated with performance of a compulsion, 
and removal of family accommodation of symptoms. The theoretical model underlying 
pharmacotherapy posits that alleviation in symptoms occurs following restoration of 
normal functioning of the serotonergic neurotransmitter system. Affecting change across 
multiple mechanisms is likely to produce greater improvement in the individual, 
(assuming that multiple mechanisms maintain pathology). The POTS trial compared 
combination treatment to control, pharmacotherapy, and CBT, and found that those that 
were administered combination therapy showed significantly more improvement in 
symptomatology compared to children in all other conditions. Approximately five other 
combination reports have been published, examining CBT with pharmacotherapy or 
multiple pharmacotherapies. More controlled studies incorporating comparisons with 
monotherapies are needed.  
 
Closing Words 
 
Let us return for a moment to Janet’s 1903 description of a child with OCD: “No 
reassuring satisfies: the patient must be forever verifying his honesty, cleanliness, sanity, 
perceptions, and what he did last”, and let me ask you, why forever? Evidence-based 
treatments proven to significantly reduce OCD symptomatology have been identified in 
clinical trials. The programme of research described in this thesis has broadened the 
scope of paediatric OCD treatment research and enhanced knowledge of the efficacy of 
these treatments. The significant contributions afforded from this research represent a 
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small piece of the overall puzzle of treating paediatric OCD. Significant gains in the 
field of psychology and psychiatry have made it possible to improve the lives of many 
children and future developments in research and clinical practice will only advance 
current efforts. As researchers, clinicians, and consumers of treatment, let us dispel with 
the entity ‘forever’, and continue our united objective to improve the lives of these 
children.   
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Appendix A 
Credibility/Expectancy Questionnaire  
THERAPY EVALUATION FORM – PARENT 
 
We would like you to indicate how much you believe, right now, that the therapy 
your child is receiving will help to reduce your child’s anxiety. Belief usually has 
two aspects to it: (1) What one thinks will happen and (2) what one feels will 
happen. Sometimes these are similar; sometimes these are different. Please answer 
the questions below. In the first set, answer in terms of what you think. In the 
second set answer in terms of what you really and truly feel. Please give honest 
answers.   
 
SET I 
 
1. At this point, how logical does the therapy offered to your child seem? 
 
1              2              3              4              5              6              7              8              9 
not at all logical       somewhat logical      very logical 
 
2. At this point, how successful do you think this treatment will be in reducing your 
child’s symptoms? 
 
1              2              3              4              5              6              7              8              9 
not at all useful          somewhat useful      very useful 
 
3. How confident would you be in recommending this treatment to a friend who 
experiences similar problems? 
 
1              2              3              4              5              6              7              8              9 
not at all confident                  somewhat confident            very confident 
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4. By the end of the therapy period, how much improvement in your child’s symptoms 
do you think will occur? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 
SET II 
 
For this set, close your eyes for a few moments, and try to identify what you really 
feel about the therapy and its likely success for your child. Then answer the 
following questions.  
 
1. At this point, how much do you really feel that therapy will help your child to reduce 
his/her symptoms? 
 
1              2              3              4              5              6              7              8              9 
not at all                      somewhat                 very much 
 
2. By the end of the therapy period, how much improvement in your child’s symptoms 
do you really feel will occur? 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
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Appendix B 
Group CBT Programme: Session-by-Session Outline 
 
Session Content 
1 • Psychoeducation 
• Introduction to OCD 
• Establishing a neurobehavioural framework 
• Externalising OCD 
• Goals of therapy 
• Introduce the tool-kit 
2 • Begin mapping OCD 
• Introduce the fear thermometer 
• Begin generating a fear thermometer hierarchy 
3 • The ‘talking back strategies’ (introduction and practice) 
• Unhelpful self-talk  
• Practicing self-talk that is on ‘your’ side 
• Talking back to OCD 
• The four-statement tool 
• More fear thermometer hierarchy work 
4 • More fear thermometer hierarchy work 
• Choose an ERP target and in-session practice (one for each child) 
5 • Update hierarchy (e.g., add rituals not on list, refine or revise SUDS 
ratings) 
• OCD and family involvement in rituals 
• Adding rituals family members do to the hierarchy 
• In-session ERP 
6 • Update hierarchy 
• In-session ERP 
• Toolkit review 
7 • Families and OCD 
• Map OCD territory with families 
• Update the hierarchy 
• Toolkit review for family  
• Review of group member progress (positives) 
• Outlining positive parental roles  
8 • Update hierarchy 
• In-session ERP 
9 • Update hierarchy 
• In-session ERP 
10 • Update hierarchy 
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• In-session ERP 
11 • Update hierarchy 
• In-session ERP 
12 • Review of toolkit 
• Relapse prevention activities 
• Presentation of certificates and celebration party 
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Group AMT Programme: Session-by-Session Outline 
 
Session Content 
1 • Introduction 
• Nature of anxiety 
• Relationship between stress and anxiety 
• Overview of anxiety management principles and techniques 
2 • Introduction to relaxation 
• Body harmony 
• Body awareness  
• One’s own space 
• Progressive muscle relaxation 
3 • Body clues 
• Recognising body clues with focus on anxious body clues 
• Brainstorm of anxiety-provoking situations 
• Progressive muscle relaxation 
• Brief deep breathing exercise 
4 • Introduction to feelings 
• Discussion about feelings, jellybean feeling game 
• Feeling worksheet activities 
5 • Feelings review 
• Dr. Calm me Down 
• Identifying pleasant events 
6 • Dicussion about breathing 
• Breathing activities (breath control game, breath flow game) 
• Deep breathing 
7 • Family activity (case study, identify ways to decrease stress and anxiety) 
• Review of tool-kit 
• Jellybean feeling game 
• Parent interview (child interviews parent about stressful/anxious situation)
• Pass-the-parcel review game (quiz questions and prizes in parcel) 
8 • Introduction to problem-solving 
• Problem-solving practice 
• Visualisation 
9 • Progressive muscle relaxation 
• Introduction to imagery and visualisation 
• Problem-solving practice 
10 • Progressive muscle relaxation 
• Introduction to imagery and visualisation 
• Problem-solving practice 
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11 • Progressive muscle relaxation 
• Goal-setting 
• Mountain of dreams game 
12 • Ways To Calm Yourself Down activity (programme review) 
• Visualisation acitivity 
• Scenario (case study, parents and child work together to problem-solve) 
• Pass-the-parcel review game 
• Presentation of certificates and celebration party 
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Appendix C 
Telephone Screening Questionnaire 
Childhood OCD Research 
INITIAL TELEPHONE SCREENING QUESTIONNAIRE 
 
Adult’s Name _____________________________  Date of Inquiry  ____________ 
Child Gender    M    F                                  Date of Contact ____________ 
Child/Adolescent’s Name ______________________________________________ 
Date of Birth _______________________________ Age _______ yrs _______ mths 
Address _____________________________________________________________ 
____________________________________________________________________ 
Phone        (Home) _____________________ (Work) ____________________ 
Best Times to Call _____________________________ Leave Message ⁯ Yes ⁯ No 
Referral Source_______________________________________________________ 
Interviewer’s Name____________________________________________________ 
Let me briefly tell you about our study. This study is about the treatment of childhood 
OCD. Our goal is to learn more about OCD and treatments for children who have 
OCD. To do this we are seeking volunteers to participate in a research program. This 
study has three phases: an assessment phase, a 12-week therapy phase, and a follow-up 
one month later. We are evaluating two different therapy programs. They are both 
unique because therapy is administered in a group format, which means that children 
meet with other children that have similar types of difficulties. Because we are 
evaluating these therapies we cannot guarantee improvement.  
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1. Please describe your child’s symptoms 
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________ 
2. How long has she/he been experiencing these symptoms? 
_____________________________________________________________________ 
3. About how much time each day is your child preoccupied with these thoughts and 
rituals? (prompt: would you say it is more or less than an hour?) 
_______________________________________________________________________ 
4. Do the symptoms cause your child a lot of distress? 
_______________________________________________________________________
_______________________________________________________________________ 
5. Do the symptoms get in the way of school? 
_______________________________________________________________________
_______________________________________________________________________ 
6. Do the symptoms get in the way of family activities? 
_______________________________________________________________________
_______________________________________________________________________ 
7. Do the symptoms interfere with friendships or peer relationships? 
_______________________________________________________________________ 
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8. How would you describe his/her mood? (depressed,  anxious)? 
_______________________________________________________________________ 
 8a. Would you say your child is depressed?       ⁯ Yes         ⁯ No 
 If yes, which is worse -       ⁯ OCD  or    ⁯ Depression 
 
9. Has your child ever received a formal diagnosis of OCD? 
       ⁯ Yes         ⁯ No 
 9a. If yes, by whom? ___________________________________ 
 9b. Is yes, how long ago? ________________________________ 
10. Has your child ever experienced other problems, besides OCD? 
       ⁯ Yes         ⁯ No 
If yes, what? 
_______________________________________________________________________
_______________________________________________________________________ 
11. Would you say that OCD is the problem that is causing the most trouble? 
   ⁯ Yes         ⁯ No 
12. Is your child currently suicidal? (Some children can feel so sad or bad that they may 
have thoughts about doing something really bad, like hurting themselves) 
   ⁯ Yes         ⁯ No 
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13. Has your child been suicidal in the past (thoughts or actions)? 
        ⁯ Yes         ⁯ No 
                             13a. If yes, how old were they then? _________________________ 
OCD TREATMENT HISTORY 
14. Is your child currently receiving, or has she/he ever received, treatment for OCD? 
 Past  ⁯ Yes         ⁯ No 
 Current  ⁯ Yes         ⁯ No 
 14a. If yes, what type of treatment was it? 
⁯ CBT 
⁯ Medication 
⁯ Supportive 
⁯ Other – Describe ___________________________________ 
   14b. If yes, how long was she/he in treatment for? ____________________ 
 14c. If yes, how often did she/he attend treatment sessions? _____________ 
 14d. If yes, who or what agency provided treatment? __________________ 
 _____________________________________________________________ 
14e. If CBT: in treatment did your child make a step plan of his/her symptoms 
and then learn to control them one by one, beginning with the easiest? 
              ⁯ Yes         ⁯ No 
 14f. If yes, was this treatment successful?            ⁯ Yes         ⁯ No 
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 14g. If not, why? _______________________________________________ 
15. Is your child currently taking, or have they ever taken, any medication for OCD?  
  ⁯ Yes         ⁯ No 
 15a. If yes, what? ______________________________________________ 
 15b. If yes, what dosage? ________________________________________ 
 15c. If yes, for how long? ________________________________________ 
 15d. If yes, have there been any undesirable side effects?    ⁯ Yes         ⁯ No 
 Describe ______________________________________________________ 
15e. Has the dosage been constant for 3 months or longer?   
  ⁯ Yes         ⁯ No 
16. Does your child have any medical problems that might make it difficult to be in a 
treatment program for OCD?    ⁯ Yes         ⁯ No 
Describe _____________________________________________________________ 
17. Has your child ever received a diagnosis of: 
 Past Current 
Schizophrenia ⁯  Yes    ⁯ No ⁯  Yes    ⁯ No 
Tourette’s disorder ⁯  Yes    ⁯ No ⁯  Yes    ⁯ No 
A substance-related disorder ⁯  Yes    ⁯ No ⁯  Yes    ⁯ No 
An intellectual disability ⁯  Yes    ⁯ No ⁯  Yes    ⁯ No 
An autistic spectrum disorder such as autism or 
Asperger’s syndrome? 
⁯  Yes    ⁯ No ⁯  Yes    ⁯ No 
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18. Do you have any concerns regarding participation in this study? 
_______________________________________________________________________
_______________________________________________________________________ 
 246
Appendixes 
 
 
STUDY CRITERIA 
Inclusion 
• Between 7 and 17 years YES NO 
• Primary DSM-IV diagnosis of OCD YES NO 
• No medication OR medication stabilisation for 3 months  YES NO 
• Willing to undergo psychological treatmSent YES NO 
• At least one parent able to attend weekly sessions YES NO 
 
Exclusion 
• Concurrent therapy for OCD (non-stabilised medication 
or psychotherapy) 
YES NO 
• Current suicide risk YES NO 
• DSM-IV diagnosis of:       
Schizophrenia YES NO 
Tourette’s disorder YES NO 
Substance-related disorders YES NO 
Intellectual disability YES NO 
Delirium, dementia, and amnestic and other cognitive 
disorders 
YES NO 
 
Ineligible     – if circled ‘no’ to any inclusion criteria items 
Ineligible    - if circled ‘yes’ to any exclusion criteria items (may be wait-
listed if medication non-stabilised) 
  
Outcome of Screening 
 
⁯ Appears eligible for the study and will be contacted for assessment. 
⁯ Eligibility questionable. Consult with clinician/supervisor and call back.  
⁯ Not eligible due to _____________________________________________ 
⁯ Not interested in study because ___________________________________ 
⁯ Repeated attempts to contact without success 
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Appendix D 
Parent Information Sheet: Study 2 
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Adolescent Information Sheet: Study 2 
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Child Information Sheet: Study 2 
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Parent Consent Form: Study 2 
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Adolescent Consent Form: Study 2 
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Appendix E 
Parent Information Sheet: Study 3 
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Adolescent Information Sheet: Study 3 
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 Child Information Sheet: Study 3 
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Parent Consent Form: Study 3 
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Adolescent Consent Form: Study 3 
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Appendix F 
Interview Schedule for Study 3 
 
Can you tell me what you heard about the therapy program being offered at Curtin? 
 
What were your thoughts about starting the therapy? 
- Probe: Was there anything you were anxious/worried about? 
- Probe: What did you picture that it would be like? 
- Probe: Good things/bad things 
 
The group was part of a research project. What were your thoughts about participating 
in research? 
 
What did you expect the group would be like? 
 
How did you feel about having your child starting the therapy program? 
 
Did you want your child to go in the therapy group when you were told about it? 
- Probe: What led to you deciding that? 
- Probe: What were some of the reasons you did/didn’t want your son/daughter to 
participate 
 
Could you tell me about some of the reasons for not participating? 
 
Who decided that your child would not join the therapy group? 
- Probe: You? Your child? Other parent? 
 
What would be some of the most positive things about your child joining the group? 
 
What would some of the most negative things? 
- Probe: How did these things affect your decision? 
 
What would you have preferred for your child– individual (one-on-one) therapy or 
group therapy? 
 
Are there any benefits of group therapy compared to individual therapy? Elaborate… 
 
Are there any benefits of individual therapy compared to group therapy? Elaborate… 
 
What did you think about participating in a research project? Did that influence your 
decision not to participate? 
 
Did you end up seeking help for the problem? What reasons made you choose this help? 
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What OCD problems (symptoms) did your child have? 
 
Had the child received a diagnosis of OCD? 
 
What made you think that your child had OCD? 
 
Who did you take your child to see? (GP, psych etc) Did the person confirm that is what 
the problem was? What suggestions did the person give? 
 
 
 
